{
  "indicators": [
    {
      "indicatorNode": {
        "nodeId": "CARDIO:SBP_day",
        "label": "Daytime SBP (ABPM)",
        "unit": "mm[Hg]",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "007-blood_pressure"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Essential Hypertension",
              "diagnosticCriteria": "Without antihypertensive medication, three measurements on different days with SBP≥140mmHg and/or DBP≥90mmHg; or 24h ambulatory BP monitoring with daytime mean SBP≥135mmHg.",
              "recommendedDrugs": [
                {
                  "drugName": "Hydrochlorothiazide",
                  "drugClass": "Thiazide Diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (15 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -15,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.15,
                      "standardDeviation": 0.08,
                      "unit": "a.u."
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -20,
                      "standardDeviation": 10,
                      "unit": "pg/mL"
                    }
                  ]
                },
                {
                  "drugName": "Valsartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "80mg",
                    "maintenanceDose": "160mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-6 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (20 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -20,
                      "standardDeviation": 8,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                },
                {
                  "drugName": "Amlodipine",
                  "drugClass": "Calcium Channel Blocker (CCB)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue - (18 * (1 - exp(-0.5*t)))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -18,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.5,
                      "standardDeviation": 1.0,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Renal Hypertension",
              "diagnosticCriteria": "Secondary hypertension due to renal parenchymal or renovascular stenosis disease; often accompanied by proteinuria, eGFR decline, or imaging evidence.",
              "recommendedDrugs": [
                {
                  "drugName": "Benazepril",
                  "drugClass": "Angiotensin-Converting Enzyme Inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-6 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (18 * (t / 6))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -18,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.15,
                      "standardDeviation": 0.08,
                      "unit": "mg/L"
                    },
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.3,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Endocrine Hypertension",
              "diagnosticCriteria": "Hypertension caused by endocrine disorders such as primary aldosteronism, pheochromocytoma, Cushing's syndrome.",
              "recommendedDrugs": [
                {
                  "drugName": "Spironolactone",
                  "drugClass": "Mineralocorticoid Receptor Antagonist",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "50mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (22 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -22,
                      "standardDeviation": 9,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:SBP_night",
        "label": "Nighttime SBP (ABPM)",
        "unit": "mm[Hg]",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "007-blood_pressure"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Non-dipper Hypertension",
              "diagnosticCriteria": "Nighttime BP reduction <10%, nighttime SBP≥120mmHg, indicating abnormal circadian rhythm.",
              "recommendedDrugs": [
                {
                  "drugName": "Benazepril",
                  "drugClass": "Angiotensin-Converting Enzyme Inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily (bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-6 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (16 * (t / 6))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -16,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 100,
                        "upperBound": 120
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.12,
                      "standardDeviation": 0.07,
                      "unit": "mg/L"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.2,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                },
                {
                  "drugName": "Telmisartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "40mg",
                    "maintenanceDose": "80mg",
                    "frequency": "Once daily (bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (18 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -18,
                      "standardDeviation": 7,
                      "targetValueRange": {
                        "lowerBound": 100,
                        "upperBound": 120
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.08,
                      "standardDeviation": 0.04,
                      "unit": "a.u."
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Obstructive Sleep Apnea-Related Hypertension",
              "diagnosticCriteria": "Polysomnography showing AHI≥5/hour with symptoms or AHI≥15/hour; nighttime non-dipper pattern (nighttime SBP decline <10%).",
              "recommendedDrugs": [
                {
                  "drugName": "Valsartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "80mg",
                    "maintenanceDose": "160mg",
                    "frequency": "Once daily (evening)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue - 18 * (1 - e^{-0.5 * t})",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -18,
                      "standardDeviation": 7,
                      "targetValueRange": {
                        "lowerBound": 100,
                        "upperBound": 119
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "unit": "g/d"
                    }
                  ]
                },
                {
                  "drugName": "Spironolactone",
                  "drugClass": "Mineralocorticoid Receptor Antagonist (MRA)",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (12 * (t / 4))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 100,
                        "upperBound": 119
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.15,
                      "standardDeviation": 0.1,
                      "unit": "g/d"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Renal Hypertension (Non-dipper Type)",
              "diagnosticCriteria": "CKD with elevated or non-declining nighttime BP; commonly presents with proteinuria and eGFR decline.",
              "recommendedDrugs": [
                {
                  "drugName": "Benazepril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once at bedtime",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (16 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -16,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 100,
                        "upperBound": 119
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.2,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:MAP",
        "label": "Mean arterial pressure",
        "unit": "mm[Hg]",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "007-blood_pressure"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Systemic Hypertension / Essential Hypertension",
              "diagnosticCriteria": "MAP≥100mmHg, calculated as MAP = DBP + 1/3(SBP-DBP); persistent MAP≥105mmHg indicates elevation.",
              "recommendedDrugs": [
                {
                  "drugName": "Amlodipine",
                  "drugClass": "Calcium Channel Blocker (CCB)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue - (12 * (1 - exp(-0.5*t)))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 70,
                        "upperBound": 95
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 5.0,
                      "standardDeviation": 2.5,
                      "unit": "ms"
                    }
                  ]
                },
                {
                  "drugName": "Irbesartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "300mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (14 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -14,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 70,
                        "upperBound": 95
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "unit": "mg/dL"
                    }
                  ]
                },
                {
                  "drugName": "Benazepril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (10 * (t / 4))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 80,
                        "upperBound": 95
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "unit": "g/d"
                    }
                  ]
                },
                {
                  "drugName": "Hydrochlorothiazide",
                  "drugClass": "Thiazide Diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (8 * (t / 4))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 80,
                        "upperBound": 95
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Arterial Stiffness Syndrome",
              "diagnosticCriteria": "Elevated MAP with arterial pulse wave velocity (PWV) >10 m/s, indicating increased arterial stiffness.",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril",
                  "drugClass": "Angiotensin-Converting Enzyme Inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (15 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -15,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 70,
                        "upperBound": 95
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:FMD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.6,
                      "unit": "%"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Kidney Disease with Volume Overload",
              "diagnosticCriteria": "CKD with fluid retention, edema, and persistently elevated MAP.",
              "recommendedDrugs": [
                {
                  "drugName": "Furosemide",
                  "drugClass": "Loop Diuretic",
                  "dosage": {
                    "initialDose": "20-40mg",
                    "maintenanceDose": "40-80mg",
                    "frequency": "Once or twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue - 7 * (1 - e^{-0.7 * t})",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -7,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 80,
                        "upperBound": 95
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.7,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -60,
                      "standardDeviation": 25,
                      "unit": "pg/mL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:LVMI",
        "label": "Left ventricular mass index",
        "unit": "g/m2",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "echo_or_mri"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Left Ventricular Hypertrophy / Hypertensive Heart Disease",
              "diagnosticCriteria": "LVMI >115 g/m² in males, >95 g/m² in females, measured by echocardiography or cardiac MRI; associated with long-term hypertension history.",
              "recommendedDrugs": [
                {
                  "drugName": "Enalapril",
                  "drugClass": "Angiotensin-Converting Enzyme Inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (12 * (t / 48))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 70,
                        "upperBound": 95
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -25,
                      "standardDeviation": 12,
                      "unit": "pg/mL"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.1,
                      "standardDeviation": 0.06,
                      "unit": "mg/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2.0,
                      "standardDeviation": 1.0,
                      "unit": "%"
                    }
                  ]
                },
                {
                  "drugName": "Candesartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "8mg",
                    "maintenanceDose": "32mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (15 * log((t/12) + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -15,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 70,
                        "upperBound": 95
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 3.5,
                      "standardDeviation": 1.8,
                      "unit": "%"
                    }
                  ]
                },
                {
                  "drugName": "Valsartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "80mg",
                    "maintenanceDose": "160-320mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "3-6 months",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue - 10 * (1 - e^{-0.3 * t})",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 70,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -30,
                      "standardDeviation": 15,
                      "unit": "pg/mL"
                    },
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "unit": "g/d"
                    }
                  ]
                },
                {
                  "drugName": "Metoprolol",
                  "drugClass": "Beta-Blocker",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-52 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue - (10 * (1 - exp(-0.08*t)))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 70,
                        "upperBound": 95
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8.0,
                      "standardDeviation": 3.5,
                      "unit": "ms"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.12,
                      "standardDeviation": 0.06,
                      "unit": "a.u."
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "CKD-Mineral Bone Disorder-Related Cardiac Hypertrophy",
              "diagnosticCriteria": "CKD with elevated PTH or FGF23, phosphorus disorder, and increased LVMI.",
              "recommendedDrugs": [
                {
                  "drugName": "Sevelamer",
                  "drugClass": "Non-Calcium Phosphate Binder",
                  "dosage": {
                    "initialDose": "800mg",
                    "maintenanceDose": "800-1600mg",
                    "frequency": "With each meal",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6 months",
                    "calculation": {
                      "method": "Slow linear decrease",
                      "formula": "currentValue - (4 * (t / 6))",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": -4,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 70,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Phosphate",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.5,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:PTH",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -30,
                      "standardDeviation": 15,
                      "unit": "pg/mL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:LVEF",
        "label": "Left ventricular ejection fraction",
        "unit": "%",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "echo_or_mri"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Heart Failure with Reduced Ejection Fraction (HFrEF)",
              "diagnosticCriteria": "LVEF<40%, with heart failure symptoms (dyspnea, fatigue, edema, etc.) and abnormal biomarkers (e.g., elevated BNP).",
              "recommendedDrugs": [
                {
                  "drugName": "Sacubitril-Valsartan",
                  "drugClass": "Angiotensin Receptor-Neprilysin Inhibitor (ARNI)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "200mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (8 * log((t/4) + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 8,
                      "standardDeviation": 3.5,
                      "targetValueRange": {
                        "lowerBound": 50,
                        "upperBound": 70
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -120,
                      "standardDeviation": 50,
                      "unit": "pg/mL"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.08,
                      "standardDeviation": 0.05,
                      "unit": "mg/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 7.0,
                      "standardDeviation": 3.0,
                      "unit": "%"
                    }
                  ]
                },
                {
                  "drugName": "Bisoprolol",
                  "drugClass": "Beta-Blocker",
                  "dosage": {
                    "initialDose": "1.25mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "16-24 weeks",
                    "calculation": {
                      "method": "Linear growth",
                      "formula": "currentValue + (6 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 6,
                      "standardDeviation": 2.5,
                      "targetValueRange": {
                        "lowerBound": 50,
                        "upperBound": 70
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10.0,
                      "standardDeviation": 4.0,
                      "unit": "ms"
                    }
                  ]
                },
                {
                  "drugName": "Metoprolol Succinate",
                  "drugClass": "Beta-Blocker",
                  "dosage": {
                    "initialDose": "23.75-47.5mg",
                    "maintenanceDose": "95-190mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Exponential growth",
                      "formula": "currentValue + 5 * (1 - e^{-0.4 * t})",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 5,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 50,
                        "upperBound": 70
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 8,
                      "standardDeviation": 4,
                      "unit": "ms"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -60,
                      "standardDeviation": 25,
                      "unit": "pg/mL"
                    }
                  ]
                },
                {
                  "drugName": "Spironolactone",
                  "drugClass": "Mineralocorticoid Receptor Antagonist",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Exponential growth",
                      "formula": "currentValue + (5 * (1 - exp(-0.06*t)))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 5,
                      "standardDeviation": 2.0,
                      "targetValueRange": {
                        "lowerBound": 50,
                        "upperBound": 70
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.15,
                      "standardDeviation": 0.08,
                      "unit": "mg/dL"
                    }
                  ]
                },
                {
                  "drugName": "Dapagliflozin",
                  "drugClass": "SGLT2 Inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear growth",
                      "formula": "currentValue + (2 * (t / 12))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 50,
                        "upperBound": 70
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "mL/min/1.73m2/y"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Dilated Cardiomyopathy",
              "diagnosticCriteria": "LVEF<40-45%, left ventricular end-diastolic diameter increased, excluding coronary artery disease, valvular disease, and other causes; or imaging shows LV dilation with reduced LVEF, excluding ischemic etiology.",
              "recommendedDrugs": [
                {
                  "drugName": "Enalapril",
                  "drugClass": "Angiotensin-Converting Enzyme Inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "2.5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (7 * log((t/4) + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 7,
                      "standardDeviation": 3.0,
                      "targetValueRange": {
                        "lowerBound": 50,
                        "upperBound": 70
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -80,
                      "standardDeviation": 35,
                      "unit": "pg/mL"
                    }
                  ]
                },
                {
                  "drugName": "Benazepril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "5-10mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic growth",
                      "formula": "currentValue + 3 * log(t + 1)",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": 50,
                        "upperBound": 70
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -40,
                      "standardDeviation": 15,
                      "unit": "pg/mL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:BNP",
        "label": "B-type natriuretic peptide",
        "unit": "pg/mL",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Acute Heart Failure",
              "diagnosticCriteria": "BNP>400 pg/mL or NT-proBNP>900 pg/mL, with acute dyspnea, pulmonary edema, and other symptoms.",
              "recommendedDrugs": [
                {
                  "drugName": "Furosemide",
                  "drugClass": "Loop Diuretic",
                  "dosage": {
                    "initialDose": "40mg",
                    "maintenanceDose": "40-80mg",
                    "frequency": "Once or twice daily",
                    "route": "Oral or IV"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue * exp(-0.3*t)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -250,
                      "standardDeviation": 100,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.7,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.12,
                      "standardDeviation": 0.07,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Sacubitril-Valsartan",
                  "drugClass": "Angiotensin Receptor-Neprilysin Inhibitor (ARNI)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "200mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Logarithmic decay",
                      "formula": "currentValue - (200 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -200,
                      "standardDeviation": 80,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 7.0,
                      "standardDeviation": 3.0,
                      "unit": "%"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Heart Failure",
              "diagnosticCriteria": "BNP>100 pg/mL or elevated NT-proBNP combined with clinical symptoms/signs, potentially reduced LVEF; or BNP>100 pg/mL or elevated NT-proBNP with clinical symptoms/signs.",
              "recommendedDrugs": [
                {
                  "drugName": "Carvedilol",
                  "drugClass": "Beta-Blocker",
                  "dosage": {
                    "initialDose": "3.125mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-16 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (80 * (t / 16))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -80,
                      "standardDeviation": 35,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 5.5,
                      "standardDeviation": 2.5,
                      "unit": "%"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.1,
                      "standardDeviation": 0.05,
                      "unit": "a.u."
                    }
                  ]
                },
                {
                  "drugName": "Furosemide",
                  "drugClass": "Loop Diuretic",
                  "dosage": {
                    "initialDose": "20-40mg",
                    "maintenanceDose": "40-160mg (adjusted by fluid status)",
                    "frequency": "Once or twice daily",
                    "route": "Oral or IV"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Logarithmic decrease",
                      "formula": "currentValue - 100 * log(t + 1)",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -100,
                      "standardDeviation": 40,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    }
                  ]
                },
                {
                  "drugName": "Dapagliflozin",
                  "drugClass": "SGLT2 Inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (60 * (t / 8))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -60,
                      "standardDeviation": 25,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "mL/min/1.73m2/y"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Pulmonary Arterial Hypertension",
              "diagnosticCriteria": "Elevated BNP (usually >150 pg/mL), with mean pulmonary arterial pressure≥25 mmHg (at rest) or >30 mmHg (during exercise).",
              "recommendedDrugs": [
                {
                  "drugName": "Bosentan",
                  "drugClass": "Endothelin Receptor Antagonist",
                  "dosage": {
                    "initialDose": "62.5mg",
                    "maintenanceDose": "125mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Logarithmic decay",
                      "formula": "currentValue - (100 * log((t/4) + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -100,
                      "standardDeviation": 45,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.4,
                      "unit": "g/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Renal Dysfunction with Volume Overload",
              "diagnosticCriteria": "CKD with elevated BNP and fluid retention signs.",
              "recommendedDrugs": [
                {
                  "drugName": "Benazepril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "5-10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-6 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (40 * (t / 6))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -40,
                      "standardDeviation": 15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.1,
                      "unit": "g/d"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:hsCRP",
        "label": "High-sensitivity C-reactive protein",
        "unit": "mg/L",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "High-Risk Atherosclerotic Cardiovascular Disease (ASCVD) / Atherosclerotic Inflammation Activation",
              "diagnosticCriteria": "hsCRP>2.0 mg/L, indicating increased cardiovascular disease risk with other cardiovascular risk factors; or hsCRP≥2 mg/L suggesting elevated inflammatory risk associated with atherosclerosis.",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "HMG-CoA Reductase Inhibitor (Statin)",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily (bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue * exp(-0.25*t)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.6,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 2.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.5,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:IMT_slope",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.005,
                      "standardDeviation": 0.003,
                      "unit": "mm/y"
                    },
                    {
                      "affectedNodeId": "CARDIO:CAC",
                      "expectedTrend": "Slowed progression",
                      "expectedMeanChange": -20,
                      "standardDeviation": 15,
                      "unit": "Agatston/year"
                    }
                  ]
                },
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "HMG-CoA Reductase Inhibitor (Statin)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily (bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue * exp(-0.3*t)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -1.8,
                      "standardDeviation": 0.7,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 2.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:ApoA1",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.08,
                      "standardDeviation": 0.04,
                      "unit": "g/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Metabolic Syndrome with Chronic Inflammation / Type 2 Diabetes-Related Chronic Inflammation",
              "diagnosticCriteria": "hsCRP>3.0 mg/L, with central obesity (WC≥90cm male, ≥80cm female), hypertension, dyslipidemia, hyperglycemia, etc.; or T2DM with elevated inflammatory markers (hsCRP>2 mg/L).",
              "recommendedDrugs": [
                {
                  "drugName": "Metformin",
                  "drugClass": "Biguanide Antidiabetic Drug",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "1500-2000mg",
                    "frequency": "Twice or three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-16 weeks",
                    "calculation": {
                      "method": "Logarithmic decay",
                      "formula": "currentValue - (1.2 * log((t/4) + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.5,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 2.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.12,
                      "unit": "a.u."
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.5,
                      "standardDeviation": 1.2,
                      "unit": "cm"
                    }
                  ]
                },
                {
                  "drugName": "Dapagliflozin",
                  "drugClass": "SGLT2 Inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (0.6 * (t / 12))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 2.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "mL/min/1.73m2/y"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Rheumatic Disease-Related Cardiovascular Risk",
              "diagnosticCriteria": "hsCRP persistently elevated >5.0 mg/L, with history of rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematosus.",
              "recommendedDrugs": [
                {
                  "drugName": "Tocilizumab",
                  "drugClass": "Interleukin-6 (IL-6) Receptor Antagonist",
                  "dosage": {
                    "initialDose": "4mg/kg",
                    "maintenanceDose": "8mg/kg",
                    "frequency": "Every 4 weeks",
                    "route": "Intravenous infusion"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue * exp(-0.15*t)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -3.5,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 3.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.25,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:FMD",
        "label": "Brachial flow-mediated dilation",
        "unit": "%",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "vascular_function"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Endothelial Dysfunction / Atherosclerosis-Induced Endothelial Dysfunction",
              "diagnosticCriteria": "FMD<6%, indicating impaired vascular endothelium-dependent dilation function, an early marker of atherosclerosis; or FMD reduction (e.g., <6%) suggesting impaired endothelium-dependent dilation function.",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "HMG-CoA Reductase Inhibitor (Statin)",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily (bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Logarithmic growth",
                      "formula": "currentValue + (2.5 * log((t/4) + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.0,
                      "targetValueRange": {
                        "lowerBound": 6,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.5,
                      "unit": "mg/L"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.6,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:IMT_slope",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.006,
                      "standardDeviation": 0.003,
                      "unit": "mm/y"
                    }
                  ]
                },
                {
                  "drugName": "Ramipril",
                  "drugClass": "Angiotensin-Converting Enzyme Inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "2.5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-16 weeks",
                    "calculation": {
                      "method": "Linear growth",
                      "formula": "currentValue + (2.0 * (t / 16))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2.0,
                      "standardDeviation": 0.8,
                      "targetValueRange": {
                        "lowerBound": 6,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:RHI",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.15,
                      "unit": "a.u."
                    }
                  ]
                },
                {
                  "drugName": "Benazepril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Exponential growth",
                      "formula": "currentValue + 1.5 * (1 - e^{-0.3 * t})",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.7,
                      "targetValueRange": {
                        "lowerBound": 6.0,
                        "upperBound": 12.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "unit": "g/d"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Early Atherosclerosis",
              "diagnosticCriteria": "FMD<5%, with carotid intima-media thickness (IMT)>0.9mm or atherosclerotic plaque formation.",
              "recommendedDrugs": [
                {
                  "drugName": "Ezetimibe",
                  "drugClass": "Cholesterol Absorption Inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "16-24 weeks",
                    "calculation": {
                      "method": "Exponential growth",
                      "formula": "currentValue + (1.8 * (1 - exp(-0.1*t)))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 1.8,
                      "standardDeviation": 0.7,
                      "targetValueRange": {
                        "lowerBound": 6,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:IMT_slope",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.015,
                      "standardDeviation": 0.008,
                      "unit": "mm/y"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Type 2 Diabetes-Related Endothelial Dysfunction",
              "diagnosticCriteria": "FMD commonly reduced in T2DM patients.",
              "recommendedDrugs": [
                {
                  "drugName": "Dapagliflozin",
                  "drugClass": "SGLT2 Inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear growth",
                      "formula": "currentValue + (1.0 * (t / 12))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "targetValueRange": {
                        "lowerBound": 6.0,
                        "upperBound": 12.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:RHI",
        "label": "Reactive hyperemia index",
        "unit": "a.u.",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "vascular_function"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Microvascular Endothelial Dysfunction / Smoking-Related Endothelial Dysfunction",
              "diagnosticCriteria": "RHI<1.67, indicating impaired peripheral microvascular endothelial function, associated with increased cardiovascular event risk; or RHI reduction (e.g., <1.67) with smoking history.",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril",
                  "drugClass": "Angiotensin-Converting Enzyme Inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-16 weeks",
                    "calculation": {
                      "method": "Logarithmic growth",
                      "formula": "currentValue + (0.4 * log((t/4) + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 1.67,
                        "upperBound": 3.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:FMD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.8,
                      "standardDeviation": 0.7,
                      "unit": "%"
                    }
                  ]
                },
                {
                  "drugName": "Olmesartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Linear growth",
                      "formula": "currentValue + (0.35 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0.35,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 1.67,
                        "upperBound": 3.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.0,
                      "standardDeviation": 0.9,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear growth",
                      "formula": "currentValue + (0.15 * (t / 12))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 0.15,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 1.67,
                        "upperBound": 2.5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:IMT_slope",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.005,
                      "standardDeviation": 0.003,
                      "unit": "mm/y"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Coronary Microvascular Disease",
              "diagnosticCriteria": "RHI<2.0, with typical angina symptoms but no significant stenosis on coronary angiography (<50%), suggesting coronary microcirculation disorder.",
              "recommendedDrugs": [
                {
                  "drugName": "Ranolazine",
                  "drugClass": "Selective If Channel Inhibitor",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "1000mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Exponential growth",
                      "formula": "currentValue + (0.5 * (1 - exp(-0.15*t)))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 1.67,
                        "upperBound": 3.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -15,
                      "standardDeviation": 8,
                      "unit": "pg/mL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Obstructive Sleep Apnea-Related Endothelial Dysfunction",
              "diagnosticCriteria": "RHI reduced in OSA patients, often coexisting with nighttime hypertension.",
              "recommendedDrugs": [
                {
                  "drugName": "Valsartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "80mg",
                    "maintenanceDose": "160mg",
                    "frequency": "Once daily (evening)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Exponential growth",
                      "formula": "currentValue + 0.12 * (1 - e^{-0.25 * t})",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 0.12,
                      "standardDeviation": 0.06,
                      "targetValueRange": {
                        "lowerBound": 1.67,
                        "upperBound": 2.5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.0,
                      "standardDeviation": 1.0,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:IMT_slope",
        "label": "Carotid IMT annual change",
        "unit": "mm/y",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "012-carotid_ultrasound"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Progressive Atherosclerosis",
              "diagnosticCriteria": "Carotid IMT annual growth rate >0.02 mm/y or progressive IMT thickening (IMT_slope>0 mm/y), suggesting atherosclerosis progression and increased cardiovascular event risk.",
              "recommendedDrugs": [
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "HMG-CoA Reductase Inhibitor (Statin)",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily (bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48-104 weeks",
                    "calculation": {
                      "method": "Linear deceleration",
                      "formula": "currentValue - (0.025 * (t / 104))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.025,
                      "standardDeviation": 0.012,
                      "targetValueRange": {
                        "lowerBound": -0.01,
                        "upperBound": 0.01
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:FMD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2.2,
                      "standardDeviation": 0.9,
                      "unit": "%"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.8,
                      "standardDeviation": 0.7,
                      "unit": "mmol/L"
                    }
                  ]
                },
                {
                  "drugName": "Ezetimibe-Simvastatin Combination",
                  "drugClass": "Cholesterol Absorption Inhibitor + Statin",
                  "dosage": {
                    "initialDose": "10/20mg",
                    "maintenanceDose": "10/40mg",
                    "frequency": "Once daily (bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "52-104 weeks",
                    "calculation": {
                      "method": "Logarithmic deceleration",
                      "formula": "currentValue - (0.03 * log((t/12) + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.03,
                      "standardDeviation": 0.015,
                      "targetValueRange": {
                        "lowerBound": -0.01,
                        "upperBound": 0.01
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:CAC",
                      "expectedTrend": "Slowed progression",
                      "expectedMeanChange": -8.0,
                      "standardDeviation": 4.0,
                      "unit": "Agatston"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "40mg",
                    "maintenanceDose": "40-80mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (0.010 * (t / 12))",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.01,
                      "standardDeviation": 0.004,
                      "targetValueRange": {
                        "lowerBound": -0.01,
                        "upperBound": 0.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:CAC",
                      "expectedTrend": "Slowed progression",
                      "expectedMeanChange": -30,
                      "standardDeviation": 20,
                      "unit": "Agatston/year"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hyperlipidemia-Related Vascular Disease",
              "diagnosticCriteria": "IMT annual growth rate >0.015 mm/y, with LDL-C>130 mg/dL or non-HDL-C>160 mg/dL.",
              "recommendedDrugs": [
                {
                  "drugName": "Alirocumab",
                  "drugClass": "PCSK9 Inhibitor",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "150mg",
                    "frequency": "Every 2 weeks",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48-104 weeks",
                    "calculation": {
                      "method": "Exponential deceleration",
                      "formula": "currentValue * exp(-0.15*(t/52))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.035,
                      "standardDeviation": 0.018,
                      "targetValueRange": {
                        "lowerBound": -0.01,
                        "upperBound": 0.01
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Lpa",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -15,
                      "standardDeviation": 8,
                      "unit": "mg/dL"
                    }
                  ]
                },
                {
                  "drugName": "Alirocumab",
                  "drugClass": "PCSK9 Inhibitor",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "75-150mg",
                    "frequency": "Every 2 weeks",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue - 0.015 * (1 - e^{-0.5 * (t/12)})",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.015,
                      "standardDeviation": 0.006,
                      "targetValueRange": {
                        "lowerBound": -0.015,
                        "upperBound": 0.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:CAC",
                      "expectedTrend": "Slowed progression",
                      "expectedMeanChange": -40,
                      "standardDeviation": 25,
                      "unit": "Agatston/year"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Metabolic Syndrome-Related Vascular Aging",
              "diagnosticCriteria": "IMT annual growth rate >0.018 mm/y, with metabolic syndrome (central obesity, elevated BP, abnormal glucose, dyslipidemia).",
              "recommendedDrugs": [
                {
                  "drugName": "Pioglitazone",
                  "drugClass": "Thiazolidinedione (TZD) Antidiabetic Drug",
                  "dosage": {
                    "initialDose": "15mg",
                    "maintenanceDose": "30mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "52-104 weeks",
                    "calculation": {
                      "method": "Logarithmic deceleration",
                      "formula": "currentValue - (0.022 * log((t/12) + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.022,
                      "standardDeviation": 0.011,
                      "targetValueRange": {
                        "lowerBound": -0.01,
                        "upperBound": 0.01
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -12,
                      "standardDeviation": 6,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:cSBP",
        "label": "Central systolic blood pressure",
        "unit": "mm[Hg]",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "010-peripheral_vascular_health"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Increased arterial stiffness",
              "diagnosticCriteria": "Central SBP ≥130 mmHg, or central-peripheral SBP difference >10 mmHg, indicating increased large artery stiffness.",
              "recommendedDrugs": [
                {
                  "drugName": "Amlodipine",
                  "drugClass": "Dihydropyridine calcium channel blocker (CCB)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-6 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (12 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 125
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 5,
                      "standardDeviation": 2,
                      "unit": "ms"
                    }
                  ]
                },
                {
                  "drugName": "Perindopril",
                  "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (10 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 3.5,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 125
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:AP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.1,
                      "standardDeviation": 0.05,
                      "unit": "mg/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Isolated systolic hypertension",
              "diagnosticCriteria": "Central SBP ≥140 mmHg with DBP <90 mmHg, commonly seen in elderly patients.",
              "recommendedDrugs": [
                {
                  "drugName": "Indapamide",
                  "drugClass": "Thiazide diuretic",
                  "dosage": {
                    "initialDose": "1.5mg",
                    "maintenanceDose": "2.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (18 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -18,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "a.u."
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Essential hypertension",
              "diagnosticCriteria": "Three measurements on different days without antihypertensive medication, office SBP ≥140 mmHg and/or DBP ≥90 mmHg; or ambulatory monitoring daytime ≥135/85 mmHg, with elevated cSBP consistent with peripheral BP.",
              "recommendedDrugs": [
                {
                  "drugName": "Losartan",
                  "drugClass": "Angiotensin II receptor blocker (ARB)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (12 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 129
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement (category decrease)",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "ordinal"
                    }
                  ]
                },
                {
                  "drugName": "Amlodipine",
                  "drugClass": "Dihydropyridine calcium channel blocker (CCB)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (10 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 129
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Atherosclerosis/Large artery stiffness",
              "diagnosticCriteria": "Elevated pulse wave velocity (PWV) or increased β-stiffness index, with increased cSBP and wave reflection.",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril",
                  "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue - 14 * (1 - e^(-0.25 * t))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -14,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 129
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement (category decrease)",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.4,
                      "unit": "ordinal"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:AP",
        "label": "Augmentation pressure",
        "unit": "mm[Hg]",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "010-peripheral_vascular_health"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Enhanced arterial wave reflection",
              "diagnosticCriteria": "Augmentation pressure ≥15 mmHg, indicating increased large artery stiffness and enhanced wave reflection.",
              "recommendedDrugs": [
                {
                  "drugName": "Nebivolol",
                  "drugClass": "Third-generation beta-blocker",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (8 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 5,
                        "upperBound": 12
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 8,
                      "standardDeviation": 3,
                      "unit": "ms"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:GLP1",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "unit": "pmol/L"
                    }
                  ]
                },
                {
                  "drugName": "Nifedipine controlled-release",
                  "drugClass": "Dihydropyridine calcium channel blocker (CCB)",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "60mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "3-6 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (10 * (t / 6))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 5,
                        "upperBound": 12
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:beta_stiff",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.5,
                      "unit": "a.u."
                    },
                    {
                      "affectedNodeId": "CARDIO:FMD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2,
                      "standardDeviation": 0.8,
                      "unit": "%"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Arterial stiffening/Enhanced wave reflection",
              "diagnosticCriteria": "Decreased peripheral or central arterial compliance, elevated wave reflection coefficient and AIx (augmentation index), with increased AP.",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (6 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -6,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 10
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement (category decrease)",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "ordinal"
                    }
                  ]
                },
                {
                  "drugName": "Metoprolol succinate",
                  "drugClass": "Beta-blocker (BB)",
                  "dosage": {
                    "initialDose": "47.5mg",
                    "maintenanceDose": "95-190mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-6 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (4 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -4,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 10
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 5,
                      "standardDeviation": 3,
                      "unit": "ms"
                    },
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Elderly hypertension",
              "diagnosticCriteria": "Age ≥65 years, widened pulse pressure, decreased arterial compliance, predominantly systolic elevation; AP commonly elevated.",
              "recommendedDrugs": [
                {
                  "drugName": "Amlodipine",
                  "drugClass": "CCB",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (5 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -5,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 10
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:beta_stiff",
        "label": "Carotid β-stiffness index",
        "unit": "a.u.",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "010-peripheral_vascular_health"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Increased carotid artery stiffness",
              "diagnosticCriteria": "β-stiffness index ≥12, indicating significantly increased carotid artery wall stiffness.",
              "recommendedDrugs": [
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin lipid-lowering drug",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (2.5 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -2.5,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 6,
                        "upperBound": 10
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -40,
                      "standardDeviation": 15,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.5,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Ezetimibe",
                  "drugClass": "Cholesterol absorption inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-16 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (1.8 * (t / 16))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -1.8,
                      "standardDeviation": 0.7,
                      "targetValueRange": {
                        "lowerBound": 6,
                        "upperBound": 10
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -18,
                      "standardDeviation": 6,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Early atherosclerosis",
              "diagnosticCriteria": "β-stiffness index ≥10, with dyslipidemia or other cardiovascular risk factors.",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin lipid-lowering drug",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (2.8 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -2.8,
                      "standardDeviation": 1.2,
                      "targetValueRange": {
                        "lowerBound": 6,
                        "upperBound": 10
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:ApoA1",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.15,
                      "standardDeviation": 0.05,
                      "unit": "g/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:IMT_slope",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.015,
                      "standardDeviation": 0.005,
                      "unit": "mm/y"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Atherosclerosis",
              "diagnosticCriteria": "Ultrasound showing carotid IMT thickening or plaque formation, with elevated β-stiffness index.",
              "recommendedDrugs": [
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Exponential decay",
                      "formula": "currentValue - 0.8 * (1 - e^(-0.15 * t))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.4,
                      "targetValueRange": {
                        "lowerBound": 3.0,
                        "upperBound": 6.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.5,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic kidney disease-mineral bone disorder (CKD-MBD)",
              "diagnosticCriteria": "Elevated serum phosphate, PTH or FGF23, with vascular calcification/arterial stiffness.",
              "recommendedDrugs": [
                {
                  "drugName": "Empagliflozin",
                  "drugClass": "SGLT2 inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (0.6 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "lowerBound": 3.0,
                        "upperBound": 6.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.4,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:CAC",
        "label": "Coronary artery calcium score",
        "unit": "Agatston",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "ct_calcium"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Coronary artery calcification",
              "diagnosticCriteria": "CAC score ≥100 Agatston units indicates moderate coronary calcification; ≥400 indicates severe calcification.",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin lipid-lowering drug",
                  "dosage": {
                    "initialDose": "40mg",
                    "maintenanceDose": "80mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "52 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (15 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication",
                        "note": "Statins can slow calcification progression but cannot reverse it"
                      },
                      "expectedMeanChange": 15,
                      "standardDeviation": 20,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Goal is to slow progression rate"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -50,
                      "standardDeviation": 18,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:ApoA1",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.18,
                      "standardDeviation": 0.06,
                      "unit": "g/L"
                    }
                  ]
                },
                {
                  "drugName": "Evolocumab",
                  "drugClass": "PCSK9 inhibitor",
                  "dosage": {
                    "initialDose": "140mg",
                    "maintenanceDose": "140mg",
                    "frequency": "Every 2 weeks",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "52 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (8 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 8,
                      "standardDeviation": 15,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Significantly slows calcification progression"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -70,
                      "standardDeviation": 20,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Lpa",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -25,
                      "standardDeviation": 10,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic kidney disease-related calcification",
              "diagnosticCriteria": "Elevated CAC score with eGFR <60 mL/min/1.73m², elevated serum phosphate or PTH.",
              "recommendedDrugs": [
                {
                  "drugName": "Sevelamer",
                  "drugClass": "Phosphate binder",
                  "dosage": {
                    "initialDose": "800mg",
                    "maintenanceDose": "2400mg",
                    "frequency": "Three times daily",
                    "route": "Oral with meals"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-52 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (20 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 20,
                      "standardDeviation": 30,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Slow calcification progression"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Phosphate",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:PTH",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -50,
                      "standardDeviation": 20,
                      "unit": "pg/mL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Coronary atherosclerosis",
              "diagnosticCriteria": "Quantitative coronary CT CAC >0 or follow-up progression rate higher than same-age population, indicating high atherosclerotic burden.",
              "recommendedDrugs": [
                {
                  "drugName": "Evolocumab",
                  "drugClass": "PCSK9 inhibitor",
                  "dosage": {
                    "initialDose": "140mg",
                    "maintenanceDose": "140mg or 420mg",
                    "frequency": "Every 2 weeks or monthly",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Growth rate reduction model",
                      "formula": "currentValue + (g0 - 20) * (t / 12)",
                      "parameters": {
                        "t": "Months after medication",
                        "g0": "Previous annual average growth (Agatston/year)"
                      },
                      "expectedMeanChange": -20,
                      "standardDeviation": 15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.8,
                      "standardDeviation": 0.6,
                      "unit": "mmol/L"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40-80mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Growth rate reduction model",
                      "formula": "currentValue + (g0 - 10) * (t / 12)",
                      "parameters": {
                        "t": "Months after medication",
                        "g0": "Previous annual average growth (Agatston/year)"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 20,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "CKD-mineral bone metabolism disorder",
              "diagnosticCriteria": "Elevated serum phosphate, PTH or FGF23, with accelerated vascular calcification.",
              "recommendedDrugs": [
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin (risk management)",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Growth rate reduction model",
                      "formula": "currentValue + (g0 - 8) * (t / 12)",
                      "parameters": {
                        "t": "Months after medication",
                        "g0": "Previous annual average growth (Agatston/year)"
                      },
                      "expectedMeanChange": -8,
                      "standardDeviation": 15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.9,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:MI",
        "label": "Myocardial infarction (incidence)",
        "unit": "event",
        "system": "CARDIO",
        "type": "outcome",
        "datasetHint": [
          "cardio_outcomes"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Acute ST-elevation myocardial infarction",
              "diagnosticCriteria": "Chest pain lasting >20 minutes, ECG ST-segment elevation ≥0.1mV (≥2 adjacent leads), elevated cardiac markers.",
              "recommendedDrugs": [
                {
                  "drugName": "Aspirin",
                  "drugClass": "Antiplatelet drug",
                  "dosage": {
                    "initialDose": "300mg loading dose",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "Long-term",
                    "calculation": {
                      "method": "Risk reduction model",
                      "formula": "relativeRiskReduction = 0.25",
                      "parameters": {
                        "note": "Reduces recurrent MI risk by approximately 25%"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Prevent recurrent events"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "g/dL"
                    }
                  ]
                },
                {
                  "drugName": "Ticagrelor",
                  "drugClass": "P2Y12 inhibitor",
                  "dosage": {
                    "initialDose": "180mg loading dose",
                    "maintenanceDose": "90mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Risk reduction model",
                      "formula": "relativeRiskReduction = 0.16",
                      "parameters": {
                        "note": "Further reduces cardiovascular event risk by 16% compared to clopidogrel"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Dual antiplatelet therapy"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.3,
                      "unit": "g/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.2,
                      "unit": "mg/dL"
                    }
                  ]
                },
                {
                  "drugName": "Metoprolol",
                  "drugClass": "Beta-blocker",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "Long-term",
                    "calculation": {
                      "method": "Risk reduction model",
                      "formula": "relativeRiskReduction = 0.15",
                      "parameters": {
                        "note": "Reduces mortality and reinfarction risk"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Improve prognosis"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 10,
                      "standardDeviation": 4,
                      "unit": "ms"
                    },
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 5,
                      "standardDeviation": 2,
                      "unit": "%"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Non-ST-elevation myocardial infarction",
              "diagnosticCriteria": "Elevated cardiac markers, ECG ST-segment depression or T-wave inversion, but no ST-segment elevation.",
              "recommendedDrugs": [
                {
                  "drugName": "Enoxaparin",
                  "drugClass": "Low molecular weight heparin",
                  "dosage": {
                    "initialDose": "1mg/kg",
                    "maintenanceDose": "1mg/kg",
                    "frequency": "Twice daily",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "5-8 days",
                    "calculation": {
                      "method": "Risk reduction model",
                      "formula": "relativeRiskReduction = 0.20",
                      "parameters": {
                        "note": "Acute phase anticoagulation therapy"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Prevent thrombus extension"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.4,
                      "unit": "g/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Atherosclerotic coronary artery disease",
              "diagnosticCriteria": "Increased coronary artery stenosis/plaque rupture risk (imaging/clinical assessment), increased annual event risk.",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "High-intensity statin",
                  "dosage": {
                    "initialDose": "40mg",
                    "maintenanceDose": "80mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk model (Cox approximation)",
                      "formula": "risk_t = currentRisk * (0.75)^(t/12)",
                      "parameters": {
                        "t": "Treatment months",
                        "currentRisk": "Current annual incidence risk (%)"
                      },
                      "expectedMeanChange": -2.0,
                      "standardDeviation": 1.0,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 1
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.5,
                      "unit": "mmol/L"
                    }
                  ]
                },
                {
                  "drugName": "Aspirin",
                  "drugClass": "Antiplatelet drug",
                  "dosage": {
                    "initialDose": "75-100mg",
                    "maintenanceDose": "75-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk model",
                      "formula": "risk_t = currentRisk * (0.90)^(t/12)",
                      "parameters": {
                        "t": "Treatment months",
                        "currentRisk": "Current annual incidence risk (%)"
                      },
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.4,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 1
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.2,
                      "unit": "g/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Elevated lipoprotein(a)-related atherosclerosis",
              "diagnosticCriteria": "Elevated lipoprotein(a) (Lpa), with atherosclerotic burden or increased event risk.",
              "recommendedDrugs": [
                {
                  "drugName": "Evolocumab",
                  "drugClass": "PCSK9 inhibitor",
                  "dosage": {
                    "initialDose": "140mg",
                    "maintenanceDose": "140mg or 420mg",
                    "frequency": "Every 2 weeks or monthly",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk model",
                      "formula": "risk_t = currentRisk * (0.80)^(t/12)",
                      "parameters": {
                        "t": "Treatment months",
                        "currentRisk": "Current annual incidence risk (%)"
                      },
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.6,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 1
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.8,
                      "standardDeviation": 0.6,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:PAD",
        "label": "Peripheral artery disease (incidence)",
        "unit": "event",
        "system": "CARDIO",
        "type": "outcome",
        "datasetHint": [
          "vascular_outcomes"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Lower extremity atherosclerotic occlusive disease",
              "diagnosticCriteria": "Ankle-brachial index (ABI) <0.9, with intermittent claudication or rest pain.",
              "recommendedDrugs": [
                {
                  "drugName": "Cilostazol",
                  "drugClass": "Phosphodiesterase III inhibitor",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Improvement model",
                      "formula": "walkingDistance + (50 * t)",
                      "parameters": {
                        "t": "Weeks after medication",
                        "note": "Improve walking distance"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Improve symptoms and walking capacity"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 6,
                      "standardDeviation": 2,
                      "unit": "ms"
                    },
                    {
                      "affectedNodeId": "CARDIO:FMD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.6,
                      "unit": "%"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin lipid-lowering drug",
                  "dosage": {
                    "initialDose": "40mg",
                    "maintenanceDose": "80mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "Long-term",
                    "calculation": {
                      "method": "Risk reduction model",
                      "formula": "relativeRiskReduction = 0.30",
                      "parameters": {
                        "note": "Reduce cardiovascular event risk"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Stabilize plaque, improve prognosis"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -55,
                      "standardDeviation": 20,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "CARDIO:IMT_slope",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.018,
                      "standardDeviation": 0.006,
                      "unit": "mm/y"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Diabetic foot vascular disease",
              "diagnosticCriteria": "Diabetic patients, ABI <0.9 or >1.3, with lower extremity ulcer or gangrene risk.",
              "recommendedDrugs": [
                {
                  "drugName": "Alprostadil",
                  "drugClass": "Prostaglandin E1",
                  "dosage": {
                    "initialDose": "10μg",
                    "maintenanceDose": "20μg",
                    "frequency": "Once daily",
                    "route": "Intravenous infusion"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Improvement model",
                      "formula": "perfusion + (15 * t)",
                      "parameters": {
                        "t": "Weeks after medication",
                        "note": "Improve lower limb perfusion"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Improve microcirculation"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Atherosclerotic peripheral artery disease",
              "diagnosticCriteria": "ABI <0.90 or imaging-confirmed lower limb arterial stenosis/occlusion.",
              "recommendedDrugs": [
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk model",
                      "formula": "risk_t = currentRisk * (0.80)^(t/12)",
                      "parameters": {
                        "t": "Treatment months",
                        "currentRisk": "Current annual incidence risk (%)"
                      },
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.5,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 1
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L"
                    }
                  ]
                },
                {
                  "drugName": "Clopidogrel",
                  "drugClass": "Antiplatelet drug",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "75mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk model",
                      "formula": "risk_t = currentRisk * (0.88)^(t/12)",
                      "parameters": {
                        "t": "Treatment months",
                        "currentRisk": "Current annual incidence risk (%)"
                      },
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.4,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 1
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.2,
                      "unit": "g/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Diabetes with peripheral artery disease",
              "diagnosticCriteria": "Confirmed diabetes history with PAD clinical or imaging evidence.",
              "recommendedDrugs": [
                {
                  "drugName": "Evolocumab",
                  "drugClass": "PCSK9 inhibitor (lipid management)",
                  "dosage": {
                    "initialDose": "140mg",
                    "maintenanceDose": "140mg or 420mg",
                    "frequency": "Every 2 weeks or monthly",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk model",
                      "formula": "risk_t = currentRisk * (0.82)^(t/12)",
                      "parameters": {
                        "t": "Treatment months",
                        "currentRisk": "Current annual incidence risk (%)"
                      },
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.5,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 1
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.8,
                      "standardDeviation": 0.6,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:HRV_RMSSD",
        "label": "Heart rate variability (RMSSD)",
        "unit": "ms",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "015-ecg"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Autonomic nervous system dysfunction",
              "diagnosticCriteria": "RMSSD <20ms, indicating decreased parasympathetic nerve activity and impaired autonomic function.",
              "recommendedDrugs": [
                {
                  "drugName": "Metoprolol succinate",
                  "drugClass": "Selective beta-1 blocker",
                  "dosage": {
                    "initialDose": "47.5mg",
                    "maintenanceDose": "95mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (15 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 15,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 25,
                        "upperBound": null,
                        "note": "Improve HRV"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -12,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3,
                      "standardDeviation": 1,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Candesartan",
                  "drugClass": "Angiotensin II receptor blocker (ARB)",
                  "dosage": {
                    "initialDose": "8mg",
                    "maintenanceDose": "16mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-12 weeks",
                    "calculation": {
                      "method": "Linear growth",
                      "formula": "currentValue + (12 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 12,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 25,
                        "upperBound": null,
                        "note": "Improve autonomic function"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.2,
                      "unit": "mL/min/1.73m2/y"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -20,
                      "standardDeviation": 10,
                      "unit": "pg/mL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Heart failure-related autonomic neuropathy",
              "diagnosticCriteria": "Reduced HRV, RMSSD <15ms, with symptoms of cardiac dysfunction.",
              "recommendedDrugs": [
                {
                  "drugName": "Carvedilol",
                  "drugClass": "Non-selective beta-blocker",
                  "dosage": {
                    "initialDose": "3.125mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (18 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 18,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 20,
                        "upperBound": null,
                        "note": "Improve cardiac function and HRV"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 8,
                      "standardDeviation": 3,
                      "unit": "%"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -80,
                      "standardDeviation": 30,
                      "unit": "pg/mL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Autonomic dysfunction (sympathetic-parasympathetic imbalance)",
              "diagnosticCriteria": "Continuous ECG analysis shows RMSSD below age- and gender-reference range, with nighttime HRV reduction.",
              "recommendedDrugs": [
                {
                  "drugName": "Metoprolol succinate",
                  "drugClass": "Beta-blocker (BB)",
                  "dosage": {
                    "initialDose": "47.5mg",
                    "maintenanceDose": "95-190mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (10 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 10,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 25,
                        "upperBound": 50
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Perindopril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Linear growth",
                      "formula": "currentValue + (6 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 6,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 25,
                        "upperBound": 50
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement (category decrease)",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "ordinal"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Alcohol-related autonomic abnormality",
              "diagnosticCriteria": "Long-term heavy alcohol consumption, reduced HRV, with increased blood pressure fluctuation.",
              "recommendedDrugs": [
                {
                  "drugName": "Metoprolol succinate",
                  "drugClass": "BB",
                  "dosage": {
                    "initialDose": "47.5mg",
                    "maintenanceDose": "95mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Linear growth",
                      "formula": "currentValue + (8 * (t / 4))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 8,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 25,
                        "upperBound": 50
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:BPV",
        "label": "Blood pressure variability (24h)",
        "unit": "mm[Hg]",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "007-blood_pressure"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Increased blood pressure variability",
              "diagnosticCriteria": "24-hour blood pressure standard deviation >15 mmHg, indicating excessive blood pressure fluctuation.",
              "recommendedDrugs": [
                {
                  "drugName": "Amlodipine",
                  "drugClass": "Long-acting calcium channel blocker (CCB)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (6 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -6,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 8,
                        "upperBound": 12,
                        "note": "Reduce blood pressure variability"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -11,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_night",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Olmesartan",
                  "drugClass": "Angiotensin II receptor blocker (ARB)",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-12 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (5 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -5,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 8,
                        "upperBound": 12,
                        "note": "Stabilize blood pressure"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:WMH_vol",
                      "expectedTrend": "Reduce progression",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "mL/y"
                    },
                    {
                      "affectedNodeId": "CARDIO:MAP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Morning surge hypertension",
              "diagnosticCriteria": "Rapid morning BP increase, morning surge >35 mmHg, increased BP variability.",
              "recommendedDrugs": [
                {
                  "drugName": "Terazosin",
                  "drugClass": "Alpha-1 receptor blocker",
                  "dosage": {
                    "initialDose": "1mg",
                    "maintenanceDose": "5mg",
                    "frequency": "Once at bedtime",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (4 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -4,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": 8,
                        "upperBound": 12,
                        "note": "Smooth morning surge"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_night",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.5,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Essential hypertension with increased blood pressure variability",
              "diagnosticCriteria": "24-hour ambulatory BP SD or ARV above population reference upper limit, with elevated mean BP.",
              "recommendedDrugs": [
                {
                  "drugName": "Chlorthalidone",
                  "drugClass": "Thiazide diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (3 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -3,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": 8,
                        "upperBound": 12
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "mg/dL"
                    }
                  ]
                },
                {
                  "drugName": "Metoprolol succinate",
                  "drugClass": "BB",
                  "dosage": {
                    "initialDose": "47.5mg",
                    "maintenanceDose": "95mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (2 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 8,
                        "upperBound": 12
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 5,
                      "standardDeviation": 3,
                      "unit": "ms"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Alcohol-related hypertension",
              "diagnosticCriteria": "Long-term high alcohol intake, elevated mean BP and BPV.",
              "recommendedDrugs": [
                {
                  "drugName": "Amlodipine",
                  "drugClass": "CCB",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (2 * (t / 4))",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 8,
                        "upperBound": 12
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:HTN_dx",
        "label": "Hypertension diagnosis",
        "unit": "binary",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "021-medical_conditions"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Essential hypertension (Grade 1)",
              "diagnosticCriteria": "SBP 140-159 mmHg or DBP 90-99 mmHg, no evidence of secondary hypertension.",
              "recommendedDrugs": [
                {
                  "drugName": "Irbesartan",
                  "drugClass": "Angiotensin II receptor blocker (ARB)",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "300mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Control rate model",
                      "formula": "controlRate = 0.65",
                      "parameters": {
                        "note": "Approximately 65% of patients achieve BP target"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "BP control <140/90 mmHg"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -16,
                      "standardDeviation": 6,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.2,
                      "unit": "category"
                    }
                  ]
                },
                {
                  "drugName": "Amlodipine/Benazepril combination",
                  "drugClass": "CCB+ACEI combination",
                  "dosage": {
                    "initialDose": "5mg/10mg",
                    "maintenanceDose": "10mg/20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Control rate model",
                      "formula": "controlRate = 0.75",
                      "parameters": {
                        "note": "Approximately 75% of patients achieve BP target"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Synergistic antihypertensive effect"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -22,
                      "standardDeviation": 7,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "CARDIO:LVMI",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "unit": "g/m2"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Essential hypertension (Grade 2)",
              "diagnosticCriteria": "SBP 160-179 mmHg or DBP 100-109 mmHg.",
              "recommendedDrugs": [
                {
                  "drugName": "Valsartan/Amlodipine combination",
                  "drugClass": "ARB+CCB combination",
                  "dosage": {
                    "initialDose": "80mg/5mg",
                    "maintenanceDose": "160mg/10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-12 weeks",
                    "calculation": {
                      "method": "Control rate model",
                      "formula": "controlRate = 0.70",
                      "parameters": {
                        "note": "Approximately 70% of patients achieve BP target"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Potent antihypertensive effect"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -28,
                      "standardDeviation": 9,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "CARDIO:cSBP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -20,
                      "standardDeviation": 7,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Valsartan/Amlodipine/Hydrochlorothiazide triple combination",
                  "drugClass": "ARB+CCB+Diuretic",
                  "dosage": {
                    "initialDose": "160mg/5mg/12.5mg",
                    "maintenanceDose": "160mg/10mg/25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Control rate model",
                      "formula": "controlRate = 0.80",
                      "parameters": {
                        "note": "Approximately 80% of patients achieve BP target"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Triple potent antihypertensive effect"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -35,
                      "standardDeviation": 10,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Essential hypertension",
              "diagnosticCriteria": "Multiple BP measurements reaching diagnostic threshold without medication (office ≥140/90 mmHg or corresponding ambulatory BP threshold).",
              "recommendedDrugs": [
                {
                  "drugName": "Hydrochlorothiazide",
                  "drugClass": "Thiazide diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks (can withdraw diagnosis after control)",
                    "calculation": {
                      "method": "Threshold-probability model",
                      "formula": "p_t = max(0, currentProb - 0.40 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication",
                        "currentProb": "Current probability of meeting diagnostic criteria (0-1)"
                      },
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL"
                    }
                  ]
                },
                {
                  "drugName": "Benazepril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Threshold-probability model",
                      "formula": "p_t = max(0, currentProb - 0.35 * (t / 12))",
                      "parameters": {
                        "t": "Weeks",
                        "currentProb": "Current probability of meeting diagnostic criteria (0-1)"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement (category decrease)",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "ordinal"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Renal hypertension",
              "diagnosticCriteria": "Elevated BP caused by renal parenchymal disease or renovascular lesions, with proteinuria/altered renal function.",
              "recommendedDrugs": [
                {
                  "drugName": "Losartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Threshold-probability model",
                      "formula": "p_t = max(0, currentProb - 0.40 * (t / 12))",
                      "parameters": {
                        "t": "Weeks",
                        "currentProb": "Current probability of meeting diagnostic criteria (0-1)"
                      },
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement (category decrease)",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "ordinal"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:ACEi_use",
        "label": "ACE inhibitor (assignment)",
        "unit": "binary",
        "system": "CARDIO",
        "type": "exposure",
        "datasetHint": [
          "018-medications"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Hypertension with left ventricular hypertrophy",
              "diagnosticCriteria": "Hypertensive patients with LVMI >115 g/m² (male) or >95 g/m² (female).",
              "recommendedDrugs": [
                {
                  "drugName": "Enalapril",
                  "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-52 weeks",
                    "calculation": {
                      "method": "LVH reversal model",
                      "formula": "LVMI reduction",
                      "parameters": {
                        "note": "Long-term treatment can reverse left ventricular hypertrophy"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Improve ventricular remodeling"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVMI",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "unit": "g/m2"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -14,
                      "standardDeviation": 5,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.08,
                      "standardDeviation": 0.04,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Ramipril",
                  "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "2.5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-52 weeks",
                    "calculation": {
                      "method": "LVH reversal model",
                      "formula": "LVMI reduction",
                      "parameters": {
                        "note": "Cardiovascular protective effect"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Improve prognosis"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVMI",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "unit": "g/m2"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -25,
                      "standardDeviation": 12,
                      "unit": "pg/mL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hypertension with chronic kidney disease",
              "diagnosticCriteria": "Hypertension with eGFR <60 mL/min/1.73m² or elevated urinary albumin/creatinine ratio.",
              "recommendedDrugs": [
                {
                  "drugName": "Fosinopril",
                  "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Renal protection model",
                      "formula": "Reduce proteinuria and slow renal function decline",
                      "parameters": {
                        "note": "Dual excretion pathway, safer in renal insufficiency"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Renal protection"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "category"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.3,
                      "unit": "mL/min/1.73m2/y"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.12,
                      "standardDeviation": 0.06,
                      "unit": "mg/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Heart failure with reduced ejection fraction",
              "diagnosticCriteria": "LVEF <40%, with heart failure symptoms.",
              "recommendedDrugs": [
                {
                  "drugName": "Captopril",
                  "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "6.25mg",
                    "maintenanceDose": "50mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Cardiac function improvement model",
                      "formula": "LVEF improvement",
                      "parameters": {
                        "note": "Reduce mortality and rehospitalization rate"
                      },
                      "expectedMeanChange": null,
                      "standardDeviation": null,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null,
                        "note": "Improve prognosis"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 6,
                      "standardDeviation": 3,
                      "unit": "%"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -100,
                      "standardDeviation": 40,
                      "unit": "pg/mL"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.15,
                      "standardDeviation": 0.07,
                      "unit": "mg/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Essential hypertension",
              "diagnosticCriteria": "Meets hypertension diagnosis and has cardiac, renal, cerebral or other target organ risk, or requires RAAS blockade therapy.",
              "recommendedDrugs": [
                {
                  "drugName": "Benazepril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks (prescription initiation)",
                    "calculation": {
                      "method": "Step function",
                      "formula": "ACEi_use_t = 1 (when prescription takes effect)",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 1,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 1,
                        "upperBound": 1
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement (category decrease)",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "ordinal"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                },
                {
                  "drugName": "Enalapril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10-20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1 week",
                    "calculation": {
                      "method": "Step function",
                      "formula": "ACEi_use_t = 1",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 1,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 1,
                        "upperBound": 1
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement (category decrease)",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "ordinal"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic kidney disease with proteinuria",
              "diagnosticCriteria": "Albuminuria A2/A3 or proteinuria ≥0.3 g/d, requires RAAS blockade for renal protection.",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks (prescription initiation)",
                    "calculation": {
                      "method": "Step function",
                      "formula": "ACEi_use_t = 1",
                      "parameters": {
                        "t": "Weeks"
                      },
                      "expectedMeanChange": 1,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 1,
                        "upperBound": 1
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Improvement (category decrease)",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "ordinal"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.4,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:ARB_use",
        "label": "ARB (assignment)",
        "unit": "binary",
        "system": "CARDIO",
        "type": "exposure",
        "datasetHint": [
          "018-medications"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Essential Hypertension",
              "diagnosticCriteria": "Without antihypertensive medication, three measurements on different days with SBP≥140mmHg and/or DBP≥90mmHg",
              "recommendedDrugs": [
                {
                  "drugName": "Valsartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "80mg",
                    "maintenanceDose": "160mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (18 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -18,
                      "standardDeviation": 7,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.2,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Losartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-6 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (16 * (t / 6))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -16,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.2,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Valsartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "80mg",
                    "maintenanceDose": "80-160mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Logistic probability model (medication assignment probability increases)",
                      "formula": "p_new = logistic(logit(p_current) + Δ)",
                      "parameters": {
                        "p_current": "Current probability of ARB_use=1 (0-1)",
                        "Δ": "+1.2 (represents increase in log odds of initiating ARB prescription)"
                      },
                      "expectedMeanChange": 0.7,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0.6,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": []
                },
                {
                  "drugName": "Losartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) + 0.9)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Diabetic Nephropathy",
              "diagnosticCriteria": "Diabetic patients with urinary albumin/creatinine ratio≥30mg/g, or eGFR<60 mL/min/1.73m²",
              "recommendedDrugs": [
                {
                  "drugName": "Irbesartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "300mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (25 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -25,
                      "standardDeviation": 8,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "unit": "g/d",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 0.1,
                      "standardDeviation": 0.05,
                      "unit": "mg/L",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Candesartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "8mg",
                    "maintenanceDose": "16-32mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Logistic probability model (more likely to initiate when proteinuria present)",
                      "formula": "p_new = logistic(logit(p_current) + 1.4)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.75,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.6,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Chronic Heart Failure",
              "diagnosticCriteria": "Clinical symptoms (dyspnea, edema) with LVEF≤40% or BNP≥100 pg/mL",
              "recommendedDrugs": [
                {
                  "drugName": "Candesartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "32mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (12 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -80,
                      "standardDeviation": 30,
                      "unit": "pg/mL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 5,
                      "standardDeviation": 2,
                      "unit": "%",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Valsartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "40-80mg",
                    "maintenanceDose": "160mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) + 1.1)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.65,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:Thiazide_use",
        "label": "Thiazide diuretic (assignment)",
        "unit": "binary",
        "system": "CARDIO",
        "type": "exposure",
        "datasetHint": [
          "018-medications"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Mild to Moderate Essential Hypertension",
              "diagnosticCriteria": "SBP 140-179mmHg and/or DBP 90-109mmHg, without other complications",
              "recommendedDrugs": [
                {
                  "drugName": "Hydrochlorothiazide",
                  "drugClass": "Thiazide Diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (15 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -15,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.15,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Indapamide",
                  "drugClass": "Thiazide-like Diuretic",
                  "dosage": {
                    "initialDose": "1.5mg",
                    "maintenanceDose": "2.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (18 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -18,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Hydrochlorothiazide",
                  "drugClass": "Thiazide Diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "12.5-25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-4 weeks",
                    "calculation": {
                      "method": "Logistic probability model (medication assignment probability increases)",
                      "formula": "p_new = logistic(logit(p_current) + 1.0)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Isolated Systolic Hypertension in Elderly",
              "diagnosticCriteria": "Age≥65 years, SBP≥140mmHg, DBP<90mmHg",
              "recommendedDrugs": [
                {
                  "drugName": "Chlorthalidone",
                  "drugClass": "Thiazide-like Diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-6 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (20 * (t / 6))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -20,
                      "standardDeviation": 7,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.5,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3,
                      "standardDeviation": 1,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Recurrent Calcium Nephrolithiasis (Renal Hypercalciuria)",
              "diagnosticCriteria": "History of at least two calcium stone episodes with elevated urinary calcium",
              "recommendedDrugs": [
                {
                  "drugName": "Indapamide",
                  "drugClass": "Thiazide-like Diuretic",
                  "dosage": {
                    "initialDose": "1.25mg",
                    "maintenanceDose": "1.25-2.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) + 0.8)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.55,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.4,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:BB_use",
        "label": "Beta-blocker (assignment)",
        "unit": "binary",
        "system": "CARDIO",
        "type": "exposure",
        "datasetHint": [
          "018-medications"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Stable Angina Pectoris",
              "diagnosticCriteria": "Typical angina symptoms, coronary angiography showing ≥50% stenosis or positive stress test",
              "recommendedDrugs": [
                {
                  "drugName": "Metoprolol",
                  "drugClass": "Selective β1 Receptor Blocker",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (12 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 15,
                      "standardDeviation": 5,
                      "unit": "ms",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Bisoprolol",
                  "drugClass": "Selective β1 Receptor Blocker",
                  "dosage": {
                    "initialDose": "2.5mg",
                    "maintenanceDose": "5-10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (15 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -15,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 18,
                      "standardDeviation": 6,
                      "unit": "ms",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Heart Failure (Heart Failure with Reduced Ejection Fraction)",
              "diagnosticCriteria": "NYHA II-IV, LVEF≤40%",
              "recommendedDrugs": [
                {
                  "drugName": "Carvedilol",
                  "drugClass": "Non-selective Beta Blocker",
                  "dosage": {
                    "initialDose": "3.125mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (10 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 100,
                        "upperBound": 120
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 6,
                      "standardDeviation": 3,
                      "unit": "%",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -100,
                      "standardDeviation": 40,
                      "unit": "pg/mL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:LVMI",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "unit": "g/m2",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Tachyarrhythmia",
              "diagnosticCriteria": "Atrial fibrillation or supraventricular tachycardia, resting heart rate >100 bpm",
              "recommendedDrugs": [
                {
                  "drugName": "Metoprolol Succinate Extended-Release",
                  "drugClass": "Selective β1 Receptor Blocker",
                  "dosage": {
                    "initialDose": "47.5mg",
                    "maintenanceDose": "95-190mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (8 * (t / 2))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 20,
                      "standardDeviation": 7,
                      "unit": "ms",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Post-Myocardial Infarction (Secondary Prevention)",
              "diagnosticCriteria": "Confirmed acute myocardial infarction during discharge and outpatient follow-up",
              "recommendedDrugs": [
                {
                  "drugName": "Metoprolol Succinate Extended-Release",
                  "drugClass": "Beta Blocker",
                  "dosage": {
                    "initialDose": "25-50mg",
                    "maintenanceDose": "100-200mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Logistic probability model (medication assignment probability increases)",
                      "formula": "p_new = logistic(logit(p_current) + 1.1)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.65,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.6,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VO2max",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.8,
                      "unit": "mL/kg/min",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Atrial Fibrillation (Ventricular Rate Control)",
              "diagnosticCriteria": "ECG confirmed atrial fibrillation, requiring ventricular rate control",
              "recommendedDrugs": [
                {
                  "drugName": "Bisoprolol",
                  "drugClass": "Beta Blocker",
                  "dosage": {
                    "initialDose": "1.25-2.5mg",
                    "maintenanceDose": "2.5-10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1 week",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) + 1.3)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.7,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:Smoking_status",
        "label": "Current smoking",
        "unit": "binary",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "055-lifestyle_and_environment"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Tobacco Dependence Syndrome",
              "diagnosticCriteria": "Continuous smoking ≥6 months, daily smoking ≥10 cigarettes, with withdrawal symptoms",
              "recommendedDrugs": [
                {
                  "drugName": "Varenicline",
                  "drugClass": "Partial Nicotinic Receptor Agonist",
                  "dosage": {
                    "initialDose": "0.5mg",
                    "maintenanceDose": "1mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Smoking cessation success rate",
                      "formula": "Success rate approximately 44%",
                      "parameters": {
                        "t": "Treatment weeks"
                      },
                      "expectedMeanChange": 0.44,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.8,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Nicotine Replacement Patch",
                  "drugClass": "Nicotine Replacement Therapy",
                  "dosage": {
                    "initialDose": "21mg/24h",
                    "maintenanceDose": "14mg/24h then reduce to 7mg/24h",
                    "frequency": "Once daily",
                    "route": "Transdermal patch"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Smoking cessation success rate",
                      "formula": "Success rate approximately 23%",
                      "parameters": {
                        "t": "Treatment weeks"
                      },
                      "expectedMeanChange": 0.23,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 8,
                      "standardDeviation": 3,
                      "unit": "ms",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.2,
                      "unit": "mg/L",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Varenicline",
                  "drugClass": "Partial Agonist (α4β2 Nicotinic Receptor)",
                  "dosage": {
                    "initialDose": "0.5mg (Day 1-3)",
                    "maintenanceDose": "1mg",
                    "frequency": "Twice daily (from Day 8)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logistic probability model (smoking probability decrease)",
                      "formula": "p_new = logistic(logit(p_current) - 0.8)",
                      "parameters": {
                        "p_current": "Current smoking probability"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.6
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Bupropion Extended-Release",
                  "drugClass": "Norepinephrine-Dopamine Reuptake Inhibitor",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "150mg",
                    "frequency": "Twice daily (from Day 4)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "7-12 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) - 0.6)",
                      "parameters": {
                        "p_current": "Current smoking probability"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.7
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2.0,
                      "standardDeviation": 2.0,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Smoking-Related Cardiovascular Disease Risk",
              "diagnosticCriteria": "Current smoking with cardiovascular risk factors (hypertension, hyperlipidemia, or diabetes)",
              "recommendedDrugs": [
                {
                  "drugName": "Bupropion Hydrochloride Extended-Release",
                  "drugClass": "Antidepressant (Smoking Cessation Indication)",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "150mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Smoking cessation success rate",
                      "formula": "Success rate approximately 30%",
                      "parameters": {
                        "t": "Treatment weeks"
                      },
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.13,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 3,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Tobacco Use Disorder",
              "diagnosticCriteria": "Meets DSM/ICD addiction/dependence diagnostic criteria, persistent smoking behavior",
              "recommendedDrugs": [
                {
                  "drugName": "Varenicline",
                  "drugClass": "Partial Agonist (α4β2 Nicotinic Receptor)",
                  "dosage": {
                    "initialDose": "0.5mg (Day 1-3)",
                    "maintenanceDose": "1mg",
                    "frequency": "Twice daily (from Day 8)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logistic probability model (smoking probability decrease)",
                      "formula": "p_new = logistic(logit(p_current) - 0.8)",
                      "parameters": {
                        "p_current": "Current smoking probability"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.6
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Bupropion Extended-Release",
                  "drugClass": "Norepinephrine-Dopamine Reuptake Inhibitor",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "150mg",
                    "frequency": "Twice daily (from Day 4)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "7-12 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) - 0.6)",
                      "parameters": {
                        "p_current": "Current smoking probability"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.7
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2.0,
                      "standardDeviation": 2.0,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Obstructive Pulmonary Disease (COPD)",
              "diagnosticCriteria": "Pulmonary function test FEV1/FVC<0.70 with smoking history",
              "recommendedDrugs": [
                {
                  "drugName": "Varenicline",
                  "drugClass": "Smoking Cessation Drug",
                  "dosage": {
                    "initialDose": "0.5mg",
                    "maintenanceDose": "1mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) - 0.9)",
                      "parameters": {
                        "p_current": "Current smoking probability"
                      },
                      "expectedMeanChange": -0.38,
                      "standardDeviation": 0.16,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.6
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:Alcohol_high",
        "label": "High alcohol intake",
        "unit": "binary",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "055-lifestyle_and_environment"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Alcohol Dependence Syndrome",
              "diagnosticCriteria": "Daily alcohol intake exceeding 40g pure alcohol for males, 20g for females, lasting ≥12 months, with withdrawal symptoms",
              "recommendedDrugs": [
                {
                  "drugName": "Naltrexone",
                  "drugClass": "Opioid Receptor Antagonist",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "50mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Reduction in alcohol consumption",
                      "formula": "Approximately 40% reduction in drinking days",
                      "parameters": {
                        "t": "Treatment weeks"
                      },
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Slight change",
                      "expectedMeanChange": 1,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:Albumin_serum",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "g/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Acamprosate Calcium",
                  "drugClass": "Glutamate Modulator",
                  "dosage": {
                    "initialDose": "666mg",
                    "maintenanceDose": "666mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Abstinence maintenance rate",
                      "formula": "Approximately 36% continuous abstinence rate",
                      "parameters": {
                        "t": "Treatment weeks"
                      },
                      "expectedMeanChange": 0.36,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Naltrexone",
                  "drugClass": "Opioid Receptor Antagonist",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "50mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Logistic probability model (high drinking probability decrease)",
                      "formula": "p_new = logistic(logit(p_current) - 0.7)",
                      "parameters": {
                        "p_current": "Current high drinking probability"
                      },
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.7
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Acamprosate",
                  "drugClass": "Glutamate/GABA Modulator",
                  "dosage": {
                    "initialDose": "666mg",
                    "maintenanceDose": "666mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) - 0.6)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": -0.22,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.75
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Alcoholic Cardiomyopathy",
              "diagnosticCriteria": "History of long-term heavy drinking, LVEF<50%, elevated BNP, excluding other causes of cardiomyopathy",
              "recommendedDrugs": [
                {
                  "drugName": "Disulfiram",
                  "drugClass": "Alcohol Metabolism Inhibitor",
                  "dosage": {
                    "initialDose": "250mg",
                    "maintenanceDose": "250mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Complete abstinence",
                      "formula": "Complete abstinence required to improve cardiac function",
                      "parameters": {
                        "t": "Weeks of abstinence"
                      },
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Improvement (after abstinence)",
                      "expectedMeanChange": 8,
                      "standardDeviation": 4,
                      "unit": "%",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease (after abstinence)",
                      "expectedMeanChange": -120,
                      "standardDeviation": 50,
                      "unit": "pg/mL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:Albumin_serum",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.15,
                      "unit": "g/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Alcohol Use Disorder (AUD)",
              "diagnosticCriteria": "In the past 12 months, meets multiple criteria for impaired/loss-of-control alcohol use",
              "recommendedDrugs": [
                {
                  "drugName": "Naltrexone",
                  "drugClass": "Opioid Receptor Antagonist",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "50mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Logistic probability model (high drinking probability decrease)",
                      "formula": "p_new = logistic(logit(p_current) - 0.7)",
                      "parameters": {
                        "p_current": "Current high drinking probability"
                      },
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.7
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Acamprosate",
                  "drugClass": "Glutamate/GABA Modulator",
                  "dosage": {
                    "initialDose": "666mg",
                    "maintenanceDose": "666mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) - 0.6)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": -0.22,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.75
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:HV",
        "label": "Hippocampal volume",
        "unit": "mL",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Early Alzheimer's Disease (MCI Stage)",
              "diagnosticCriteria": "Mild cognitive decline, hippocampal volume reduction >1.5 SD, memory score decline",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase Inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Slowing atrophy rate",
                      "formula": "Approximately 30% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 3.0,
                        "upperBound": 4.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement or stabilization",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Mild improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Memantine",
                  "drugClass": "NMDA Receptor Antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Slowing atrophy rate",
                      "formula": "Approximately 25% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.25,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 3.0,
                        "upperBound": 4.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Lecanemab",
                  "drugClass": "Anti-Aβ Monoclonal Antibody",
                  "dosage": {
                    "initialDose": "10mg/kg",
                    "maintenanceDose": "10mg/kg",
                    "frequency": "Every two weeks",
                    "route": "Intravenous infusion"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Linear slope reduction (hippocampal volume annual decline reduction)",
                      "formula": "HV_t = currentValue - (declineRate_base - delta) * (t/12)",
                      "parameters": {
                        "t": "Months after treatment",
                        "declineRate_base": "1.0 mL/year (assumed)",
                        "delta": "0.2 mL/year (reduction magnitude)"
                      },
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "count",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Temporal Lobe Epilepsy with Hippocampal Sclerosis",
              "diagnosticCriteria": "Recurrent focal seizures, imaging shows hippocampal volume reduction and T2 signal increase",
              "recommendedDrugs": [
                {
                  "drugName": "Levetiracetam",
                  "drugClass": "Antiepileptic Drug",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "1000-1500mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Control epileptic seizures",
                      "formula": "Seizure frequency reduction >50%",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 2.5,
                        "upperBound": 4.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 3,
                      "standardDeviation": 2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Slight improvement",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.8,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Stress-Related Hippocampal Atrophy",
              "diagnosticCriteria": "History of long-term depression or anxiety, hippocampal volume reduction, mild cognitive decline",
              "recommendedDrugs": [
                {
                  "drugName": "Sertraline",
                  "drugClass": "Selective Serotonin Reuptake Inhibitor (SSRI)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Neuroprotective effect",
                      "formula": "May promote hippocampal neurogenesis",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 3.0,
                        "upperBound": 4.5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Significant improvement",
                      "expectedMeanChange": -6,
                      "standardDeviation": 2.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Significant improvement",
                      "expectedMeanChange": -5,
                      "standardDeviation": 2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Sertraline",
                  "drugClass": "Selective Serotonin Reuptake Inhibitor (SSRI)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-12 months",
                    "calculation": {
                      "method": "Linear micro-increase/atrophy slowing",
                      "formula": "HV_t = currentValue + 0.05 * (t/6)",
                      "parameters": {
                        "t": "Months after treatment"
                      },
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.05,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Short-term increase (initial phase)",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Major Depressive Disorder (Recurrent-Remitting Type)",
              "diagnosticCriteria": "Meets diagnostic criteria for depressive episode, excluding organic lesions",
              "recommendedDrugs": [
                {
                  "drugName": "Sertraline",
                  "drugClass": "Selective 5-HT Reuptake Inhibitor (SSRI)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-12 months",
                    "calculation": {
                      "method": "Linear micro-increase/atrophy slowing",
                      "formula": "HV_t = currentValue + 0.05 * (t/6)",
                      "parameters": {
                        "t": "Months after treatment"
                      },
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.05,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Short-term increase (initial phase)",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:CT_thick",
        "label": "Global cortical thickness",
        "unit": "mm",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Alzheimer's Disease",
              "diagnosticCriteria": "Progressive cognitive decline, global cortical thickness reduction >2 SD, especially in temporoparietal regions",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase Inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48 weeks",
                    "calculation": {
                      "method": "Slowing cortical atrophy",
                      "formula": "Approximately 35% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.35,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 2.3,
                        "upperBound": 2.8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ProcSpeed",
                      "expectedTrend": "Mild improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Memantine Combined with Donepezil",
                  "drugClass": "NMDA Receptor Antagonist + Cholinesterase Inhibitor",
                  "dosage": {
                    "initialDose": "Memantine 5mg + Donepezil 5mg",
                    "maintenanceDose": "Memantine 20mg + Donepezil 10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48-72 weeks",
                    "calculation": {
                      "method": "Combined therapy slowing atrophy",
                      "formula": "Approximately 40% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 2.3,
                        "upperBound": 2.8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Significant improvement",
                      "expectedMeanChange": 3.5,
                      "standardDeviation": 2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Significant improvement",
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Frontotemporal Dementia",
              "diagnosticCriteria": "Behavioral or language abnormalities predominant, frontal and anterior temporal cortical thinning",
              "recommendedDrugs": [
                {
                  "drugName": "Memantine Hydrochloride",
                  "drugClass": "NMDA Receptor Antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Slowing atrophy progression",
                      "formula": "Approximately 20% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 2.0,
                        "upperBound": 2.6
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Mild improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Mild improvement",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Cerebral Small Vessel Disease",
              "diagnosticCriteria": "White matter lesions with cortical thinning, cognitive decline, vascular risk factors",
              "recommendedDrugs": [
                {
                  "drugName": "Nimodipine",
                  "drugClass": "Calcium Channel Blocker",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "30mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Improving cerebral blood flow to protect cortex",
                      "formula": "Approximately 25% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.25,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 2.2,
                        "upperBound": 2.7
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:CBF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 5,
                      "standardDeviation": 2,
                      "unit": "mL/100g/min",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Cerebral Small Vessel Disease (with Hypertension)",
              "diagnosticCriteria": "Imaging shows WMH/lacunes/microbleeds with long-term hypertension history",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "4-8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Linear slope reduction (cortical thickness thinning rate decrease)",
                      "formula": "CT_t = currentValue - (0.04 - 0.01) * (t/12)",
                      "parameters": {
                        "t": "Months",
                        "0.04": "mm/year, baseline thinning rate (example)",
                        "0.01": "mm/year, treatment-reduced rate"
                      },
                      "expectedMeanChange": 0.01,
                      "standardDeviation": 0.005,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Atherosclerotic High-Risk State (Hyperlipidemia)",
              "diagnosticCriteria": "Elevated non-HDL cholesterol/LDL-C",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "10-20mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Inflammation burden decrease → cortical thinning slope slightly reduced (empirical model)",
                      "formula": "CT_t = currentValue - (0.04 - 0.005) * (t/12)",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": 0.005,
                      "standardDeviation": 0.004,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:WMH_vol",
        "label": "White matter hyperintensity volume",
        "unit": "mL",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Cerebral Small Vessel Disease",
              "diagnosticCriteria": "MRI shows diffuse or patchy white matter hyperintensities, often with cognitive decline",
              "recommendedDrugs": [
                {
                  "drugName": "Edaravone",
                  "drugClass": "Free Radical Scavenger",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "30mg",
                    "frequency": "Twice daily (IV infusion)",
                    "route": "Intravenous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Slowing white matter lesion progression",
                      "formula": "Approximately 30% reduction in annual progression rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:CBF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 4,
                      "standardDeviation": 2,
                      "unit": "mL/100g/min",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Stable or mild improvement",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.8,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Aspirin + Statin",
                  "drugClass": "Antiplatelet + Lipid-lowering Drug",
                  "dosage": {
                    "initialDose": "Aspirin 100mg + Atorvastatin 20mg",
                    "maintenanceDose": "Aspirin 100mg + Atorvastatin 20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48 weeks",
                    "calculation": {
                      "method": "Slowing white matter lesion progression",
                      "formula": "Approximately 25% reduction in annual progression rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.5,
                      "unit": "mg/L",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Stable",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hypertensive Encephalopathy",
              "diagnosticCriteria": "History of long-term hypertension, white matter hyperintensity volume increase, poor blood pressure control",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril",
                  "drugClass": "Angiotensin-Converting Enzyme Inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Blood pressure control reduces white matter damage",
                      "formula": "Approximately 35% reduction in annual progression rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -18,
                      "standardDeviation": 6,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:CBF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "unit": "mL/100g/min",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:CVR",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.02,
                      "unit": "%/mmHg",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Multiple Sclerosis",
              "diagnosticCriteria": "Relapsing-remitting clinical symptoms, MRI shows multiple demyelinating lesions",
              "recommendedDrugs": [
                {
                  "drugName": "Fingolimod",
                  "drugClass": "Sphingosine-1-Phosphate Receptor Modulator",
                  "dosage": {
                    "initialDose": "0.5mg",
                    "maintenanceDose": "0.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Reducing new lesions",
                      "formula": "Approximately 54% reduction in relapse rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.54,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 20
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 5,
                      "unit": "ms",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Stable or improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Cerebral Small Vessel Disease/Hypertension-Related Brain Lesions",
              "diagnosticCriteria": "MRI shows increased WMH with long-term elevated blood pressure",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril + Indapamide",
                  "drugClass": "ACEI + Thiazide-like Diuretic",
                  "dosage": {
                    "initialDose": "Perindopril 4mg + Indapamide 1.25mg",
                    "maintenanceDose": "Perindopril 4-8mg + Indapamide 1.25-2.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Linear growth rate decrease (WMH volume annual increase slowing)",
                      "formula": "WMH_t = currentValue + (growthRate_base - 0.8) * (t/12)",
                      "parameters": {
                        "growthRate_base": "2.0 mL/year (example)",
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.4,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase (from indapamide)",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Valsartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "80mg",
                    "maintenanceDose": "80-160mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Linear growth rate decrease",
                      "formula": "WMH_t = currentValue + (growthRate_base - 0.5) * (t/12)",
                      "parameters": {
                        "growthRate_base": "2.0 mL/year (example)",
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Type 2 Diabetes with Elevated Blood Pressure",
              "diagnosticCriteria": "Confirmed T2DM with clinic or ambulatory blood pressure elevation",
              "recommendedDrugs": [
                {
                  "drugName": "Candesartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "8mg",
                    "maintenanceDose": "16-32mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Linear growth rate decrease",
                      "formula": "WMH_t = currentValue + (growthRate_base - 0.4) * (t/12)",
                      "parameters": {
                        "growthRate_base": "2.0 mL/year (example)",
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.25,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:Lacunes",
        "label": "Lacunar infarcts (count)",
        "unit": "count",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Lacunar Infarction",
              "diagnosticCriteria": "MRI shows deep infarcts <15mm in diameter, often with hypertension or diabetes",
              "recommendedDrugs": [
                {
                  "drugName": "Clopidogrel",
                  "drugClass": "Antiplatelet Drug",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "75mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "Long-term maintenance",
                    "calculation": {
                      "method": "Reducing new lacunes",
                      "formula": "Approximately 25% reduction in annual new infarct risk",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Slight increase in risk",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.15,
                      "unit": "count",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Aspirin Combined with Clopidogrel (Short-term)",
                  "drugClass": "Dual Antiplatelet",
                  "dosage": {
                    "initialDose": "Aspirin 100mg + Clopidogrel 75mg",
                    "maintenanceDose": "Switch to monotherapy after 21 days",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "3 weeks dual + long-term monotherapy",
                    "calculation": {
                      "method": "Acute phase reducing recurrence",
                      "formula": "32% reduction in 90-day stroke recurrence risk",
                      "parameters": {
                        "t": "Days after medication"
                      },
                      "expectedMeanChange": -0.32,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "count",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "g/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Aspirin",
                  "drugClass": "Antiplatelet Drug",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Event generation rate decrease (new lacunes reduction)",
                      "formula": "count_new_t = count_base - 0.2 * (t/12)",
                      "parameters": {
                        "t": "Months",
                        "count_base": "Expected annual new lacune count (example 0.4)"
                      },
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "count",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Event risk decrease (new lacunes reduction)",
                      "formula": "count_new_t = count_base - 0.1 * (t/12)",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Cerebral Small Vessel Disease with Lacunes",
              "diagnosticCriteria": "Multiple lacunar infarcts, with white matter hyperintensities and vascular risk factors",
              "recommendedDrugs": [
                {
                  "drugName": "Cilostazol",
                  "drugClass": "Phosphodiesterase-3 Inhibitor",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "Long-term maintenance",
                    "calculation": {
                      "method": "Reducing stroke recurrence",
                      "formula": "Approximately 20% reduction in stroke recurrence risk",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:WMH_vol",
                      "expectedTrend": "Slowed progression",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.15,
                      "unit": "mL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hypertension with Asymptomatic Brain Infarcts",
              "diagnosticCriteria": "Poor blood pressure control, imaging reveals multiple lacunes but asymptomatic",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril + Indapamide",
                  "drugClass": "ACEI + Diuretic Combination",
                  "dosage": {
                    "initialDose": "Perindopril 4mg + Indapamide 1.25mg",
                    "maintenanceDose": "Perindopril 8mg + Indapamide 2.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Intensive blood pressure lowering reduces new infarcts",
                      "formula": "Approximately 40% reduction in new lacune risk",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Significant decrease",
                      "expectedMeanChange": -22,
                      "standardDeviation": 8,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:WMH_vol",
                      "expectedTrend": "Slowed progression",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "mL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Lacunar Cerebral Infarction History (Small Vessel Disease)",
              "diagnosticCriteria": "MRI shows basal ganglia/thalamus/brainstem ≤15mm lacunar lesions",
              "recommendedDrugs": [
                {
                  "drugName": "Aspirin",
                  "drugClass": "Antiplatelet Drug",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Event generation rate decrease (new lacunes reduction)",
                      "formula": "count_new_t = count_base - 0.2 * (t/12)",
                      "parameters": {
                        "t": "Months",
                        "count_base": "Expected annual new lacune count (example 0.4)"
                      },
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "count",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Event risk decrease (new lacunes reduction)",
                      "formula": "count_new_t = count_base - 0.1 * (t/12)",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:Microbleeds",
        "label": "Cerebral microbleeds (count)",
        "unit": "count",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Cerebral Amyloid Angiopathy",
              "diagnosticCriteria": "Multiple microbleeds (≥5) in lobar regions, typically elderly patients, possibly with cognitive decline",
              "recommendedDrugs": [
                {
                  "drugName": "Strict Blood Pressure Control (without antiplatelet drugs)",
                  "drugClass": "Comprehensive Blood Pressure Management",
                  "dosage": {
                    "initialDose": "Target SBP<130mmHg",
                    "maintenanceDose": "Maintain SBP 110-130mmHg",
                    "frequency": "Continuous",
                    "route": "Multiple antihypertensive combinations"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Reducing new microbleeds",
                      "formula": "Approximately 30% reduction in new microbleed rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 10
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease to target",
                      "expectedMeanChange": -20,
                      "standardDeviation": 8,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Stable",
                      "expectedMeanChange": 0,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "GV-971 (Sodium Oligomannate Capsules)",
                  "drugClass": "Anti-Alzheimer's Disease Drug",
                  "dosage": {
                    "initialDose": "450mg",
                    "maintenanceDose": "450mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Improving cognition slowing lesions",
                      "formula": "Cognitive score improvement approximately 2.5 points",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.8,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hypertensive Microangiopathy",
              "diagnosticCriteria": "Multiple microbleeds in deep brain tissue (basal ganglia, thalamus), history of long-term hypertension",
              "recommendedDrugs": [
                {
                  "drugName": "Irbesartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "300mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48 weeks",
                    "calculation": {
                      "method": "Blood pressure control reduces new microbleeds",
                      "formula": "Approximately 35% reduction in new microbleed rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -18,
                      "standardDeviation": 7,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_night",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -20,
                      "standardDeviation": 8,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Lacunes",
                      "expectedTrend": "Slowed progression",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.15,
                      "unit": "count",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Anticoagulation-Related Microbleeds",
              "diagnosticCriteria": "Patients on anticoagulant therapy (e.g., warfarin), imaging shows increased microbleeds",
              "recommendedDrugs": [
                {
                  "drugName": "Dabigatran Etexilate (Switch Anticoagulant)",
                  "drugClass": "Direct Thrombin Inhibitor",
                  "dosage": {
                    "initialDose": "110mg",
                    "maintenanceDose": "110-150mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Reducing intracranial bleeding risk",
                      "formula": "Approximately 60% reduction in bleeding risk compared to warfarin",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.25,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 12
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Monitoring required",
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.03,
                      "unit": "mg/L",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Apixaban",
                  "drugClass": "Factor Xa Inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "5mg (or 2.5mg if dose reduction criteria met)",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Reducing intracranial bleeding risk",
                      "formula": "Approximately 58% reduction in bleeding risk compared to warfarin",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.58,
                      "standardDeviation": 0.23,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 12
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.3,
                      "unit": "g/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Cerebral Amyloid Angiopathy (CAA)",
              "diagnosticCriteria": "Elderly patients, lobar posterior parietal/occipital subcortical microbleeds, with amyloid-related presentations",
              "recommendedDrugs": [
                {
                  "drugName": "Candesartan",
                  "drugClass": "ARB (Blood pressure control, reducing new microbleed risk)",
                  "dosage": {
                    "initialDose": "8mg",
                    "maintenanceDose": "16-32mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Event generation rate decrease",
                      "formula": "CMB_new_t = CMB_base - 0.1 * (t/12)",
                      "parameters": {
                        "t": "Months",
                        "CMB_base": "Expected annual new microbleed count (example 0.3)"
                      },
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Hypertensive Arteriosclerosis",
              "diagnosticCriteria": "Long-term hypertension, deep (basal ganglia/brainstem) microbleeds predominant",
              "recommendedDrugs": [
                {
                  "drugName": "Amlodipine",
                  "drugClass": "Dihydropyridine Calcium Channel Blocker (blood pressure lowering)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "5-10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Event generation rate decrease",
                      "formula": "CMB_new_t = CMB_base - 0.08 * (t/12)",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.08,
                      "standardDeviation": 0.06,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:ARB_use",
        "label": "ARB (assignment)",
        "unit": "binary",
        "system": "CARDIO",
        "type": "exposure",
        "datasetHint": [
          "018-medications"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Essential Hypertension",
              "diagnosticCriteria": "Without antihypertensive medication, three measurements on different days with SBP≥140mmHg and/or DBP≥90mmHg",
              "recommendedDrugs": [
                {
                  "drugName": "Valsartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "80mg",
                    "maintenanceDose": "160mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (18 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -18,
                      "standardDeviation": 7,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.2,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Losartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-6 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (16 * (t / 6))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -16,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.2,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Valsartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "80mg",
                    "maintenanceDose": "80-160mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Logistic probability model (medication assignment probability increases)",
                      "formula": "p_new = logistic(logit(p_current) + Δ)",
                      "parameters": {
                        "p_current": "Current probability of ARB_use=1 (0-1)",
                        "Δ": "+1.2 (represents increase in log odds of initiating ARB prescription)"
                      },
                      "expectedMeanChange": 0.7,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0.6,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": []
                },
                {
                  "drugName": "Losartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) + 0.9)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Diabetic Nephropathy",
              "diagnosticCriteria": "Diabetic patients with urinary albumin/creatinine ratio≥30mg/g, or eGFR<60 mL/min/1.73m²",
              "recommendedDrugs": [
                {
                  "drugName": "Irbesartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "300mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (25 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -25,
                      "standardDeviation": 8,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "unit": "g/d",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 0.1,
                      "standardDeviation": 0.05,
                      "unit": "mg/L",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Candesartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "8mg",
                    "maintenanceDose": "16-32mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Logistic probability model (more likely to initiate when proteinuria present)",
                      "formula": "p_new = logistic(logit(p_current) + 1.4)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.75,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.6,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Chronic Heart Failure",
              "diagnosticCriteria": "Clinical symptoms (dyspnea, edema) with LVEF≤40% or BNP≥100 pg/mL",
              "recommendedDrugs": [
                {
                  "drugName": "Candesartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "32mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (12 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -80,
                      "standardDeviation": 30,
                      "unit": "pg/mL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 5,
                      "standardDeviation": 2,
                      "unit": "%",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Valsartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "40-80mg",
                    "maintenanceDose": "160mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) + 1.1)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.65,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:Thiazide_use",
        "label": "Thiazide diuretic (assignment)",
        "unit": "binary",
        "system": "CARDIO",
        "type": "exposure",
        "datasetHint": [
          "018-medications"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Mild to Moderate Essential Hypertension",
              "diagnosticCriteria": "SBP 140-179mmHg and/or DBP 90-109mmHg, without other complications",
              "recommendedDrugs": [
                {
                  "drugName": "Hydrochlorothiazide",
                  "drugClass": "Thiazide Diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (15 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -15,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.15,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Indapamide",
                  "drugClass": "Thiazide-like Diuretic",
                  "dosage": {
                    "initialDose": "1.5mg",
                    "maintenanceDose": "2.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (18 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -18,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Hydrochlorothiazide",
                  "drugClass": "Thiazide Diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "12.5-25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-4 weeks",
                    "calculation": {
                      "method": "Logistic probability model (medication assignment probability increases)",
                      "formula": "p_new = logistic(logit(p_current) + 1.0)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Isolated Systolic Hypertension in Elderly",
              "diagnosticCriteria": "Age≥65 years, SBP≥140mmHg, DBP<90mmHg",
              "recommendedDrugs": [
                {
                  "drugName": "Chlorthalidone",
                  "drugClass": "Thiazide-like Diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-6 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (20 * (t / 6))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -20,
                      "standardDeviation": 7,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.5,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3,
                      "standardDeviation": 1,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Recurrent Calcium Nephrolithiasis (Renal Hypercalciuria)",
              "diagnosticCriteria": "History of at least two calcium stone episodes with elevated urinary calcium",
              "recommendedDrugs": [
                {
                  "drugName": "Indapamide",
                  "drugClass": "Thiazide-like Diuretic",
                  "dosage": {
                    "initialDose": "1.25mg",
                    "maintenanceDose": "1.25-2.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) + 0.8)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.55,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.4,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:BB_use",
        "label": "Beta-blocker (assignment)",
        "unit": "binary",
        "system": "CARDIO",
        "type": "exposure",
        "datasetHint": [
          "018-medications"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Stable Angina Pectoris",
              "diagnosticCriteria": "Typical angina symptoms, coronary angiography showing ≥50% stenosis or positive stress test",
              "recommendedDrugs": [
                {
                  "drugName": "Metoprolol",
                  "drugClass": "Selective β1 Receptor Blocker",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (12 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 15,
                      "standardDeviation": 5,
                      "unit": "ms",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Bisoprolol",
                  "drugClass": "Selective β1 Receptor Blocker",
                  "dosage": {
                    "initialDose": "2.5mg",
                    "maintenanceDose": "5-10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (15 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -15,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 18,
                      "standardDeviation": 6,
                      "unit": "ms",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Heart Failure (Heart Failure with Reduced Ejection Fraction)",
              "diagnosticCriteria": "NYHA II-IV, LVEF≤40%",
              "recommendedDrugs": [
                {
                  "drugName": "Carvedilol",
                  "drugClass": "Non-selective Beta Blocker",
                  "dosage": {
                    "initialDose": "3.125mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (10 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 100,
                        "upperBound": 120
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 6,
                      "standardDeviation": 3,
                      "unit": "%",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -100,
                      "standardDeviation": 40,
                      "unit": "pg/mL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:LVMI",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "unit": "g/m2",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Tachyarrhythmia",
              "diagnosticCriteria": "Atrial fibrillation or supraventricular tachycardia, resting heart rate >100 bpm",
              "recommendedDrugs": [
                {
                  "drugName": "Metoprolol Succinate Extended-Release",
                  "drugClass": "Selective β1 Receptor Blocker",
                  "dosage": {
                    "initialDose": "47.5mg",
                    "maintenanceDose": "95-190mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (8 * (t / 2))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 110,
                        "upperBound": 130
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 20,
                      "standardDeviation": 7,
                      "unit": "ms",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Post-Myocardial Infarction (Secondary Prevention)",
              "diagnosticCriteria": "Confirmed acute myocardial infarction during discharge and outpatient follow-up",
              "recommendedDrugs": [
                {
                  "drugName": "Metoprolol Succinate Extended-Release",
                  "drugClass": "Beta Blocker",
                  "dosage": {
                    "initialDose": "25-50mg",
                    "maintenanceDose": "100-200mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Logistic probability model (medication assignment probability increases)",
                      "formula": "p_new = logistic(logit(p_current) + 1.1)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.65,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.6,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VO2max",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.8,
                      "unit": "mL/kg/min",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Atrial Fibrillation (Ventricular Rate Control)",
              "diagnosticCriteria": "ECG confirmed atrial fibrillation, requiring ventricular rate control",
              "recommendedDrugs": [
                {
                  "drugName": "Bisoprolol",
                  "drugClass": "Beta Blocker",
                  "dosage": {
                    "initialDose": "1.25-2.5mg",
                    "maintenanceDose": "2.5-10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1 week",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) + 1.3)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": 0.7,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:Smoking_status",
        "label": "Current smoking",
        "unit": "binary",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "055-lifestyle_and_environment"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Tobacco Dependence Syndrome",
              "diagnosticCriteria": "Continuous smoking ≥6 months, daily smoking ≥10 cigarettes, with withdrawal symptoms",
              "recommendedDrugs": [
                {
                  "drugName": "Varenicline",
                  "drugClass": "Partial Nicotinic Receptor Agonist",
                  "dosage": {
                    "initialDose": "0.5mg",
                    "maintenanceDose": "1mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Smoking cessation success rate",
                      "formula": "Success rate approximately 44%",
                      "parameters": {
                        "t": "Treatment weeks"
                      },
                      "expectedMeanChange": 0.44,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.8,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Nicotine Replacement Patch",
                  "drugClass": "Nicotine Replacement Therapy",
                  "dosage": {
                    "initialDose": "21mg/24h",
                    "maintenanceDose": "14mg/24h then reduce to 7mg/24h",
                    "frequency": "Once daily",
                    "route": "Transdermal patch"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Smoking cessation success rate",
                      "formula": "Success rate approximately 23%",
                      "parameters": {
                        "t": "Treatment weeks"
                      },
                      "expectedMeanChange": 0.23,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 8,
                      "standardDeviation": 3,
                      "unit": "ms",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.2,
                      "unit": "mg/L",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Varenicline",
                  "drugClass": "Partial Agonist (α4β2 Nicotinic Receptor)",
                  "dosage": {
                    "initialDose": "0.5mg (Day 1-3)",
                    "maintenanceDose": "1mg",
                    "frequency": "Twice daily (from Day 8)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logistic probability model (smoking probability decrease)",
                      "formula": "p_new = logistic(logit(p_current) - 0.8)",
                      "parameters": {
                        "p_current": "Current smoking probability"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.6
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Bupropion Extended-Release",
                  "drugClass": "Norepinephrine-Dopamine Reuptake Inhibitor",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "150mg",
                    "frequency": "Twice daily (from Day 4)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "7-12 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) - 0.6)",
                      "parameters": {
                        "p_current": "Current smoking probability"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.7
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2.0,
                      "standardDeviation": 2.0,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Smoking-Related Cardiovascular Disease Risk",
              "diagnosticCriteria": "Current smoking with cardiovascular risk factors (hypertension, hyperlipidemia, or diabetes)",
              "recommendedDrugs": [
                {
                  "drugName": "Bupropion Hydrochloride Extended-Release",
                  "drugClass": "Antidepressant (Smoking Cessation Indication)",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "150mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Smoking cessation success rate",
                      "formula": "Success rate approximately 30%",
                      "parameters": {
                        "t": "Treatment weeks"
                      },
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.13,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 3,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Tobacco Use Disorder",
              "diagnosticCriteria": "Meets DSM/ICD addiction/dependence diagnostic criteria, persistent smoking behavior",
              "recommendedDrugs": [
                {
                  "drugName": "Varenicline",
                  "drugClass": "Partial Agonist (α4β2 Nicotinic Receptor)",
                  "dosage": {
                    "initialDose": "0.5mg (Day 1-3)",
                    "maintenanceDose": "1mg",
                    "frequency": "Twice daily (from Day 8)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logistic probability model (smoking probability decrease)",
                      "formula": "p_new = logistic(logit(p_current) - 0.8)",
                      "parameters": {
                        "p_current": "Current smoking probability"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.6
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Bupropion Extended-Release",
                  "drugClass": "Norepinephrine-Dopamine Reuptake Inhibitor",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "150mg",
                    "frequency": "Twice daily (from Day 4)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "7-12 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) - 0.6)",
                      "parameters": {
                        "p_current": "Current smoking probability"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.7
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2.0,
                      "standardDeviation": 2.0,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Obstructive Pulmonary Disease (COPD)",
              "diagnosticCriteria": "Pulmonary function test FEV1/FVC<0.70 with smoking history",
              "recommendedDrugs": [
                {
                  "drugName": "Varenicline",
                  "drugClass": "Smoking Cessation Drug",
                  "dosage": {
                    "initialDose": "0.5mg",
                    "maintenanceDose": "1mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) - 0.9)",
                      "parameters": {
                        "p_current": "Current smoking probability"
                      },
                      "expectedMeanChange": -0.38,
                      "standardDeviation": 0.16,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.6
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "CARDIO:Alcohol_high",
        "label": "High alcohol intake",
        "unit": "binary",
        "system": "CARDIO",
        "type": "state",
        "datasetHint": [
          "055-lifestyle_and_environment"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Alcohol Dependence Syndrome",
              "diagnosticCriteria": "Daily alcohol intake exceeding 40g pure alcohol for males, 20g for females, lasting ≥12 months, with withdrawal symptoms",
              "recommendedDrugs": [
                {
                  "drugName": "Naltrexone",
                  "drugClass": "Opioid Receptor Antagonist",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "50mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Reduction in alcohol consumption",
                      "formula": "Approximately 40% reduction in drinking days",
                      "parameters": {
                        "t": "Treatment weeks"
                      },
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Slight change",
                      "expectedMeanChange": 1,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:Albumin_serum",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "g/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Acamprosate Calcium",
                  "drugClass": "Glutamate Modulator",
                  "dosage": {
                    "initialDose": "666mg",
                    "maintenanceDose": "666mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Abstinence maintenance rate",
                      "formula": "Approximately 36% continuous abstinence rate",
                      "parameters": {
                        "t": "Treatment weeks"
                      },
                      "expectedMeanChange": 0.36,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Naltrexone",
                  "drugClass": "Opioid Receptor Antagonist",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "50mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Logistic probability model (high drinking probability decrease)",
                      "formula": "p_new = logistic(logit(p_current) - 0.7)",
                      "parameters": {
                        "p_current": "Current high drinking probability"
                      },
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.7
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Acamprosate",
                  "drugClass": "Glutamate/GABA Modulator",
                  "dosage": {
                    "initialDose": "666mg",
                    "maintenanceDose": "666mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) - 0.6)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": -0.22,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.75
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Alcoholic Cardiomyopathy",
              "diagnosticCriteria": "History of long-term heavy drinking, LVEF<50%, elevated BNP, excluding other causes of cardiomyopathy",
              "recommendedDrugs": [
                {
                  "drugName": "Disulfiram",
                  "drugClass": "Alcohol Metabolism Inhibitor",
                  "dosage": {
                    "initialDose": "250mg",
                    "maintenanceDose": "250mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Complete abstinence",
                      "formula": "Complete abstinence required to improve cardiac function",
                      "parameters": {
                        "t": "Weeks of abstinence"
                      },
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Improvement (after abstinence)",
                      "expectedMeanChange": 8,
                      "standardDeviation": 4,
                      "unit": "%",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease (after abstinence)",
                      "expectedMeanChange": -120,
                      "standardDeviation": 50,
                      "unit": "pg/mL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:Albumin_serum",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.15,
                      "unit": "g/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Alcohol Use Disorder (AUD)",
              "diagnosticCriteria": "In the past 12 months, meets multiple criteria for impaired/loss-of-control alcohol use",
              "recommendedDrugs": [
                {
                  "drugName": "Naltrexone",
                  "drugClass": "Opioid Receptor Antagonist",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "50mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Logistic probability model (high drinking probability decrease)",
                      "formula": "p_new = logistic(logit(p_current) - 0.7)",
                      "parameters": {
                        "p_current": "Current high drinking probability"
                      },
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.7
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Acamprosate",
                  "drugClass": "Glutamate/GABA Modulator",
                  "dosage": {
                    "initialDose": "666mg",
                    "maintenanceDose": "666mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logistic probability model",
                      "formula": "p_new = logistic(logit(p_current) - 0.6)",
                      "parameters": {
                        "p_current": "Current probability"
                      },
                      "expectedMeanChange": -0.22,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0.0,
                        "upperBound": 0.75
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:HV",
        "label": "Hippocampal volume",
        "unit": "mL",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Early Alzheimer's Disease (MCI Stage)",
              "diagnosticCriteria": "Mild cognitive decline, hippocampal volume reduction >1.5 SD, memory score decline",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase Inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Slowing atrophy rate",
                      "formula": "Approximately 30% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 3.0,
                        "upperBound": 4.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement or stabilization",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Mild improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Memantine",
                  "drugClass": "NMDA Receptor Antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Slowing atrophy rate",
                      "formula": "Approximately 25% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.25,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 3.0,
                        "upperBound": 4.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Slight increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Lecanemab",
                  "drugClass": "Anti-Aβ Monoclonal Antibody",
                  "dosage": {
                    "initialDose": "10mg/kg",
                    "maintenanceDose": "10mg/kg",
                    "frequency": "Every two weeks",
                    "route": "Intravenous infusion"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Linear slope reduction (hippocampal volume annual decline reduction)",
                      "formula": "HV_t = currentValue - (declineRate_base - delta) * (t/12)",
                      "parameters": {
                        "t": "Months after treatment",
                        "declineRate_base": "1.0 mL/year (assumed)",
                        "delta": "0.2 mL/year (reduction magnitude)"
                      },
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "count",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Temporal Lobe Epilepsy with Hippocampal Sclerosis",
              "diagnosticCriteria": "Recurrent focal seizures, imaging shows hippocampal volume reduction and T2 signal increase",
              "recommendedDrugs": [
                {
                  "drugName": "Levetiracetam",
                  "drugClass": "Antiepileptic Drug",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "1000-1500mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Control epileptic seizures",
                      "formula": "Seizure frequency reduction >50%",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 2.5,
                        "upperBound": 4.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 3,
                      "standardDeviation": 2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Slight improvement",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.8,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Stress-Related Hippocampal Atrophy",
              "diagnosticCriteria": "History of long-term depression or anxiety, hippocampal volume reduction, mild cognitive decline",
              "recommendedDrugs": [
                {
                  "drugName": "Sertraline",
                  "drugClass": "Selective Serotonin Reuptake Inhibitor (SSRI)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Neuroprotective effect",
                      "formula": "May promote hippocampal neurogenesis",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 3.0,
                        "upperBound": 4.5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Significant improvement",
                      "expectedMeanChange": -6,
                      "standardDeviation": 2.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Significant improvement",
                      "expectedMeanChange": -5,
                      "standardDeviation": 2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Sertraline",
                  "drugClass": "Selective Serotonin Reuptake Inhibitor (SSRI)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-12 months",
                    "calculation": {
                      "method": "Linear micro-increase/atrophy slowing",
                      "formula": "HV_t = currentValue + 0.05 * (t/6)",
                      "parameters": {
                        "t": "Months after treatment"
                      },
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.05,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Short-term increase (initial phase)",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Major Depressive Disorder (Recurrent-Remitting Type)",
              "diagnosticCriteria": "Meets diagnostic criteria for depressive episode, excluding organic lesions",
              "recommendedDrugs": [
                {
                  "drugName": "Sertraline",
                  "drugClass": "Selective 5-HT Reuptake Inhibitor (SSRI)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-12 months",
                    "calculation": {
                      "method": "Linear micro-increase/atrophy slowing",
                      "formula": "HV_t = currentValue + 0.05 * (t/6)",
                      "parameters": {
                        "t": "Months after treatment"
                      },
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.05,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Short-term increase (initial phase)",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:CT_thick",
        "label": "Global cortical thickness",
        "unit": "mm",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Alzheimer's Disease",
              "diagnosticCriteria": "Progressive cognitive decline, global cortical thickness reduction >2 SD, especially in temporoparietal regions",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase Inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48 weeks",
                    "calculation": {
                      "method": "Slowing cortical atrophy",
                      "formula": "Approximately 35% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.35,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 2.3,
                        "upperBound": 2.8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ProcSpeed",
                      "expectedTrend": "Mild improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Memantine Combined with Donepezil",
                  "drugClass": "NMDA Receptor Antagonist + Cholinesterase Inhibitor",
                  "dosage": {
                    "initialDose": "Memantine 5mg + Donepezil 5mg",
                    "maintenanceDose": "Memantine 20mg + Donepezil 10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48-72 weeks",
                    "calculation": {
                      "method": "Combined therapy slowing atrophy",
                      "formula": "Approximately 40% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 2.3,
                        "upperBound": 2.8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Significant improvement",
                      "expectedMeanChange": 3.5,
                      "standardDeviation": 2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Significant improvement",
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Frontotemporal Dementia",
              "diagnosticCriteria": "Behavioral or language abnormalities predominant, frontal and anterior temporal cortical thinning",
              "recommendedDrugs": [
                {
                  "drugName": "Memantine Hydrochloride",
                  "drugClass": "NMDA Receptor Antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Slowing atrophy progression",
                      "formula": "Approximately 20% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 2.0,
                        "upperBound": 2.6
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Mild improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Mild improvement",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Cerebral Small Vessel Disease",
              "diagnosticCriteria": "White matter lesions with cortical thinning, cognitive decline, vascular risk factors",
              "recommendedDrugs": [
                {
                  "drugName": "Nimodipine",
                  "drugClass": "Calcium Channel Blocker",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "30mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Improving cerebral blood flow to protect cortex",
                      "formula": "Approximately 25% reduction in annual atrophy rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": 0.25,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 2.2,
                        "upperBound": 2.7
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:CBF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 5,
                      "standardDeviation": 2,
                      "unit": "mL/100g/min",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Cerebral Small Vessel Disease (with Hypertension)",
              "diagnosticCriteria": "Imaging shows WMH/lacunes/microbleeds with long-term hypertension history",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "4-8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Linear slope reduction (cortical thickness thinning rate decrease)",
                      "formula": "CT_t = currentValue - (0.04 - 0.01) * (t/12)",
                      "parameters": {
                        "t": "Months",
                        "0.04": "mm/year, baseline thinning rate (example)",
                        "0.01": "mm/year, treatment-reduced rate"
                      },
                      "expectedMeanChange": 0.01,
                      "standardDeviation": 0.005,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Atherosclerotic High-Risk State (Hyperlipidemia)",
              "diagnosticCriteria": "Elevated non-HDL cholesterol/LDL-C",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "10-20mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Inflammation burden decrease → cortical thinning slope slightly reduced (empirical model)",
                      "formula": "CT_t = currentValue - (0.04 - 0.005) * (t/12)",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": 0.005,
                      "standardDeviation": 0.004,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:WMH_vol",
        "label": "White matter hyperintensity volume",
        "unit": "mL",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Cerebral Small Vessel Disease",
              "diagnosticCriteria": "MRI shows diffuse or patchy white matter hyperintensities, often with cognitive decline",
              "recommendedDrugs": [
                {
                  "drugName": "Edaravone",
                  "drugClass": "Free Radical Scavenger",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "30mg",
                    "frequency": "Twice daily (IV infusion)",
                    "route": "Intravenous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Slowing white matter lesion progression",
                      "formula": "Approximately 30% reduction in annual progression rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:CBF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 4,
                      "standardDeviation": 2,
                      "unit": "mL/100g/min",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Stable or mild improvement",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.8,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Aspirin + Statin",
                  "drugClass": "Antiplatelet + Lipid-lowering Drug",
                  "dosage": {
                    "initialDose": "Aspirin 100mg + Atorvastatin 20mg",
                    "maintenanceDose": "Aspirin 100mg + Atorvastatin 20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48 weeks",
                    "calculation": {
                      "method": "Slowing white matter lesion progression",
                      "formula": "Approximately 25% reduction in annual progression rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.5,
                      "unit": "mg/L",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Stable",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 1,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hypertensive Encephalopathy",
              "diagnosticCriteria": "History of long-term hypertension, white matter hyperintensity volume increase, poor blood pressure control",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril",
                  "drugClass": "Angiotensin-Converting Enzyme Inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Blood pressure control reduces white matter damage",
                      "formula": "Approximately 35% reduction in annual progression rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -18,
                      "standardDeviation": 6,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:CBF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "unit": "mL/100g/min",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:CVR",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.02,
                      "unit": "%/mmHg",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Multiple Sclerosis",
              "diagnosticCriteria": "Relapsing-remitting clinical symptoms, MRI shows multiple demyelinating lesions",
              "recommendedDrugs": [
                {
                  "drugName": "Fingolimod",
                  "drugClass": "Sphingosine-1-Phosphate Receptor Modulator",
                  "dosage": {
                    "initialDose": "0.5mg",
                    "maintenanceDose": "0.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Reducing new lesions",
                      "formula": "Approximately 54% reduction in relapse rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.54,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 20
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 5,
                      "unit": "ms",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Stable or improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1.2,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Cerebral Small Vessel Disease/Hypertension-Related Brain Lesions",
              "diagnosticCriteria": "MRI shows increased WMH with long-term elevated blood pressure",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril + Indapamide",
                  "drugClass": "ACEI + Thiazide-like Diuretic",
                  "dosage": {
                    "initialDose": "Perindopril 4mg + Indapamide 1.25mg",
                    "maintenanceDose": "Perindopril 4-8mg + Indapamide 1.25-2.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Linear growth rate decrease (WMH volume annual increase slowing)",
                      "formula": "WMH_t = currentValue + (growthRate_base - 0.8) * (t/12)",
                      "parameters": {
                        "growthRate_base": "2.0 mL/year (example)",
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.4,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase (from indapamide)",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Valsartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "80mg",
                    "maintenanceDose": "80-160mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Linear growth rate decrease",
                      "formula": "WMH_t = currentValue + (growthRate_base - 0.5) * (t/12)",
                      "parameters": {
                        "growthRate_base": "2.0 mL/year (example)",
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Type 2 Diabetes with Elevated Blood Pressure",
              "diagnosticCriteria": "Confirmed T2DM with clinic or ambulatory blood pressure elevation",
              "recommendedDrugs": [
                {
                  "drugName": "Candesartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "8mg",
                    "maintenanceDose": "16-32mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Linear growth rate decrease",
                      "formula": "WMH_t = currentValue + (growthRate_base - 0.4) * (t/12)",
                      "parameters": {
                        "growthRate_base": "2.0 mL/year (example)",
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.25,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:Lacunes",
        "label": "Lacunar infarcts (count)",
        "unit": "count",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Lacunar Infarction",
              "diagnosticCriteria": "MRI shows deep infarcts <15mm in diameter, often with hypertension or diabetes",
              "recommendedDrugs": [
                {
                  "drugName": "Clopidogrel",
                  "drugClass": "Antiplatelet Drug",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "75mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "Long-term maintenance",
                    "calculation": {
                      "method": "Reducing new lacunes",
                      "formula": "Approximately 25% reduction in annual new infarct risk",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Slight increase in risk",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.15,
                      "unit": "count",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Aspirin Combined with Clopidogrel (Short-term)",
                  "drugClass": "Dual Antiplatelet",
                  "dosage": {
                    "initialDose": "Aspirin 100mg + Clopidogrel 75mg",
                    "maintenanceDose": "Switch to monotherapy after 21 days",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "3 weeks dual + long-term monotherapy",
                    "calculation": {
                      "method": "Acute phase reducing recurrence",
                      "formula": "32% reduction in 90-day stroke recurrence risk",
                      "parameters": {
                        "t": "Days after medication"
                      },
                      "expectedMeanChange": -0.32,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "count",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "g/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Aspirin",
                  "drugClass": "Antiplatelet Drug",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Event generation rate decrease (new lacunes reduction)",
                      "formula": "count_new_t = count_base - 0.2 * (t/12)",
                      "parameters": {
                        "t": "Months",
                        "count_base": "Expected annual new lacune count (example 0.4)"
                      },
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "count",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Event risk decrease (new lacunes reduction)",
                      "formula": "count_new_t = count_base - 0.1 * (t/12)",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Cerebral Small Vessel Disease with Lacunes",
              "diagnosticCriteria": "Multiple lacunar infarcts, with white matter hyperintensities and vascular risk factors",
              "recommendedDrugs": [
                {
                  "drugName": "Cilostazol",
                  "drugClass": "Phosphodiesterase-3 Inhibitor",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "Long-term maintenance",
                    "calculation": {
                      "method": "Reducing stroke recurrence",
                      "formula": "Approximately 20% reduction in stroke recurrence risk",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:WMH_vol",
                      "expectedTrend": "Slowed progression",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.15,
                      "unit": "mL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hypertension with Asymptomatic Brain Infarcts",
              "diagnosticCriteria": "Poor blood pressure control, imaging reveals multiple lacunes but asymptomatic",
              "recommendedDrugs": [
                {
                  "drugName": "Perindopril + Indapamide",
                  "drugClass": "ACEI + Diuretic Combination",
                  "dosage": {
                    "initialDose": "Perindopril 4mg + Indapamide 1.25mg",
                    "maintenanceDose": "Perindopril 8mg + Indapamide 2.5mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Intensive blood pressure lowering reduces new infarcts",
                      "formula": "Approximately 40% reduction in new lacune risk",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Significant decrease",
                      "expectedMeanChange": -22,
                      "standardDeviation": 8,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:WMH_vol",
                      "expectedTrend": "Slowed progression",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "mL",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Lacunar Cerebral Infarction History (Small Vessel Disease)",
              "diagnosticCriteria": "MRI shows basal ganglia/thalamus/brainstem ≤15mm lacunar lesions",
              "recommendedDrugs": [
                {
                  "drugName": "Aspirin",
                  "drugClass": "Antiplatelet Drug",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Event generation rate decrease (new lacunes reduction)",
                      "formula": "count_new_t = count_base - 0.2 * (t/12)",
                      "parameters": {
                        "t": "Months",
                        "count_base": "Expected annual new lacune count (example 0.4)"
                      },
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "count",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Event risk decrease (new lacunes reduction)",
                      "formula": "count_new_t = count_base - 0.1 * (t/12)",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:Microbleeds",
        "label": "Cerebral microbleeds (count)",
        "unit": "count",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Cerebral Amyloid Angiopathy",
              "diagnosticCriteria": "Multiple microbleeds (≥5) in lobar regions, typically elderly patients, possibly with cognitive decline",
              "recommendedDrugs": [
                {
                  "drugName": "Strict Blood Pressure Control (without antiplatelet drugs)",
                  "drugClass": "Comprehensive Blood Pressure Management",
                  "dosage": {
                    "initialDose": "Target SBP<130mmHg",
                    "maintenanceDose": "Maintain SBP 110-130mmHg",
                    "frequency": "Continuous",
                    "route": "Multiple antihypertensive combinations"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Reducing new microbleeds",
                      "formula": "Approximately 30% reduction in new microbleed rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 10
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease to target",
                      "expectedMeanChange": -20,
                      "standardDeviation": 8,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Stable",
                      "expectedMeanChange": 0,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "GV-971 (Sodium Oligomannate Capsules)",
                  "drugClass": "Anti-Alzheimer's Disease Drug",
                  "dosage": {
                    "initialDose": "450mg",
                    "maintenanceDose": "450mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Improving cognition slowing lesions",
                      "formula": "Cognitive score improvement approximately 2.5 points",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 15
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.8,
                      "unit": "score",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.5,
                      "unit": "score",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hypertensive Microangiopathy",
              "diagnosticCriteria": "Multiple microbleeds in deep brain tissue (basal ganglia, thalamus), history of long-term hypertension",
              "recommendedDrugs": [
                {
                  "drugName": "Irbesartan",
                  "drugClass": "Angiotensin II Receptor Blocker (ARB)",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "300mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48 weeks",
                    "calculation": {
                      "method": "Blood pressure control reduces new microbleeds",
                      "formula": "Approximately 35% reduction in new microbleed rate",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -18,
                      "standardDeviation": 7,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_night",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -20,
                      "standardDeviation": 8,
                      "unit": "mm[Hg]",
                      "validationStatus": "VALID"
                    },
                    {
                      "affectedNodeId": "NEURO:Lacunes",
                      "expectedTrend": "Slowed progression",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.15,
                      "unit": "count",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Anticoagulation-Related Microbleeds",
              "diagnosticCriteria": "Patients on anticoagulant therapy (e.g., warfarin), imaging shows increased microbleeds",
              "recommendedDrugs": [
                {
                  "drugName": "Dabigatran Etexilate (Switch Anticoagulant)",
                  "drugClass": "Direct Thrombin Inhibitor",
                  "dosage": {
                    "initialDose": "110mg",
                    "maintenanceDose": "110-150mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Reducing intracranial bleeding risk",
                      "formula": "Approximately 60% reduction in bleeding risk compared to warfarin",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.25,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 12
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Monitoring required",
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.03,
                      "unit": "mg/L",
                      "validationStatus": "VALID"
                    }
                  ]
                },
                {
                  "drugName": "Apixaban",
                  "drugClass": "Factor Xa Inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "5mg (or 2.5mg if dose reduction criteria met)",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Reducing intracranial bleeding risk",
                      "formula": "Approximately 58% reduction in bleeding risk compared to warfarin",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": -0.58,
                      "standardDeviation": 0.23,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 12
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.3,
                      "unit": "g/dL",
                      "validationStatus": "VALID"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Cerebral Amyloid Angiopathy (CAA)",
              "diagnosticCriteria": "Elderly patients, lobar posterior parietal/occipital subcortical microbleeds, with amyloid-related presentations",
              "recommendedDrugs": [
                {
                  "drugName": "Candesartan",
                  "drugClass": "ARB (Blood pressure control, reducing new microbleed risk)",
                  "dosage": {
                    "initialDose": "8mg",
                    "maintenanceDose": "16-32mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Event generation rate decrease",
                      "formula": "CMB_new_t = CMB_base - 0.1 * (t/12)",
                      "parameters": {
                        "t": "Months",
                        "CMB_base": "Expected annual new microbleed count (example 0.3)"
                      },
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Hypertensive Arteriosclerosis",
              "diagnosticCriteria": "Long-term hypertension, deep (basal ganglia/brainstem) microbleeds predominant",
              "recommendedDrugs": [
                {
                  "drugName": "Amlodipine",
                  "drugClass": "Dihydropyridine Calcium Channel Blocker (blood pressure lowering)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "5-10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Event generation rate decrease",
                      "formula": "CMB_new_t = CMB_base - 0.08 * (t/12)",
                      "parameters": {
                        "t": "Months"
                      },
                      "expectedMeanChange": -0.08,
                      "standardDeviation": 0.06,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:SCI",
        "label": "Silent cerebral infarcts",
        "unit": "binary",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Cerebral small vessel disease",
              "diagnosticCriteria": "Imaging findings of lacunar infarcts, white matter hyperintensities and other cerebral small vessel disease markers, without obvious clinical symptoms.",
              "recommendedDrugs": [
                {
                  "drugName": "Aspirin",
                  "drugClass": "Antiplatelet agent",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-12 months",
                    "calculation": {
                      "method": "Risk reduction",
                      "formula": "Reduce new SCI risk by approximately 30%",
                      "parameters": {
                        "preventionEffect": "Reduce new lesion probability"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "count"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.2,
                      "unit": "mg/L"
                    },
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "g/dL"
                    }
                  ]
                },
                {
                  "drugName": "Clopidogrel",
                  "drugClass": "P2Y12 receptor antagonist",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "75mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-12 months",
                    "calculation": {
                      "method": "Risk reduction",
                      "formula": "Reduce new SCI risk by approximately 35%",
                      "parameters": {
                        "preventionEffect": "Reduce new lesion probability"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.25,
                      "unit": "count"
                    },
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "g/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Cardiogenic embolism",
              "diagnosticCriteria": "Presence of cardiac diseases such as atrial fibrillation or valvular heart disease, with imaging showing multiple cerebral infarctions.",
              "recommendedDrugs": [
                {
                  "drugName": "Warfarin",
                  "drugClass": "Vitamin K antagonist",
                  "dosage": {
                    "initialDose": "2-5mg",
                    "maintenanceDose": "Adjusted based on INR",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-12 months",
                    "calculation": {
                      "method": "Risk reduction",
                      "formula": "Reduce new SCI risk by approximately 60%",
                      "parameters": {
                        "INRTarget": "2.0-3.0"
                      },
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.5,
                      "unit": "count"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Atrial fibrillation-related cardiogenic microembolism",
              "diagnosticCriteria": "ECG/Holter monitoring confirmed atrial fibrillation, MRI showing scattered asymptomatic cortical/subcortical punctate infarctions.",
              "recommendedDrugs": [
                {
                  "drugName": "Apixaban",
                  "drugClass": "Direct oral anticoagulant (Xa inhibitor)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "5mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "52 weeks",
                    "calculation": {
                      "method": "Relative risk reduction (RRR)",
                      "formula": "newRisk = currentRisk * (1 - 0.30)",
                      "parameters": {
                        "t": "Weeks after medication (for time-based updates, RRR assessed at 52 weeks)"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "unit": "g/dL"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk reduction (RRR)",
                      "formula": "newRisk = currentRisk * (1 - 0.20)",
                      "parameters": {},
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:CBF",
        "label": "Cerebral blood flow",
        "unit": "mL/100g/min",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Cerebral hypoperfusion",
              "diagnosticCriteria": "Cerebral blood flow below normal range (normal: 50-60 mL/100g/min), possibly accompanied by cognitive decline or dizziness.",
              "recommendedDrugs": [
                {
                  "drugName": "Nimodipine",
                  "drugClass": "Calcium channel blocker",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "60mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (8 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 8,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 50,
                        "upperBound": 60
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Ginkgo biloba extract",
                  "drugClass": "Cerebral circulation improver",
                  "dosage": {
                    "initialDose": "120mg",
                    "maintenanceDose": "240mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (5 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 5,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 50,
                        "upperBound": 60
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic cerebral ischemia",
              "diagnosticCriteria": "Long-term cerebral hypoperfusion with cognitive decline, gait instability and other clinical manifestations.",
              "recommendedDrugs": [
                {
                  "drugName": "Butylphthalide",
                  "drugClass": "Neuroprotective agent",
                  "dosage": {
                    "initialDose": "200mg",
                    "maintenanceDose": "200mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (10 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 10,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 50,
                        "upperBound": 60
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:ProcSpeed",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.2,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Carotid/intracranial atherosclerosis and stenosis",
              "diagnosticCriteria": "Carotid ultrasound/CTA/MRA showing ≥50% stenosis (NEURO:Carotid_sten/NEURO:ICAS), perfusion imaging showing regional CBF reduction.",
              "recommendedDrugs": [
                {
                  "drugName": "Cilostazol",
                  "drugClass": "PDE3 inhibitor, antiplatelet/vasodilator",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "newValue = currentValue + (4 * t / 12)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 4,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 45,
                        "upperBound": 60
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Emax-type improvement",
                      "formula": "ΔCBF = 3 * (1 - exp(-0.2 * t))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": 45,
                        "upperBound": 60
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Iron deficiency anemia-induced cerebral hypoperfusion",
              "diagnosticCriteria": "Decreased hemoglobin (RENAL:Hb) with fatigue and pale skin/mucosa; generalized CBF reduction.",
              "recommendedDrugs": [
                {
                  "drugName": "Oral iron supplement (ferrous sulfate or ferrous fumarate)",
                  "drugClass": "Hematopoietic promoter",
                  "dosage": {
                    "initialDose": "Equivalent elemental iron 100mg/day",
                    "maintenanceDose": "Equivalent elemental iron 60-100mg/day",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "newValue = currentValue + (3 * t / 12)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 3,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 45,
                        "upperBound": 60
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "g/dL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:CVR",
        "label": "Cerebrovascular reactivity",
        "unit": "%/mmHg",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Impaired cerebrovascular reactivity",
              "diagnosticCriteria": "Reduced cerebrovascular reactivity to CO2 stimulation, indicating cerebrovascular regulatory dysfunction.",
              "recommendedDrugs": [
                {
                  "drugName": "Amlodipine",
                  "drugClass": "Calcium channel blocker",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (0.5 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 2.5,
                        "upperBound": 4.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "CARDIO:FMD",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "unit": "%"
                    }
                  ]
                },
                {
                  "drugName": "Perindopril",
                  "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (0.6 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.25,
                      "targetValueRange": {
                        "lowerBound": 2.5,
                        "upperBound": 4.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -15,
                      "standardDeviation": 6,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "NEURO:CBF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 5,
                      "standardDeviation": 2,
                      "unit": "mL/100g/min"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Atherosclerotic cerebrovascular disease/endothelial dysfunction",
              "diagnosticCriteria": "Carotid or intracranial artery stenosis (NEURO:Carotid_sten/NEURO:ICAS) or smoking history (CARDIO:Smoking_status), reduced CVR on CO2 challenge or acetazolamide challenge test.",
              "recommendedDrugs": [
                {
                  "drugName": "Cilostazol",
                  "drugClass": "PDE3 inhibitor",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "newValue = currentValue + (0.10 * t / 12)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0.1,
                      "standardDeviation": 0.05,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Exponential improvement",
                      "formula": "ΔCVR = 0.06 * (1 - exp(-0.15 * t))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0.06,
                      "standardDeviation": 0.03,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L"
                    }
                  ]
                },
                {
                  "drugName": "Losartan",
                  "drugClass": "ARB",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "newValue = currentValue + (0.05 * t / 12)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.03,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:ExecFunc",
        "label": "Executive function score",
        "unit": "score",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_cognitive"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Mild cognitive impairment",
              "diagnosticCriteria": "Executive function test scores below normal range, but daily living abilities basically preserved, not meeting diagnostic criteria for dementia.",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Linear improvement",
                      "formula": "currentValue + (3 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": "Lower limit of normal range",
                        "upperBound": "Upper limit of normal range"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Possible worsening",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Memantine",
                  "drugClass": "NMDA receptor antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (2.5 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.2,
                      "targetValueRange": {
                        "lowerBound": "Lower limit of normal range",
                        "upperBound": "Upper limit of normal range"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.5,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Vascular cognitive impairment",
              "diagnosticCriteria": "Presence of cerebrovascular lesions with executive dysfunction as the main manifestation.",
              "recommendedDrugs": [
                {
                  "drugName": "Nimodipine",
                  "drugClass": "Calcium channel blocker",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "60mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear improvement",
                      "formula": "currentValue + (2.5 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.3,
                      "targetValueRange": {
                        "lowerBound": "Lower limit of normal range",
                        "upperBound": "Upper limit of normal range"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "NEURO:CBF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 6,
                      "standardDeviation": 3,
                      "unit": "mL/100g/min"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Vascular mild cognitive impairment (small vessel disease phenotype)",
              "diagnosticCriteria": "Executive dysfunction predominant, imaging showing increased NEURO:WMH_vol/presence of NEURO:Lacunes, daily living abilities basically preserved.",
              "recommendedDrugs": [
                {
                  "drugName": "Cilostazol",
                  "drugClass": "PDE3 inhibitor/antiplatelet",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "newValue = currentValue + (2 * t / 24)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Mild linear increase",
                      "formula": "newValue = currentValue + (1 * t / 24)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 1,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Depression-related cognitive impairment",
              "diagnosticCriteria": "Elevated PHQ-9 (NEURO:PHQ9), impaired executive function and attention control, excluding dementia.",
              "recommendedDrugs": [
                {
                  "drugName": "Sertraline",
                  "drugClass": "SSRI",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "PHQ improvement drives linear increase in executive score",
                      "formula": "ΔExec ≈ 0.3 * Δ(PHQ9)",
                      "parameters": {
                        "Δ(PHQ9)": "PHQ9 decrease in points"
                      },
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:ProcSpeed",
        "label": "Processing speed score",
        "unit": "score",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_cognitive"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Cerebral small vessel disease-related cognitive impairment",
              "diagnosticCriteria": "Presence of white matter lesions with slowed information processing speed as prominent manifestation.",
              "recommendedDrugs": [
                {
                  "drugName": "Piracetam",
                  "drugClass": "Nootropic",
                  "dosage": {
                    "initialDose": "800mg",
                    "maintenanceDose": "1200mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Linear improvement",
                      "formula": "currentValue + (2 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": "Lower limit of normal range",
                        "upperBound": "Upper limit of normal range"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.6,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Aniracetam",
                  "drugClass": "Nootropic",
                  "dosage": {
                    "initialDose": "200mg",
                    "maintenanceDose": "400mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (2.5 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.2,
                      "targetValueRange": {
                        "lowerBound": "Lower limit of normal range",
                        "upperBound": "Upper limit of normal range"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Attention deficit disorder",
              "diagnosticCriteria": "Inattention, slowed information processing speed, affecting work and learning efficiency.",
              "recommendedDrugs": [
                {
                  "drugName": "Methylphenidate",
                  "drugClass": "Central stimulant",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Linear improvement",
                      "formula": "currentValue + (4 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 4,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": "Lower limit of normal range",
                        "upperBound": "Upper limit of normal range"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Possible increase",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.2,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 5,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Excessive daytime sleepiness (sleep disorder-related)",
              "diagnosticCriteria": "Elevated NEURO:Sleepiness score, slowed attention/reaction speed.",
              "recommendedDrugs": [
                {
                  "drugName": "Modafinil",
                  "drugClass": "Wakefulness-promoting agent",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "200mg",
                    "frequency": "Once daily in the morning",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "newValue = currentValue + (3 * t / 8)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Methylphenidate",
                  "drugClass": "Central stimulant",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Twice daily (morning/afternoon)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "newValue = currentValue + (3 * t / 8)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Cerebral small vessel disease",
              "diagnosticCriteria": "Imaging showing increased NEURO:WMH_vol or presence of NEURO:Microbleeds, with decreased information processing speed.",
              "recommendedDrugs": [
                {
                  "drugName": "Cilostazol",
                  "drugClass": "PDE3 inhibitor/antiplatelet",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "newValue = currentValue + (2 * t / 24)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:Memory",
        "label": "Episodic memory score",
        "unit": "score",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_cognitive"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Early Alzheimer's disease",
              "diagnosticCriteria": "Significant decline in episodic memory with abnormal biomarkers (e.g., decreased CSF Aβ42, elevated tau protein).",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Linear improvement",
                      "formula": "currentValue + (3.5 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 3.5,
                      "standardDeviation": 1.8,
                      "targetValueRange": {
                        "lowerBound": "Lower limit of normal range",
                        "upperBound": "Upper limit of normal range"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Possible worsening",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Possible increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.5,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Rivastigmine",
                  "drugClass": "Cholinesterase inhibitor",
                  "dosage": {
                    "initialDose": "1.5mg",
                    "maintenanceDose": "6mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "16-24 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (3 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": "Lower limit of normal range",
                        "upperBound": "Upper limit of normal range"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Possible worsening",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.7,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Memantine",
                  "drugClass": "NMDA receptor antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg (divided doses)",
                    "frequency": "1-2 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Emax-type improvement",
                      "formula": "ΔMemory = 1.5 * (1 - exp(-0.25 * t))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1.0,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hippocampal atrophy-related memory impairment",
              "diagnosticCriteria": "Imaging showing reduced hippocampal volume, impaired memory function.",
              "recommendedDrugs": [
                {
                  "drugName": "Memantine",
                  "drugClass": "NMDA receptor antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Linear improvement",
                      "formula": "currentValue + (2.5 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.3,
                      "targetValueRange": {
                        "lowerBound": "Lower limit of normal range",
                        "upperBound": "Upper limit of normal range"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.4,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Depression-related memory decline",
              "diagnosticCriteria": "Elevated NEURO:PHQ9 score, subjective memory complaints but objective scale scores heavily influenced by suggestion.",
              "recommendedDrugs": [
                {
                  "drugName": "Sertraline",
                  "drugClass": "SSRI",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Symptom relief drives memory score improvement",
                      "formula": "ΔMemory ≈ 0.2 * Δ(PHQ9)",
                      "parameters": {
                        "Δ(PHQ9)": "PHQ9 decrease in points"
                      },
                      "expectedMeanChange": 1,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 100
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:PHQ9",
        "label": "Depression severity (PHQ-9)",
        "unit": "score",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "questionnaires"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Major depressive disorder",
              "diagnosticCriteria": "PHQ-9 score ≥10, meeting DSM-5 diagnostic criteria for major depressive disorder, lasting at least 2 weeks.",
              "recommendedDrugs": [
                {
                  "drugName": "Sertraline",
                  "drugClass": "Selective serotonin reuptake inhibitor (SSRI)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (8 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -4,
                      "standardDeviation": 2,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "May increase initially",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Escitalopram",
                  "drugClass": "Selective serotonin reuptake inhibitor (SSRI)",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (9 * log(t + 1) / log(9))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -9,
                      "standardDeviation": 3.5,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 2.5,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Venlafaxine",
                  "drugClass": "Serotonin-norepinephrine reuptake inhibitor (SNRI)",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "150mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (10 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "May increase",
                      "expectedMeanChange": 3,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -6,
                      "standardDeviation": 3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Duloxetine",
                  "drugClass": "SNRI",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "60mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Exponential decrease",
                      "formula": "ΔPHQ9 = -9 * (1 - exp(-0.30 * t))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -7,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.4,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Bupropion",
                  "drugClass": "NDRI",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "300mg",
                    "frequency": "Once daily or divided morning/evening",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Exponential decrease",
                      "formula": "ΔPHQ9 = -7 * (1 - exp(-0.30 * t))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -6,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Post-stroke depression",
              "diagnosticCriteria": "Depression symptoms appearing after stroke with elevated PHQ-9 score.",
              "recommendedDrugs": [
                {
                  "drugName": "Citalopram",
                  "drugClass": "Selective serotonin reuptake inhibitor (SSRI)",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (7 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -7,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Sertraline",
                  "drugClass": "SSRI",
                  "dosage": {
                    "initialDose": "25-50mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Exponential decrease",
                      "formula": "ΔPHQ9 = -6 * (1 - exp(-0.30 * t))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -5,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.2,
                      "unit": "score"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:GAD7",
        "label": "Anxiety severity (GAD-7)",
        "unit": "score",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "questionnaires"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Generalized anxiety disorder",
              "diagnosticCriteria": "GAD-7 score ≥10, meeting DSM-5 diagnostic criteria for generalized anxiety disorder, symptoms persisting for at least 6 months.",
              "recommendedDrugs": [
                {
                  "drugName": "Duloxetine",
                  "drugClass": "Serotonin-norepinephrine reuptake inhibitor (SNRI)",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "60mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (8 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -8,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 2.5,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "May increase",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.7,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Paroxetine",
                  "drugClass": "Selective serotonin reuptake inhibitor (SSRI)",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (9 * log(t + 1) / log(9))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -9,
                      "standardDeviation": 3.5,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -6,
                      "standardDeviation": 3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Pregabalin",
                  "drugClass": "Antiepileptic/anxiolytic drug",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "150mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-6 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "currentValue - (7 * (t / 6))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -7,
                      "standardDeviation": 2.8,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.2,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:ProcSpeed",
                      "expectedTrend": "May decrease",
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.6,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Escitalopram",
                  "drugClass": "SSRI",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Exponential decrease",
                      "formula": "ΔGAD7 = -7 * (1 - exp(-0.35 * t))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -6,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Buspirone",
                  "drugClass": "5-HT1A partial agonist",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "15mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "newValue = currentValue - (4 * t / 8)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -4,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.2,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Panic disorder",
              "diagnosticCriteria": "Recurrent panic attacks with intense anxiety and somatic symptoms.",
              "recommendedDrugs": [
                {
                  "drugName": "Alprazolam",
                  "drugClass": "Benzodiazepine",
                  "dosage": {
                    "initialDose": "0.25mg",
                    "maintenanceDose": "0.5mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Rapid decrease",
                      "formula": "currentValue - (6 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -6,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Significant increase",
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "May decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Acute anxiety/panic attack (short-term intervention)",
              "diagnosticCriteria": "Recurrent sudden intense anxiety or panic attacks with autonomic symptoms.",
              "recommendedDrugs": [
                {
                  "drugName": "Diazepam (short-term, as needed)",
                  "drugClass": "Benzodiazepine",
                  "dosage": {
                    "initialDose": "2mg",
                    "maintenanceDose": "2-5mg",
                    "frequency": "1-2 times daily as needed (not recommended for long-term use)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Rapid linear decrease",
                      "formula": "newValue = currentValue - (5 * t / 2)",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -5,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 4
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Significant increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.6,
                      "unit": "score"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:CognitiveDecline",
        "label": "Cognitive decline (event)",
        "unit": "event",
        "system": "NEURO",
        "type": "outcome",
        "datasetHint": [
          "neuro_outcomes"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Mild cognitive impairment progression",
              "diagnosticCriteria": "Annual decline in cognitive function exceeding normal aging expectations.",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Risk reduction",
                      "formula": "Reduce cognitive decline event incidence by approximately 30%",
                      "parameters": {
                        "HR": "0.70"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Possible worsening",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "May increase",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Ginkgo biloba extract",
                  "drugClass": "Cerebral circulation improver",
                  "dosage": {
                    "initialDose": "120mg",
                    "maintenanceDose": "240mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Risk reduction",
                      "formula": "Reduce cognitive decline event incidence by approximately 20%",
                      "parameters": {
                        "HR": "0.80"
                      },
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Memory",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:ExecFunc",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.7,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Memantine",
                  "drugClass": "NMDA receptor antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg (divided doses)",
                    "frequency": "1-2 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk reduction (HR reduction)",
                      "formula": "newHR = baselineHR * (1 - 0.10)",
                      "parameters": {
                        "baselineHR": "Pre-medication HR"
                      },
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Cerebrovascular disease-related cognitive decline",
              "diagnosticCriteria": "Presence of cerebrovascular lesions with stepwise cognitive decline.",
              "recommendedDrugs": [
                {
                  "drugName": "Nimodipine",
                  "drugClass": "Calcium channel blocker",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "60mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Risk reduction",
                      "formula": "Reduce vascular cognitive decline event incidence by approximately 35%",
                      "parameters": {
                        "HR": "0.65"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.18,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "NEURO:CBF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 7,
                      "standardDeviation": 3,
                      "unit": "mL/100g/min"
                    }
                  ]
                },
                {
                  "drugName": "Aspirin",
                  "drugClass": "Antiplatelet agent",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Risk reduction",
                      "formula": "Reduce vascular cognitive decline event incidence by approximately 25%",
                      "parameters": {
                        "HR": "0.75"
                      },
                      "expectedMeanChange": -0.25,
                      "standardDeviation": 0.13,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "count"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Alzheimer's disease-related mild cognitive impairment (MCI due to AD)",
              "diagnosticCriteria": "Objective cognitive impairment but daily function basically preserved; imaging/biomarkers suggest Alzheimer's disease pathology possibility.",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk reduction (HR reduction)",
                      "formula": "newHR = baselineHR * (1 - 0.12)",
                      "parameters": {
                        "baselineHR": "Pre-medication cognitive decline risk HR"
                      },
                      "expectedMeanChange": -0.12,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Memantine",
                  "drugClass": "NMDA receptor antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg (divided doses)",
                    "frequency": "1-2 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk reduction (HR reduction)",
                      "formula": "newHR = baselineHR * (1 - 0.10)",
                      "parameters": {
                        "baselineHR": "Pre-medication HR"
                      },
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Vascular cognitive impairment (small vessel disease-driven)",
              "diagnosticCriteria": "Executive function/processing speed decline predominant, imaging showing increased NEURO:WMH_vol and NEURO:Lacunes.",
              "recommendedDrugs": [
                {
                  "drugName": "Cilostazol",
                  "drugClass": "PDE3 inhibitor/antiplatelet",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk reduction (HR reduction)",
                      "formula": "newHR = baselineHR * (1 - 0.12)",
                      "parameters": {},
                      "expectedMeanChange": -0.12,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:WMH_vol",
                      "expectedTrend": "Decrease (annual growth slowed)",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.6,
                      "unit": "mL"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Relative risk reduction (HR reduction)",
                      "formula": "newHR = baselineHR * (1 - 0.10)",
                      "parameters": {},
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:Dementia",
        "label": "All-cause dementia (incidence)",
        "unit": "event",
        "system": "NEURO",
        "type": "outcome",
        "datasetHint": [
          "neuro_outcomes"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Alzheimer's disease",
              "diagnosticCriteria": "Progressive memory and cognitive decline meeting Alzheimer's disease clinical diagnostic criteria, may be accompanied by abnormal biomarkers.",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Delay progression",
                      "formula": "Delay dementia progression by 6-12 months",
                      "parameters": {
                        "delayMonths": "6-12"
                      },
                      "expectedMeanChange": -0.15,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Possible worsening",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Possible increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.5,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Memantine",
                  "drugClass": "NMDA receptor antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Delay progression",
                      "formula": "Delay moderate to severe dementia progression by 4-8 months",
                      "parameters": {
                        "delayMonths": "4-8"
                      },
                      "expectedMeanChange": -0.12,
                      "standardDeviation": 0.07,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.4,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Donepezil combined with Memantine",
                  "drugClass": "Combination therapy",
                  "dosage": {
                    "initialDose": "Donepezil 5mg + Memantine 5mg",
                    "maintenanceDose": "Donepezil 10mg + Memantine 20mg",
                    "frequency": "Once daily + Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Delay progression",
                      "formula": "Combination therapy delays dementia progression by 8-14 months",
                      "parameters": {
                        "delayMonths": "8-14"
                      },
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Possible worsening",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Possible increase",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.7,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Vascular dementia",
              "diagnosticCriteria": "Cognitive dysfunction after cerebrovascular lesion, meeting diagnostic criteria for vascular dementia.",
              "recommendedDrugs": [
                {
                  "drugName": "Galantamine",
                  "drugClass": "Cholinesterase inhibitor",
                  "dosage": {
                    "initialDose": "8mg",
                    "maintenanceDose": "24mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Delay progression",
                      "formula": "Delay vascular dementia progression by 5-10 months",
                      "parameters": {
                        "delayMonths": "5-10"
                      },
                      "expectedMeanChange": -0.18,
                      "standardDeviation": 0.09,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Possible worsening",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.7,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "CARDIO:BPV",
                      "expectedTrend": "May increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.8,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Nimodipine",
                  "drugClass": "Calcium channel blocker",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "60mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Risk reduction",
                      "formula": "Reduce vascular dementia incidence risk by approximately 30%",
                      "parameters": {
                        "HR": "0.70"
                      },
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 5,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "NEURO:CBF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 8,
                      "standardDeviation": 3.5,
                      "unit": "mL/100g/min"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Mixed dementia",
              "diagnosticCriteria": "Coexistence of Alzheimer's disease pathology and cerebrovascular lesions.",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 months",
                    "calculation": {
                      "method": "Delay progression",
                      "formula": "Delay mixed dementia progression by 6-10 months",
                      "parameters": {
                        "delayMonths": "6-10"
                      },
                      "expectedMeanChange": -0.16,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Possible worsening",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.8,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Alzheimer's disease preclinical/early stage",
              "diagnosticCriteria": "Mild cognitive impairment stage, biomarkers or imaging suggest Alzheimer's disease pathology.",
              "recommendedDrugs": [
                {
                  "drugName": "Donepezil",
                  "drugClass": "Cholinesterase inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 years",
                    "calculation": {
                      "method": "Relative risk reduction",
                      "formula": "newHR = baselineHR * (1 - 0.12)",
                      "parameters": {},
                      "expectedMeanChange": -0.12,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                },
                {
                  "drugName": "Memantine",
                  "drugClass": "NMDA receptor antagonist",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "20mg (divided doses)",
                    "frequency": "1-2 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 years",
                    "calculation": {
                      "method": "Relative risk reduction",
                      "formula": "newHR = baselineHR * (1 - 0.10)",
                      "parameters": {},
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Vascular/mixed dementia high risk state",
              "diagnosticCriteria": "High atherosclerosis risk, large NEURO:WMH_vol or increased NEURO:Lacunes, impaired executive function/processing speed.",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 years",
                    "calculation": {
                      "method": "Relative risk reduction",
                      "formula": "newHR = baselineHR * (1 - 0.12)",
                      "parameters": {},
                      "expectedMeanChange": -0.12,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L"
                    }
                  ]
                },
                {
                  "drugName": "Losartan",
                  "drugClass": "ARB (vascular risk management)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1 year",
                    "calculation": {
                      "method": "Relative risk reduction (indirect through vascular mechanism)",
                      "formula": "newHR = baselineHR * (1 - 0.10)",
                      "parameters": {},
                      "expectedMeanChange": -0.1,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:NIHSS",
        "label": "Stroke severity (NIHSS)",
        "unit": "score",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_outcomes"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Acute Ischemic Stroke",
              "diagnosticCriteria": "Acute neurological deficit with imaging-confirmed cerebral infarction, NIHSS score ≥5 indicates moderate to severe stroke.",
              "recommendedDrugs": [
                {
                  "drugName": "Alteplase (rt-PA)",
                  "drugClass": "Recombinant Tissue Plasminogen Activator",
                  "dosage": {
                    "initialDose": "0.9mg/kg",
                    "maintenanceDose": "N/A",
                    "frequency": "Single intravenous administration",
                    "route": "Intravenous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 hours",
                    "calculation": {
                      "method": "Exponential decline",
                      "formula": "currentValue * exp(-0.3 * t)",
                      "parameters": {
                        "t": "Hours after treatment / 24"
                      },
                      "expectedMeanChange": -4,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "unit": "count"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Requires strict control",
                      "expectedMeanChange": 0,
                      "standardDeviation": 5,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Edaravone",
                  "drugClass": "Free Radical Scavenger",
                  "dosage": {
                    "initialDose": "30mg",
                    "maintenanceDose": "30mg",
                    "frequency": "Twice daily",
                    "route": "Intravenous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "14 days",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (2 * (t / 14))",
                      "parameters": {
                        "t": "Days after treatment"
                      },
                      "expectedMeanChange": -2,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 10
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Intracerebral Hemorrhage",
              "diagnosticCriteria": "CT or MRI confirmed intracranial bleeding with neurological deficits.",
              "recommendedDrugs": [
                {
                  "drugName": "Mannitol",
                  "drugClass": "Osmotic Diuretic",
                  "dosage": {
                    "initialDose": "125ml",
                    "maintenanceDose": "125ml",
                    "frequency": "Every 6-8 hours",
                    "route": "Intravenous infusion"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "7 days",
                    "calculation": {
                      "method": "Stepwise decline",
                      "formula": "currentValue - (3 * floor(t / 2))",
                      "parameters": {
                        "t": "Days after treatment"
                      },
                      "expectedMeanChange": -5,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 8
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:mRS",
        "label": "Modified Rankin Scale",
        "unit": "score",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_outcomes"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Post-Stroke Functional Impairment",
              "diagnosticCriteria": "Residual neurological disability after stroke, mRS score 2-5.",
              "recommendedDrugs": [
                {
                  "drugName": "Butylphthalide",
                  "drugClass": "Neuroprotective Agent",
                  "dosage": {
                    "initialDose": "200mg",
                    "maintenanceDose": "200mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic improvement",
                      "formula": "currentValue - (1.5 * log(t + 1) / log(13))",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.5,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 2
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    }
                  ]
                },
                {
                  "drugName": "Baclofen",
                  "drugClass": "Muscle Relaxant",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "15-20mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8 weeks",
                    "calculation": {
                      "method": "Linear improvement",
                      "formula": "currentValue - (0.5 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 3
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 3,
                      "standardDeviation": 2,
                      "unit": "score"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:ICAS",
        "label": "Intracranial atherosclerosis burden",
        "unit": "score",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "neuro_imaging"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Intracranial Atherosclerosis",
              "diagnosticCriteria": "DSA, CTA or MRA showing intracranial artery stenosis ≥50%.",
              "recommendedDrugs": [
                {
                  "drugName": "Aspirin + Clopidogrel",
                  "drugClass": "Dual Antiplatelet Therapy",
                  "dosage": {
                    "initialDose": "Aspirin 100mg + Clopidogrel 75mg",
                    "maintenanceDose": "Aspirin 100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Slow linear improvement",
                      "formula": "currentValue - (0.5 * (t / 12))",
                      "parameters": {
                        "t": "Months after treatment"
                      },
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 3
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Microbleeds",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.5,
                      "unit": "count"
                    },
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "g/dL"
                    }
                  ]
                },
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once nightly",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 months",
                    "calculation": {
                      "method": "Logarithmic improvement",
                      "formula": "currentValue - (1.2 * log(t + 1) / log(25))",
                      "parameters": {
                        "t": "Months after treatment"
                      },
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.6,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 2
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.03,
                      "unit": "mg/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:Carotid_sten",
        "label": "Carotid stenosis (%)",
        "unit": "%",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "012-carotid_ultrasound"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Carotid Artery Stenosis",
              "diagnosticCriteria": "Carotid ultrasound, CTA or MRA showing carotid stenosis ≥50%.",
              "recommendedDrugs": [
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once nightly",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 months",
                    "calculation": {
                      "method": "Logarithmic improvement",
                      "formula": "currentValue - (8 * log(t + 1) / log(25))",
                      "parameters": {
                        "t": "Months after treatment"
                      },
                      "expectedMeanChange": -8,
                      "standardDeviation": 4,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 50
                      }
                    }
                  },
                  "sideEffects": []
                },
                {
                  "drugName": "Cilostazol",
                  "drugClass": "Antiplatelet Agent",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Linear improvement",
                      "formula": "currentValue - (5 * (t / 12))",
                      "parameters": {
                        "t": "Months after treatment"
                      },
                      "expectedMeanChange": -5,
                      "standardDeviation": 3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 60
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 5,
                      "standardDeviation": 3,
                      "unit": "ms"
                    },
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 1,
                      "standardDeviation": 1,
                      "unit": "score"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "NEURO:Sleepiness",
        "label": "Daytime sleepiness score",
        "unit": "score",
        "system": "NEURO",
        "type": "state",
        "datasetHint": [
          "questionnaires"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Obstructive Sleep Apnea Syndrome",
              "diagnosticCriteria": "Polysomnography with AHI ≥15 events/hour, accompanied by excessive daytime sleepiness (ESS >10).",
              "recommendedDrugs": [
                {
                  "drugName": "Modafinil",
                  "drugClass": "Wakefulness-Promoting Agent",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "200mg",
                    "frequency": "Once in the morning",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Exponential improvement",
                      "formula": "currentValue * exp(-0.4 * t)",
                      "parameters": {
                        "t": "Weeks after treatment / 4"
                      },
                      "expectedMeanChange": -6,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 10
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 5,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "NEURO:GAD7",
                      "expectedTrend": "Possible increase",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1.5,
                      "unit": "score"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Narcolepsy",
              "diagnosticCriteria": "Recurrent irresistible sleep episodes, with or without cataplexy.",
              "recommendedDrugs": [
                {
                  "drugName": "Methylphenidate",
                  "drugClass": "Central Nervous System Stimulant",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20-40mg",
                    "frequency": "2-3 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2 weeks",
                    "calculation": {
                      "method": "Linear improvement",
                      "formula": "currentValue - (5 * (t / 2))",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -5,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 8,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:eGFR_slope",
        "label": "eGFR annual change",
        "unit": "mL/min/1.73m2/y",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Chronic Kidney Disease Progression",
              "diagnosticCriteria": "Annual eGFR decline >5 mL/min/1.73m², sustained for more than 3 months.",
              "recommendedDrugs": [
                {
                  "drugName": "Canagliflozin",
                  "drugClass": "SGLT2 Inhibitor",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Slope improvement",
                      "formula": "currentValue + (3 * (t / 12))",
                      "parameters": {
                        "t": "Months after treatment"
                      },
                      "expectedMeanChange": 3,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": -2,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -4,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Perindopril",
                  "drugClass": "ACE Inhibitor",
                  "dosage": {
                    "initialDose": "4mg",
                    "maintenanceDose": "8mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 months",
                    "calculation": {
                      "method": "Slope improvement",
                      "formula": "currentValue + (2.5 * (t / 12))",
                      "parameters": {
                        "t": "Months after treatment"
                      },
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.2,
                      "targetValueRange": {
                        "lowerBound": -2,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:ACR_cat",
        "label": "Albuminuria category (A1/A2/A3)",
        "unit": "ordinal",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Diabetic Nephropathy",
              "diagnosticCriteria": "History of diabetes, urine albumin-to-creatinine ratio (ACR) >30mg/g, other kidney diseases excluded.",
              "recommendedDrugs": [
                {
                  "drugName": "Telmisartan",
                  "drugClass": "Angiotensin Receptor Blocker",
                  "dosage": {
                    "initialDose": "40mg",
                    "maintenanceDose": "80mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Categorical improvement",
                      "formula": "Increased probability of improvement from A3 to A2 or A1",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "targetValueRange": {
                        "lowerBound": 1,
                        "upperBound": 1
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Finerenone",
                  "drugClass": "Non-Steroidal Mineralocorticoid Receptor Antagonist",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Logarithmic improvement",
                      "formula": "Probability of categorical improvement increases logarithmically with treatment time",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -1,
                      "standardDeviation": 0.5,
                      "targetValueRange": {
                        "lowerBound": 1,
                        "upperBound": 2
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.8,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:Hyperfil",
        "label": "Glomerular hyperfiltration",
        "unit": "binary",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Early Diabetic Nephropathy",
              "diagnosticCriteria": "History of diabetes, eGFR >120 mL/min/1.73m², defined as glomerular hyperfiltration.",
              "recommendedDrugs": [
                {
                  "drugName": "Ramipril",
                  "drugClass": "ACE Inhibitor",
                  "dosage": {
                    "initialDose": "2.5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Binary conversion",
                      "formula": "Gradual normalization of hyperfiltration state",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 5,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.08,
                      "standardDeviation": 0.05,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Dapagliflozin",
                  "drugClass": "SGLT2 Inhibitor",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8 weeks",
                    "calculation": {
                      "method": "Binary conversion",
                      "formula": "Rapid normalization of hyperfiltration state",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -0.7,
                      "standardDeviation": 0.25,
                      "targetValueRange": {
                        "lowerBound": 0,
                        "upperBound": 0
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:CysC",
        "label": "Cystatin C",
        "unit": "mg/L",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Chronic Kidney Disease",
              "diagnosticCriteria": "Serum cystatin C >1.20 mg/L, indicating decreased renal function.",
              "recommendedDrugs": [
                {
                  "drugName": "Irbesartan",
                  "drugClass": "Angiotensin Receptor Blocker",
                  "dosage": {
                    "initialDose": "150mg",
                    "maintenanceDose": "300mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Logarithmic decline",
                      "formula": "currentValue - (0.15 * log(t + 1) / log(25))",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -0.15,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.2
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -13,
                      "standardDeviation": 6,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Sodium Bicarbonate",
                  "drugClass": "Alkalizing Agent",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "1000-1500mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.08 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -0.08,
                      "standardDeviation": 0.05,
                      "targetValueRange": {
                        "lowerBound": 0.5,
                        "upperBound": 1.2
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 3,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:UricAcid",
        "label": "Uric acid",
        "unit": "mg/dL",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Hyperuricemia",
              "diagnosticCriteria": "Male serum uric acid >7.0 mg/dL, female >6.0 mg/dL.",
              "recommendedDrugs": [
                {
                  "drugName": "Febuxostat",
                  "drugClass": "Xanthine Oxidase Inhibitor",
                  "dosage": {
                    "initialDose": "40mg",
                    "maintenanceDose": "80mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Exponential decline",
                      "formula": "currentValue * exp(-0.35 * t)",
                      "parameters": {
                        "t": "Weeks after treatment / 4"
                      },
                      "expectedMeanChange": -2.5,
                      "standardDeviation": 0.8,
                      "targetValueRange": {
                        "lowerBound": 3,
                        "upperBound": 6
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:MI",
                      "expectedTrend": "Requires monitoring",
                      "expectedMeanChange": 0.0001,
                      "standardDeviation": 0.0001,
                      "unit": "event"
                    }
                  ]
                },
                {
                  "drugName": "Allopurinol",
                  "drugClass": "Xanthine Oxidase Inhibitor",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "300mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (2.2 * (t / 6))",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -2.2,
                      "standardDeviation": 0.7,
                      "targetValueRange": {
                        "lowerBound": 3,
                        "upperBound": 6
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Possible mild improvement",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "mL/min/1.73m2/y"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.2,
                      "unit": "mg/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Gout",
              "diagnosticCriteria": "Hyperuricemia with arthritis attacks, or urate crystals found in joint fluid.",
              "recommendedDrugs": [
                {
                  "drugName": "Benzbromarone",
                  "drugClass": "Uricosuric Agent",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "50-100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (2.8 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after treatment"
                      },
                      "expectedMeanChange": -2.8,
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "lowerBound": 3,
                        "upperBound": 6
                      }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:Phosphate",
        "label": "Serum phosphate",
        "unit": "mg/dL",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ]
      },
      "subIndicators": {
        "potentialDiseases": [
          {
            "diseaseName": "Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)",
            "diagnosticCriteria": "eGFR <60 mL/min/1.73m² with serum phosphate >4.5 mg/dL, accompanied by elevated PTH and calcium-phosphate metabolism disorder.",
            "recommendedDrugs": [
              {
                "drugName": "Sevelamer",
                "drugClass": "Non-calcium non-metal phosphate binder",
                "dosage": {
                  "initialDose": "800mg",
                  "maintenanceDose": "2400-4800mg",
                  "frequency": "Three times daily with meals",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-6 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (1.2 * (t / 6))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -1.2,
                    "standardDeviation": 0.4,
                    "targetValueRange": {
                      "lowerBound": 2.5,
                      "upperBound": 4.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:MetabolicAcid",
                    "expectedTrend": "Improvement",
                    "expectedMeanChange": 0.1,
                    "standardDeviation": 0.05,
                    "unit": "mmol/L"
                  }
                ]
              },
              {
                "drugName": "Sevelamer carbonate",
                "drugClass": "Non-calcium phosphate binder",
                "dosage": {
                  "initialDose": "800 mg",
                  "maintenanceDose": "1600-2400 mg",
                  "frequency": "Once per meal",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-8 weeks",
                  "calculation": {
                    "method": "Emax model",
                    "formula": "currentValue - (1.2 * (t / (t + 2)))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -1.2,
                    "standardDeviation": 0.4,
                    "targetValueRange": {
                      "lowerBound": 2.5,
                      "upperBound": 4.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.25,
                    "standardDeviation": 0.1,
                    "unit": "mmol/L"
                  },
                  {
                    "affectedNodeId": "RENAL:FGF23",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -15,
                    "standardDeviation": 8,
                    "unit": "pg/mL"
                  }
                ]
              },
              {
                "drugName": "Lanthanum carbonate",
                "drugClass": "Non-calcium phosphate binder",
                "dosage": {
                  "initialDose": "750mg",
                  "maintenanceDose": "1500-3000mg",
                  "frequency": "Three times daily with meals",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-8 weeks",
                  "calculation": {
                    "method": "Logarithmic model",
                    "formula": "currentValue - (1.5 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -1.5,
                    "standardDeviation": 0.5,
                    "targetValueRange": {
                      "lowerBound": 2.5,
                      "upperBound": 4.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.3,
                    "standardDeviation": 0.1,
                    "unit": "mg/dL"
                  }
                ]
              },
              {
                "drugName": "Calcium acetate",
                "drugClass": "Calcium-based phosphate binder",
                "dosage": {
                  "initialDose": "667 mg",
                  "maintenanceDose": "1334-2668 mg",
                  "frequency": "Once per meal",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "2-4 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (0.8 * (t / 4))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.8,
                    "standardDeviation": 0.3,
                    "targetValueRange": {
                      "lowerBound": 2.5,
                      "upperBound": 4.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.3,
                    "standardDeviation": 0.15,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "RENAL:PTH",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -30,
                    "standardDeviation": 15,
                    "unit": "pg/mL"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Tumor Lysis Syndrome",
            "diagnosticCriteria": "Post-chemotherapy serum phosphate >6.5 mg/dL, accompanied by elevated uric acid, potassium and decreased calcium.",
            "recommendedDrugs": [
              {
                "drugName": "Rasburicase",
                "drugClass": "Recombinant urate oxidase",
                "dosage": {
                  "initialDose": "0.2mg/kg",
                  "maintenanceDose": "0.2mg/kg",
                  "frequency": "Once daily",
                  "route": "Intravenous injection"
                },
                "expectedIndicatorChange": {
                  "timeframe": "24-48 hours",
                  "calculation": {
                    "method": "Exponential decline",
                    "formula": "currentValue * exp(-0.3 * t)",
                    "parameters": {
                      "t": "Days after medication"
                    },
                    "expectedMeanChange": -2.5,
                    "standardDeviation": 0.8,
                    "targetValueRange": {
                      "lowerBound": 2.5,
                      "upperBound": 4.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:UricAcid",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -5.0,
                    "standardDeviation": 1.5,
                    "unit": "mg/dL"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Tumor Lysis Syndrome-induced Hyperphosphatemia",
            "diagnosticCriteria": "Serum phosphate ≥4.5 mg/dL within 48-72 hours after chemotherapy for malignant tumors, combined with hyperuricemia/hyperkalemia or elevated creatinine.",
            "recommendedDrugs": [
              {
                "drugName": "Lanthanum carbonate",
                "drugClass": "Non-calcium phosphate binder",
                "dosage": {
                  "initialDose": "500 mg",
                  "maintenanceDose": "500-1000 mg",
                  "frequency": "Once per meal",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "1-2 weeks",
                  "calculation": {
                    "method": "Exponential decay",
                    "formula": "currentValue - (1.0 * (1 - exp(-0.7 * t)))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -1.0,
                    "standardDeviation": 0.35,
                    "targetValueRange": {
                      "lowerBound": 2.5,
                      "upperBound": 4.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Mild increase",
                    "expectedMeanChange": 0.1,
                    "standardDeviation": 0.05,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "RENAL:Albumin_serum",
                    "expectedTrend": "No significant change",
                    "expectedMeanChange": 0,
                    "standardDeviation": 0.05,
                    "unit": "g/dL"
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:Calcium",
        "label": "Serum calcium",
        "unit": "mg/dL",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ]
      },
      "subIndicators": {
        "potentialDiseases": [
          {
            "diseaseName": "Primary Hyperparathyroidism (PHPT)",
            "diagnosticCriteria": "Serum calcium >10.5 mg/dL with inappropriately elevated PTH.",
            "recommendedDrugs": [
              {
                "drugName": "Cinacalcet",
                "drugClass": "Calcimimetic",
                "dosage": {
                  "initialDose": "30mg",
                  "maintenanceDose": "60-180mg",
                  "frequency": "Once or twice daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "2-4 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (0.8 * (t / 4))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.8,
                    "standardDeviation": 0.3,
                    "targetValueRange": {
                      "lowerBound": 8.5,
                      "upperBound": 10.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:PTH",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -150,
                    "standardDeviation": 50,
                    "unit": "pg/mL"
                  },
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.5,
                    "standardDeviation": 0.2,
                    "unit": "mg/dL"
                  }
                ]
              },
              {
                "drugName": "Cinacalcet",
                "drugClass": "Calcium-sensing receptor agonist (Calcimimetic)",
                "dosage": {
                  "initialDose": "30 mg",
                  "maintenanceDose": "60-90 mg",
                  "frequency": "Once daily or divided doses",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "2-4 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (0.6 * (t / 4))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.6,
                    "standardDeviation": 0.3,
                    "targetValueRange": {
                      "lowerBound": 8.5,
                      "upperBound": 10.2
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:PTH",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -50,
                    "standardDeviation": 20,
                    "unit": "pg/mL"
                  },
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.3,
                    "standardDeviation": 0.15,
                    "unit": "mg/dL"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Hypocalcemia",
            "diagnosticCriteria": "Serum calcium <8.5 mg/dL, possibly accompanied by tetany, paresthesia or arrhythmia.",
            "recommendedDrugs": [
              {
                "drugName": "Calcium gluconate",
                "drugClass": "Calcium supplement",
                "dosage": {
                  "initialDose": "1-2g",
                  "maintenanceDose": "1-2g",
                  "frequency": "2-3 times daily",
                  "route": "Oral or intravenous injection"
                },
                "expectedIndicatorChange": {
                  "timeframe": "1-2 weeks",
                  "calculation": {
                    "method": "Linear increase",
                    "formula": "currentValue + (1.0 * (t / 2))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 1.0,
                    "standardDeviation": 0.3,
                    "targetValueRange": {
                      "lowerBound": 8.5,
                      "upperBound": 10.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.3,
                    "standardDeviation": 0.1,
                    "unit": "mg/dL"
                  }
                ]
              },
              {
                "drugName": "Calcitriol",
                "drugClass": "Active vitamin D",
                "dosage": {
                  "initialDose": "0.25μg",
                  "maintenanceDose": "0.5-1.0μg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "2-4 weeks",
                  "calculation": {
                    "method": "Logarithmic model",
                    "formula": "currentValue + (0.8 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 0.8,
                    "standardDeviation": 0.25,
                    "targetValueRange": {
                      "lowerBound": 8.5,
                      "upperBound": 10.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:PTH",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -50,
                    "standardDeviation": 20,
                    "unit": "pg/mL"
                  },
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.4,
                    "standardDeviation": 0.15,
                    "unit": "mg/dL"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "CKD Secondary Hyperparathyroidism-induced Hypocalcemia",
            "diagnosticCriteria": "CKD stages 3-5 with elevated PTH and serum calcium <8.5 mg/dL.",
            "recommendedDrugs": [
              {
                "drugName": "Calcitriol (Active Vitamin D3)",
                "drugClass": "Vitamin D receptor agonist",
                "dosage": {
                  "initialDose": "0.25 μg",
                  "maintenanceDose": "0.5-1.0 μg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-8 weeks",
                  "calculation": {
                    "method": "Logarithmic model",
                    "formula": "currentValue + (0.5 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 0.5,
                    "standardDeviation": 0.2,
                    "targetValueRange": {
                      "lowerBound": 8.5,
                      "upperBound": 10.2
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:PTH",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -40,
                    "standardDeviation": 15,
                    "unit": "pg/mL"
                  },
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.3,
                    "standardDeviation": 0.15,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "RENAL:FGF23",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 10,
                    "standardDeviation": 6,
                    "unit": "pg/mL"
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:PTH",
        "label": "Parathyroid hormone",
        "unit": "pg/mL",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ]
      },
      "subIndicators": {
        "potentialDiseases": [
          {
            "diseaseName": "Secondary Hyperparathyroidism (CKD-related)",
            "diagnosticCriteria": "CKD patients with PTH >70 pg/mL (stage G3) or >110 pg/mL (stages G4-5), accompanied by hyperphosphatemia or hypocalcemia.",
            "recommendedDrugs": [
              {
                "drugName": "Cinacalcet",
                "drugClass": "Calcimimetic",
                "dosage": {
                  "initialDose": "30mg",
                  "maintenanceDose": "60-180mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-8 weeks",
                  "calculation": {
                    "method": "Logarithmic decline",
                    "formula": "currentValue - (200 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -200,
                    "standardDeviation": 80,
                    "targetValueRange": {
                      "lowerBound": 15,
                      "upperBound": 65
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.5,
                    "standardDeviation": 0.2,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.6,
                    "standardDeviation": 0.3,
                    "unit": "mg/dL"
                  }
                ]
              },
              {
                "drugName": "Cinacalcet",
                "drugClass": "Calcimimetic",
                "dosage": {
                  "initialDose": "30 mg",
                  "maintenanceDose": "60-90 mg",
                  "frequency": "Once daily or divided doses",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "2-4 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (120 * (t / 4))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -120,
                    "standardDeviation": 40,
                    "targetValueRange": {
                      "lowerBound": 150,
                      "upperBound": 300
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.5,
                    "standardDeviation": 0.2,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.2,
                    "standardDeviation": 0.1,
                    "unit": "mg/dL"
                  }
                ]
              },
              {
                "drugName": "Paricalcitol",
                "drugClass": "Vitamin D analog",
                "dosage": {
                  "initialDose": "1-2μg",
                  "maintenanceDose": "2-4μg",
                  "frequency": "Three times weekly (dialysis patients)",
                  "route": "Intravenous injection or oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-12 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (150 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -150,
                    "standardDeviation": 60,
                    "targetValueRange": {
                      "lowerBound": 150,
                      "upperBound": 300
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.4,
                    "standardDeviation": 0.15,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.5,
                    "standardDeviation": 0.2,
                    "unit": "mg/dL"
                  }
                ]
              },
              {
                "drugName": "Paricalcitol",
                "drugClass": "Selective vitamin D receptor agonist",
                "dosage": {
                  "initialDose": "1 μg",
                  "maintenanceDose": "2-4 μg",
                  "frequency": "Every other day or three times weekly",
                  "route": "Oral/Intravenous"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-12 weeks",
                  "calculation": {
                    "method": "Emax model",
                    "formula": "currentValue - (80 * (t / (t + 4)))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -80,
                    "standardDeviation": 30,
                    "targetValueRange": {
                      "lowerBound": 150,
                      "upperBound": 300
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.2,
                    "standardDeviation": 0.1,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.2,
                    "standardDeviation": 0.1,
                    "unit": "mg/dL"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Vitamin D Deficiency-related Secondary Hyperparathyroidism",
            "diagnosticCriteria": "PTH >65 pg/mL, accompanied by 25-hydroxyvitamin D <20 ng/mL.",
            "recommendedDrugs": [
              {
                "drugName": "Cholecalciferol (Vitamin D3)",
                "drugClass": "Vitamin D supplement",
                "dosage": {
                  "initialDose": "50000IU",
                  "maintenanceDose": "800-2000IU",
                  "frequency": "Once weekly (initial), then daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-12 weeks",
                  "calculation": {
                    "method": "Logarithmic decline",
                    "formula": "currentValue - (100 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -100,
                    "standardDeviation": 40,
                    "targetValueRange": {
                      "lowerBound": 15,
                      "upperBound": 65
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.3,
                    "standardDeviation": 0.1,
                    "unit": "mg/dL"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Primary Hyperparathyroidism",
            "diagnosticCriteria": "Elevated serum calcium with elevated PTH, excluding secondary causes.",
            "recommendedDrugs": [
              {
                "drugName": "Cinacalcet",
                "drugClass": "Calcimimetic",
                "dosage": {
                  "initialDose": "30 mg",
                  "maintenanceDose": "60-90 mg",
                  "frequency": "Once daily or divided doses",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "2-8 weeks",
                  "calculation": {
                    "method": "Logarithmic model",
                    "formula": "currentValue - (100 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -150,
                    "standardDeviation": 50,
                    "targetValueRange": {
                      "lowerBound": 60,
                      "upperBound": 90
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.6,
                    "standardDeviation": 0.3,
                    "unit": "mg/dL"
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:FGF23",
        "label": "Fibroblast growth factor 23",
        "unit": "pg/mL",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ]
      },
      "subIndicators": {
        "potentialDiseases": [
          {
            "diseaseName": "Chronic Kidney Disease (CKD)",
            "diagnosticCriteria": "CKD patients with FGF23 >100 pg/mL, accompanied by declining renal function and mineral metabolism disorder.",
            "recommendedDrugs": [
              {
                "drugName": "Sevelamer",
                "drugClass": "Phosphate binder",
                "dosage": {
                  "initialDose": "800mg",
                  "maintenanceDose": "2400-4800mg",
                  "frequency": "Three times daily with meals",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-16 weeks",
                  "calculation": {
                    "method": "Logarithmic decline",
                    "formula": "currentValue - (150 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -150,
                    "standardDeviation": 80,
                    "targetValueRange": {
                      "lowerBound": 40,
                      "upperBound": 100
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -1.0,
                    "standardDeviation": 0.4,
                    "unit": "mg/dL"
                  }
                ]
              },
              {
                "drugName": "Sevelamer carbonate",
                "drugClass": "Non-calcium phosphate binder",
                "dosage": {
                  "initialDose": "800 mg",
                  "maintenanceDose": "1600-2400 mg",
                  "frequency": "Once per meal",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-12 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (25 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -25,
                    "standardDeviation": 12,
                    "targetValueRange": {
                      "lowerBound": 30,
                      "upperBound": 100
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.9,
                    "standardDeviation": 0.3,
                    "unit": "mg/dL"
                  }
                ]
              },
              {
                "drugName": "Nisevetimab",
                "drugClass": "Anti-FGF23 monoclonal antibody",
                "dosage": {
                  "initialDose": "0.3mg/kg",
                  "maintenanceDose": "0.6-1.2mg/kg",
                  "frequency": "Once monthly",
                  "route": "Subcutaneous injection"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-8 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (300 * (t / 8))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -300,
                    "standardDeviation": 120,
                    "targetValueRange": {
                      "lowerBound": 40,
                      "upperBound": 100
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.8,
                    "standardDeviation": 0.3,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.4,
                    "standardDeviation": 0.15,
                    "unit": "mg/dL"
                  }
                ]
              },
              {
                "drugName": "Tenapanor",
                "drugClass": "Intestinal Na+/H+ exchanger 3 inhibitor (Phosphate-lowering drug)",
                "dosage": {
                  "initialDose": "50 mg",
                  "maintenanceDose": "50 mg",
                  "frequency": "Twice daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-8 weeks",
                  "calculation": {
                    "method": "Emax model",
                    "formula": "currentValue - (30 * (t / (t + 3)))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -30,
                    "standardDeviation": 10,
                    "targetValueRange": {
                      "lowerBound": 30,
                      "upperBound": 100
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -1.0,
                    "standardDeviation": 0.4,
                    "unit": "mg/dL"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "X-linked Hypophosphatemic Rickets",
            "diagnosticCriteria": "FGF23 >150 pg/mL, accompanied by hypophosphatemia and abnormal vitamin D metabolism.",
            "recommendedDrugs": [
              {
                "drugName": "Burosumab",
                "drugClass": "Anti-FGF23 monoclonal antibody",
                "dosage": {
                  "initialDose": "0.8mg/kg",
                  "maintenanceDose": "1.0mg/kg",
                  "frequency": "Once every 2 weeks",
                  "route": "Subcutaneous injection"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-12 weeks",
                  "calculation": {
                    "method": "Exponential decline",
                    "formula": "currentValue * exp(-0.15 * t)",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -400,
                    "standardDeviation": 150,
                    "targetValueRange": {
                      "lowerBound": 40,
                      "upperBound": 100
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 1.2,
                    "standardDeviation": 0.4,
                    "unit": "mg/dL"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Tumor-induced Osteomalacia (TO)",
            "diagnosticCriteria": "Hypophosphatemia, elevated FGF23, evidence of focal mesenchymal tumor.",
            "recommendedDrugs": [
              {
                "drugName": "Burosumab",
                "drugClass": "Anti-FGF23 monoclonal antibody",
                "dosage": {
                  "initialDose": "0.3 mg/kg",
                  "maintenanceDose": "0.3-1.0 mg/kg",
                  "frequency": "Once every 4 weeks",
                  "route": "Subcutaneous"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12-24 weeks",
                  "calculation": {
                    "method": "Logarithmic model",
                    "formula": "currentValue - (40 * log(t/4 + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -40,
                    "standardDeviation": 15,
                    "targetValueRange": {
                      "lowerBound": 30,
                      "upperBound": 80
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.8,
                    "standardDeviation": 0.3,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "RENAL:Calcium",
                    "expectedTrend": "Mild increase",
                    "expectedMeanChange": 0.1,
                    "standardDeviation": 0.05,
                    "unit": "mg/dL"
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:Albumin_serum",
        "label": "Serum albumin",
        "unit": "g/dL",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ]
      },
      "subIndicators": {
        "potentialDiseases": [
          {
            "diseaseName": "Nephrotic Syndrome",
            "diagnosticCriteria": "Serum albumin <3.0 g/dL, accompanied by massive proteinuria (>3.5g/24h), edema and hyperlipidemia.",
            "recommendedDrugs": [
              {
                "drugName": "Propranolol",
                "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                "dosage": {
                  "initialDose": "10mg",
                  "maintenanceDose": "20-40mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12-24 weeks",
                  "calculation": {
                    "method": "Logarithmic increase",
                    "formula": "currentValue + (0.5 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 0.5,
                    "standardDeviation": 0.2,
                    "targetValueRange": {
                      "lowerBound": 3.5,
                      "upperBound": 5.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -2.0,
                    "standardDeviation": 0.8,
                    "unit": "g/day"
                  },
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Improvement",
                    "expectedMeanChange": 1.5,
                    "standardDeviation": 0.5,
                    "unit": "mL/min/1.73m²/year"
                  }
                ]
              },
              {
                "drugName": "Benazepril",
                "drugClass": "ACEI",
                "dosage": {
                  "initialDose": "10 mg",
                  "maintenanceDose": "20 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12 weeks",
                  "calculation": {
                    "method": "Linear increase",
                    "formula": "currentValue + (0.3 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 0.3,
                    "standardDeviation": 0.15,
                    "targetValueRange": {
                      "lowerBound": 3.5,
                      "upperBound": 5.0
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.4,
                    "standardDeviation": 0.2,
                    "unit": "g/d"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -5,
                    "standardDeviation": 3,
                    "unit": "mm[Hg]"
                  },
                  {
                    "affectedNodeId": "RENAL:CysC",
                    "expectedTrend": "Mild increase",
                    "expectedMeanChange": 0.05,
                    "standardDeviation": 0.03,
                    "unit": "mg/L"
                  }
                ]
              },
              {
                "drugName": "Rituximab",
                "drugClass": "CD20 monoclonal antibody",
                "dosage": {
                  "initialDose": "375mg/m²",
                  "maintenanceDose": "375mg/m²",
                  "frequency": "Once weekly for 4 doses",
                  "route": "Intravenous infusion"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-16 weeks",
                  "calculation": {
                    "method": "Linear increase",
                    "formula": "currentValue + (0.8 * (t / 16))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 0.8,
                    "standardDeviation": 0.3,
                    "targetValueRange": {
                      "lowerBound": 3.5,
                      "upperBound": 5.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -3.5,
                    "standardDeviation": 1.2,
                    "unit": "g/day"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Protein-energy Malnutrition",
            "diagnosticCriteria": "Serum albumin <3.5 g/dL, accompanied by decreased BMI, muscle wasting and weight loss.",
            "recommendedDrugs": [
              {
                "drugName": "Human albumin",
                "drugClass": "Albumin preparation",
                "dosage": {
                  "initialDose": "20g",
                  "maintenanceDose": "20-40g",
                  "frequency": "As needed",
                  "route": "Intravenous infusion"
                },
                "expectedIndicatorChange": {
                  "timeframe": "1-2 weeks",
                  "calculation": {
                    "method": "Linear increase",
                    "formula": "currentValue + (0.6 * (t / 2))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 0.6,
                    "standardDeviation": 0.2,
                    "targetValueRange": {
                      "lowerBound": 3.5,
                      "upperBound": 5.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:BPV",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 5,
                    "standardDeviation": 2,
                    "unit": "mm[Hg]"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Hypoalbuminemia (Malnutrition/Inflammation)",
            "diagnosticCriteria": "Serum albumin <3.5 g/dL, combined with medical history suggesting malnutrition or chronic inflammation.",
            "recommendedDrugs": [
              {
                "drugName": "Human albumin injection",
                "drugClass": "Volume and colloid support",
                "dosage": {
                  "initialDose": "20 g",
                  "maintenanceDose": "20-40 g",
                  "frequency": "As needed",
                  "route": "Intravenous infusion"
                },
                "expectedIndicatorChange": {
                  "timeframe": "24-48 hours",
                  "calculation": {
                    "method": "Transient increase with partial decline",
                    "formula": "currentValue + (0.6 * (1 - exp(-1.2 * t/1)))",
                    "parameters": {
                      "t": "Days after medication"
                    },
                    "expectedMeanChange": 0.6,
                    "standardDeviation": 0.2,
                    "targetValueRange": {
                      "lowerBound": 3.5,
                      "upperBound": 5.0
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:BNP",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 20,
                    "standardDeviation": 10,
                    "unit": "pg/mL"
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:Hb",
        "label": "Hemoglobin",
        "unit": "g/dL",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests"
        ]
      },
      "subIndicators": {
        "potentialDiseases": [
          {
            "diseaseName": "Renal Anemia",
            "diagnosticCriteria": "CKD patients with hemoglobin <11 g/dL (males <13 g/dL, females <12 g/dL), accompanied by relative erythropoietin deficiency.",
            "recommendedDrugs": [
              {
                "drugName": "Darbepoetin alfa",
                "drugClass": "Erythropoiesis-stimulating agent (ESA)",
                "dosage": {
                  "initialDose": "0.45μg/kg",
                  "maintenanceDose": "0.45-0.75μg/kg",
                  "frequency": "Once weekly or once every two weeks",
                  "route": "Subcutaneous or intravenous injection"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-8 weeks",
                  "calculation": {
                    "method": "Linear increase",
                    "formula": "currentValue + (1.5 * (t / 8))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 1.5,
                    "standardDeviation": 0.5,
                    "targetValueRange": {
                      "lowerBound": 10,
                      "upperBound": 12
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 8,
                    "standardDeviation": 4,
                    "unit": "mm[Hg]"
                  },
                  {
                    "affectedNodeId": "CARDIO:MI",
                    "expectedTrend": "Increased risk",
                    "notes": "High hemoglobin target (>13g/dL) may increase cardiovascular event risk"
                  }
                ]
              },
              {
                "drugName": "Roxadustat",
                "drugClass": "Hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI)",
                "dosage": {
                  "initialDose": "100mg",
                  "maintenanceDose": "70-200mg",
                  "frequency": "Three times weekly",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "6-12 weeks",
                  "calculation": {
                    "method": "Logarithmic increase",
                    "formula": "currentValue + (1.8 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 1.8,
                    "standardDeviation": 0.6,
                    "targetValueRange": {
                      "lowerBound": 10,
                      "upperBound": 12
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 5,
                    "standardDeviation": 3,
                    "unit": "mm[Hg]"
                  }
                ]
              },
              {
                "drugName": "Iron sucrose",
                "drugClass": "Intravenous iron",
                "dosage": {
                  "initialDose": "200mg",
                  "maintenanceDose": "200-500mg",
                  "frequency": "Once every 1-4 weeks",
                  "route": "Intravenous injection"
                },
                "expectedIndicatorChange": {
                  "timeframe": "2-4 weeks",
                  "calculation": {
                    "method": "Linear increase",
                    "formula": "currentValue + (0.8 * (t / 4))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 0.8,
                    "standardDeviation": 0.3,
                    "targetValueRange": {
                      "lowerBound": 10,
                      "upperBound": 12
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:hsCRP",
                    "expectedTrend": "Temporary increase",
                    "expectedMeanChange": 2.0,
                    "standardDeviation": 1.0,
                    "unit": "mg/L"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Iron Deficiency Anemia",
            "diagnosticCriteria": "Hemoglobin <12 g/dL (females) or <13 g/dL (males), accompanied by ferritin <30 ng/mL or transferrin saturation <20%.",
            "recommendedDrugs": [
              {
                "drugName": "Ferrous sulfate",
                "drugClass": "Oral iron supplement",
                "dosage": {
                  "initialDose": "325mg",
                  "maintenanceDose": "325mg",
                  "frequency": "1-3 times daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-8 weeks",
                  "calculation": {
                    "method": "Linear increase",
                    "formula": "currentValue + (1.2 * (t / 8))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 1.2,
                    "standardDeviation": 0.4,
                    "targetValueRange": {
                      "lowerBound": 12,
                      "upperBound": 16
                    }
                  }
                },
                "sideEffects": []
              }
            ]
          },
          {
            "diseaseName": "CKD-related Anemia",
            "diagnosticCriteria": "Hb <12 g/dL (females) or <13 g/dL (males), excluding iron deficiency, bleeding, etc.",
            "recommendedDrugs": [
              {
                "drugName": "Darbepoetin alfa",
                "drugClass": "Erythropoiesis-stimulating agent (ESA)",
                "dosage": {
                  "initialDose": "0.45 μg/kg",
                  "maintenanceDose": "0.45-0.75 μg/kg",
                  "frequency": "Once weekly or every 2 weeks",
                  "route": "Subcutaneous/Intravenous"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-12 weeks",
                  "calculation": {
                    "method": "Linear increase",
                    "formula": "currentValue + (1.5 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 1.5,
                    "standardDeviation": 0.5,
                    "targetValueRange": {
                      "lowerBound": 10,
                      "upperBound": 12
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 2,
                    "standardDeviation": 2,
                    "unit": "mm[Hg]"
                  }
                ]
              },
              {
                "drugName": "Iron sucrose",
                "drugClass": "Intravenous iron",
                "dosage": {
                  "initialDose": "200 mg",
                  "maintenanceDose": "200 mg × 3-5 times",
                  "frequency": "1-2 times weekly",
                  "route": "Intravenous"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-8 weeks",
                  "calculation": {
                    "method": "Logarithmic model",
                    "formula": "currentValue + (0.8 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 0.8,
                    "standardDeviation": 0.4,
                    "targetValueRange": {
                      "lowerBound": 10,
                      "upperBound": 12
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:hsCRP",
                    "expectedTrend": "Short-term increase",
                    "expectedMeanChange": 0.5,
                    "standardDeviation": 0.3,
                    "unit": "mg/L"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Iron Deficiency Anemia",
            "diagnosticCriteria": "Decreased Hb with low ferritin and decreased transferrin saturation.",
            "recommendedDrugs": [
              {
                "drugName": "Ferrous fumarate",
                "drugClass": "Oral iron supplement",
                "dosage": {
                  "initialDose": "100 mg (elemental iron)",
                  "maintenanceDose": "100-200 mg",
                  "frequency": "1-2 times daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-12 weeks",
                  "calculation": {
                    "method": "Linear increase",
                    "formula": "currentValue + (1.2 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 1.2,
                    "standardDeviation": 0.5,
                    "targetValueRange": {
                      "lowerBound": 12,
                      "upperBound": 13
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "NEURO:PHQ9",
                    "expectedTrend": "No significant change",
                    "expectedMeanChange": 0,
                    "standardDeviation": 0,
                    "unit": "score"
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:Proteinuria_gd",
        "label": "Proteinuria (g/day)",
        "unit": "g/day",
        "system": "RENAL",
        "type": "state",
        "datasetHint": [
          "016-blood_tests",
          "urine_tests"
        ]
      },
      "subIndicators": {
        "potentialDiseases": [
          {
            "diseaseName": "Diabetic Kidney Disease",
            "diagnosticCriteria": "Diabetic patients with urine protein >0.5 g/day, accompanied by declining eGFR and retinopathy.",
            "recommendedDrugs": [
              {
                "drugName": "Irbesartan",
                "drugClass": "Angiotensin II receptor blocker (ARB)",
                "dosage": {
                  "initialDose": "150mg",
                  "maintenanceDose": "300mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-12 weeks",
                  "calculation": {
                    "method": "Logarithmic decline",
                    "formula": "currentValue - (currentValue * 0.35 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -1.5,
                    "standardDeviation": 0.6,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -12,
                    "standardDeviation": 5,
                    "unit": "mm[Hg]"
                  },
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Improvement",
                    "expectedMeanChange": 2.0,
                    "standardDeviation": 0.8,
                    "unit": "mL/min/1.73m²/year"
                  }
                ]
              },
              {
                "drugName": "Dapagliflozin",
                "drugClass": "Sodium-glucose cotransporter 2 inhibitor (SGLT2i)",
                "dosage": {
                  "initialDose": "10mg",
                  "maintenanceDose": "10mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "4-8 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (0.8 * (t / 8))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.8,
                    "standardDeviation": 0.3,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Initial mild decline then improvement",
                    "expectedMeanChange": 3.0,
                    "standardDeviation": 1.0,
                    "unit": "mL/min/1.73m²/year"
                  }
                ]
              },
              {
                "drugName": "Benazepril",
                "drugClass": "ACEI",
                "dosage": {
                  "initialDose": "10 mg",
                  "maintenanceDose": "20 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-12 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (0.40 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.4,
                    "standardDeviation": 0.2,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:CysC",
                    "expectedTrend": "Mild increase",
                    "expectedMeanChange": 0.05,
                    "standardDeviation": 0.03,
                    "unit": "mg/L"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -5,
                    "standardDeviation": 3,
                    "unit": "mm[Hg]"
                  }
                ]
              },
              {
                "drugName": "Finerenone",
                "drugClass": "Non-steroidal mineralocorticoid receptor antagonist",
                "dosage": {
                  "initialDose": "10mg",
                  "maintenanceDose": "20mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12-24 weeks",
                  "calculation": {
                    "method": "Logarithmic decline",
                    "formula": "currentValue - (currentValue * 0.30 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -1.2,
                    "standardDeviation": 0.5,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Improvement",
                    "expectedMeanChange": 1.8,
                    "standardDeviation": 0.7,
                    "unit": "mL/min/1.73m²/year"
                  },
                  {
                    "affectedNodeId": "CARDIO:MI",
                    "expectedTrend": "Risk reduction",
                    "notes": "Reduces cardiovascular event incidence"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Primary Glomerular Disease",
            "diagnosticCriteria": "Urine protein >3.5 g/day, possibly accompanied by hematuria, edema and hypoalbuminemia.",
            "recommendedDrugs": [
              {
                "drugName": "Cyclophosphamide",
                "drugClass": "Alkylating immunosuppressant",
                "dosage": {
                  "initialDose": "0.5-1.0g/m²",
                  "maintenanceDose": "0.5-1.0g/m²",
                  "frequency": "Once monthly for 6 months",
                  "route": "Intravenous injection"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12-24 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (2.5 * (t / 24))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -2.5,
                    "standardDeviation": 1.0,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Albumin_serum",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.8,
                    "standardDeviation": 0.3,
                    "unit": "g/dL"
                  }
                ]
              },
              {
                "drugName": "Tacrolimus",
                "drugClass": "Calcineurin inhibitor",
                "dosage": {
                  "initialDose": "0.05-0.1mg/kg",
                  "maintenanceDose": "Maintain blood concentration 5-10ng/mL",
                  "frequency": "Twice daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-16 weeks",
                  "calculation": {
                    "method": "Logarithmic decline",
                    "formula": "currentValue - (currentValue * 0.45 * log(t + 1))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -2.0,
                    "standardDeviation": 0.8,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.5
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 10,
                    "standardDeviation": 5,
                    "unit": "mm[Hg]"
                  },
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Possible decline",
                    "expectedMeanChange": -1.5,
                    "standardDeviation": 0.6,
                    "unit": "mL/min/1.73m²/year"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Diabetic Kidney Disease (DKD)",
            "diagnosticCriteria": "Diabetes history with persistent proteinuria (≥0.3 g/d).",
            "recommendedDrugs": [
              {
                "drugName": "Dapagliflozin",
                "drugClass": "SGLT2 inhibitor",
                "dosage": {
                  "initialDose": "10 mg",
                  "maintenanceDose": "10 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12-16 weeks",
                  "calculation": {
                    "method": "Exponential decay",
                    "formula": "currentValue - (0.35 * (1 - exp(-0.3 * t)))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.35,
                    "standardDeviation": 0.15,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -3,
                    "standardDeviation": 2,
                    "unit": "mm[Hg]"
                  },
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.1,
                    "standardDeviation": 0.05,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "METABOLIC_ENDO:TyG",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.2,
                    "standardDeviation": 0.1,
                    "unit": "a.u."
                  }
                ]
              },
              {
                "drugName": "Benazepril",
                "drugClass": "ACEI",
                "dosage": {
                  "initialDose": "10 mg",
                  "maintenanceDose": "20 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-12 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (0.40 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.4,
                    "standardDeviation": 0.2,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:CysC",
                    "expectedTrend": "Mild increase",
                    "expectedMeanChange": 0.05,
                    "standardDeviation": 0.03,
                    "unit": "mg/L"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -5,
                    "standardDeviation": 3,
                    "unit": "mm[Hg]"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "IgA Nephropathy",
            "diagnosticCriteria": "Renal biopsy confirms IgA deposition with persistent proteinuria.",
            "recommendedDrugs": [
              {
                "drugName": "Valsartan",
                "drugClass": "ARB",
                "dosage": {
                  "initialDose": "80 mg",
                  "maintenanceDose": "160 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12 weeks",
                  "calculation": {
                    "method": "Linear decline",
                    "formula": "currentValue - (0.30 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.3,
                    "standardDeviation": 0.15,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:UricAcid",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.4,
                    "standardDeviation": 0.2,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -6,
                    "standardDeviation": 3,
                    "unit": "mm[Hg]"
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:SGLT2i_use",
        "label": "SGLT2 inhibitor (assignment)",
        "unit": "binary",
        "system": "RENAL",
        "type": "exposure",
        "datasetHint": [
          "018-medications"
        ]
      },
      "subIndicators": {
        "potentialDiseases": [
          {
            "diseaseName": "Type 2 Diabetes with Chronic Kidney Disease",
            "diagnosticCriteria": "Type 2 diabetes patients with eGFR 20-90 mL/min/1.73m², with or without albuminuria.",
            "recommendedDrugs": [
              {
                "drugName": "Empagliflozin",
                "drugClass": "SGLT2 inhibitor",
                "dosage": {
                  "initialDose": "10mg",
                  "maintenanceDose": "10-25mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "Continuous use",
                  "calculation": {
                    "method": "Binary assignment",
                    "formula": "SGLT2i_use = 1",
                    "parameters": {
                      "exposure": "Using SGLT2i"
                    },
                    "expectedMeanChange": 1,
                    "standardDeviation": 0,
                    "targetValueRange": {
                      "lowerBound": 1,
                      "upperBound": 1
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Long-term improvement (initial mild decline)",
                    "expectedMeanChange": 2.5,
                    "standardDeviation": 0.8,
                    "unit": "mL/min/1.73m²/year"
                  },
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.6,
                    "standardDeviation": 0.3,
                    "unit": "g/day"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -4,
                    "standardDeviation": 2,
                    "unit": "mm[Hg]"
                  }
                ]
              },
              {
                "drugName": "Dapagliflozin",
                "drugClass": "SGLT2 inhibitor",
                "dosage": {
                  "initialDose": "10mg",
                  "maintenanceDose": "10mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "Continuous use",
                  "calculation": {
                    "method": "Binary assignment",
                    "formula": "SGLT2i_use = 1",
                    "parameters": {
                      "exposure": "Using SGLT2i"
                    },
                    "expectedMeanChange": 1,
                    "standardDeviation": 0,
                    "targetValueRange": {
                      "lowerBound": 1,
                      "upperBound": 1
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Long-term improvement",
                    "expectedMeanChange": 2.8,
                    "standardDeviation": 0.9,
                    "unit": "mL/min/1.73m²/year"
                  },
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.8,
                    "standardDeviation": 0.4,
                    "unit": "g/day"
                  },
                  {
                    "affectedNodeId": "CARDIO:LVMI",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -5,
                    "standardDeviation": 2,
                    "unit": "g/m2"
                  }
                ]
              },
              {
                "drugName": "Dapagliflozin",
                "drugClass": "SGLT2 inhibitor",
                "dosage": {
                  "initialDose": "10 mg",
                  "maintenanceDose": "10 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "52 weeks",
                  "calculation": {
                    "method": "Linear increase (for RENAL:eGFR_slope)",
                    "formula": "currentValue + (1.0 * (t / 52))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 1.0,
                    "standardDeviation": 0.5,
                    "targetValueRange": {
                      "lowerBound": -1.0,
                      "upperBound": 0.0
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -3,
                    "standardDeviation": 2,
                    "unit": "mm[Hg]"
                  },
                  {
                    "affectedNodeId": "RENAL:Phosphate",
                    "expectedTrend": "Mild increase",
                    "expectedMeanChange": 0.1,
                    "standardDeviation": 0.05,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "METABOLIC_ENDO:TyG",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.2,
                    "standardDeviation": 0.1,
                    "unit": "a.u."
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Chronic Heart Failure",
            "diagnosticCriteria": "Heart failure with reduced ejection fraction (HFrEF) or heart failure with mildly reduced ejection fraction (HFmrEF).",
            "recommendedDrugs": [
              {
                "drugName": "Dapagliflozin",
                "drugClass": "SGLT2 inhibitor",
                "dosage": {
                  "initialDose": "10mg",
                  "maintenanceDose": "10mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "Continuous use",
                  "calculation": {
                    "method": "Binary assignment",
                    "formula": "SGLT2i_use = 1",
                    "parameters": {
                      "exposure": "Using SGLT2i"
                    },
                    "expectedMeanChange": 1,
                    "standardDeviation": 0,
                    "targetValueRange": {
                      "lowerBound": 1,
                      "upperBound": 1
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:BNP",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -100,
                    "standardDeviation": 40,
                    "unit": "pg/mL"
                  },
                  {
                    "affectedNodeId": "CARDIO:LVEF",
                    "expectedTrend": "Improvement",
                    "expectedMeanChange": 3,
                    "standardDeviation": 1.5,
                    "unit": "%"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Proteinuric CKD (Non-diabetic)",
            "diagnosticCriteria": "Persistent proteinuria ≥0.3 g/d, eGFR may be normal or decreased.",
            "recommendedDrugs": [
              {
                "drugName": "Empagliflozin",
                "drugClass": "SGLT2 inhibitor",
                "dosage": {
                  "initialDose": "10 mg",
                  "maintenanceDose": "10-25 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "24-52 weeks",
                  "calculation": {
                    "method": "Linear increase (for RENAL:eGFR_slope)",
                    "formula": "currentValue + (0.8 * (t / 52))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": 0.8,
                    "standardDeviation": 0.4,
                    "targetValueRange": {
                      "lowerBound": -1.0,
                      "upperBound": 0.0
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.25,
                    "standardDeviation": 0.12,
                    "unit": "g/d"
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:ACEi_use",
        "label": "ACE inhibitor (assignment)",
        "unit": "binary",
        "system": "RENAL",
        "type": "exposure",
        "datasetHint": [
          "018-medications"
        ]
      },
      "subIndicators": {
        "potentialDiseases": [
          {
            "diseaseName": "Chronic Kidney Disease with Proteinuria",
            "diagnosticCriteria": "CKD patients with urine albumin/creatinine ratio >30 mg/g or proteinuria >0.15 g/day.",
            "recommendedDrugs": [
              {
                "drugName": "Benazepril",
                "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                "dosage": {
                  "initialDose": "5-10mg",
                  "maintenanceDose": "10-20mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "Continuous use",
                  "calculation": {
                    "method": "Binary assignment",
                    "formula": "ACEi_use = 1",
                    "parameters": {
                      "exposure": "Using ACEI"
                    },
                    "expectedMeanChange": 1,
                    "standardDeviation": 0,
                    "targetValueRange": {
                      "lowerBound": 1,
                      "upperBound": 1
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -1.2,
                    "standardDeviation": 0.5,
                    "unit": "g/day"
                  },
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Long-term improvement",
                    "expectedMeanChange": 2.2,
                    "standardDeviation": 0.8,
                    "unit": "mL/min/1.73m²/year"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -10,
                    "standardDeviation": 4,
                    "unit": "mm[Hg]"
                  }
                ]
              },
              {
                "drugName": "Benazepril",
                "drugClass": "ACEI",
                "dosage": {
                  "initialDose": "10 mg",
                  "maintenanceDose": "20 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12 weeks",
                  "calculation": {
                    "method": "Linear decline (for RENAL:Proteinuria_gd)",
                    "formula": "currentValue - (0.45 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.45,
                    "standardDeviation": 0.2,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -6,
                    "standardDeviation": 3,
                    "unit": "mm[Hg]"
                  },
                  {
                    "affectedNodeId": "RENAL:CysC",
                    "expectedTrend": "Mild increase",
                    "expectedMeanChange": 0.05,
                    "standardDeviation": 0.03,
                    "unit": "mg/L"
                  },
                  {
                    "affectedNodeId": "RENAL:Albumin_serum",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.2,
                    "standardDeviation": 0.1,
                    "unit": "g/dL"
                  }
                ]
              },
              {
                "drugName": "Ramipril",
                "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                "dosage": {
                  "initialDose": "2.5-5mg",
                  "maintenanceDose": "10mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "Continuous use",
                  "calculation": {
                    "method": "Binary assignment",
                    "formula": "ACEi_use = 1",
                    "parameters": {
                      "exposure": "Using ACEI"
                    },
                    "expectedMeanChange": 1,
                    "standardDeviation": 0,
                    "targetValueRange": {
                      "lowerBound": 1,
                      "upperBound": 1
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -1.0,
                    "standardDeviation": 0.4,
                    "unit": "g/day"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -12,
                    "standardDeviation": 5,
                    "unit": "mm[Hg]"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Diabetic Kidney Disease",
            "diagnosticCriteria": "Diabetic patients with microalbuminuria (30-300 mg/day) or overt proteinuria (>300 mg/day).",
            "recommendedDrugs": [
              {
                "drugName": "Enalapril",
                "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                "dosage": {
                  "initialDose": "5mg",
                  "maintenanceDose": "10-20mg",
                  "frequency": "Once or twice daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "Continuous use",
                  "calculation": {
                    "method": "Binary assignment",
                    "formula": "ACEi_use = 1",
                    "parameters": {
                      "exposure": "Using ACEI"
                    },
                    "expectedMeanChange": 1,
                    "standardDeviation": 0,
                    "targetValueRange": {
                      "lowerBound": 1,
                      "upperBound": 1
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -1.5,
                    "standardDeviation": 0.6,
                    "unit": "g/day"
                  },
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Long-term improvement",
                    "expectedMeanChange": 1.8,
                    "standardDeviation": 0.7,
                    "unit": "mL/min/1.73m²/year"
                  }
                ]
              },
              {
                "drugName": "Perindopril",
                "drugClass": "ACEI",
                "dosage": {
                  "initialDose": "4 mg",
                  "maintenanceDose": "8 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12-24 weeks",
                  "calculation": {
                    "method": "Exponential decay (for RENAL:Proteinuria_gd)",
                    "formula": "currentValue - (0.40 * (1 - exp(-0.25 * t)))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.4,
                    "standardDeviation": 0.18,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -5,
                    "standardDeviation": 3,
                    "unit": "mm[Hg]"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Hypertension with Proteinuric CKD",
            "diagnosticCriteria": "Persistent proteinuria ≥0.3 g/d, with or without hypertension.",
            "recommendedDrugs": [
              {
                "drugName": "Benazepril",
                "drugClass": "ACEI",
                "dosage": {
                  "initialDose": "10 mg",
                  "maintenanceDose": "20 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12 weeks",
                  "calculation": {
                    "method": "Linear decline (for RENAL:Proteinuria_gd)",
                    "formula": "currentValue - (0.45 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.45,
                    "standardDeviation": 0.2,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -6,
                    "standardDeviation": 3,
                    "unit": "mm[Hg]"
                  },
                  {
                    "affectedNodeId": "RENAL:CysC",
                    "expectedTrend": "Mild increase",
                    "expectedMeanChange": 0.05,
                    "standardDeviation": 0.03,
                    "unit": "mg/L"
                  },
                  {
                    "affectedNodeId": "RENAL:Albumin_serum",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.2,
                    "standardDeviation": 0.1,
                    "unit": "g/dL"
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:ARB_use",
        "label": "ARB (assignment)",
        "unit": "binary",
        "system": "RENAL",
        "type": "exposure",
        "datasetHint": [
          "018-medications"
        ]
      },
      "subIndicators": {
        "potentialDiseases": [
          {
            "diseaseName": "Chronic Kidney Disease with Proteinuria",
            "diagnosticCriteria": "CKD patients with urine albumin/creatinine ratio >30 mg/g or proteinuria >0.15 g/day, especially those intolerant to ACEI.",
            "recommendedDrugs": [
              {
                "drugName": "Irbesartan",
                "drugClass": "Angiotensin II receptor blocker (ARB)",
                "dosage": {
                  "initialDose": "150mg",
                  "maintenanceDose": "300mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "Continuous use",
                  "calculation": {
                    "method": "Binary assignment",
                    "formula": "ARB_use = 1",
                    "parameters": {
                      "exposure": "Using ARB"
                    },
                    "expectedMeanChange": 1,
                    "standardDeviation": 0,
                    "targetValueRange": {
                      "lowerBound": 1,
                      "upperBound": 1
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -1.5,
                    "standardDeviation": 0.6,
                    "unit": "g/day"
                  },
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Long-term improvement",
                    "expectedMeanChange": 2.0,
                    "standardDeviation": 0.8,
                    "unit": "mL/min/1.73m²/year"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -12,
                    "standardDeviation": 5,
                    "unit": "mm[Hg]"
                  }
                ]
              },
              {
                "drugName": "Losartan",
                "drugClass": "Angiotensin II receptor blocker (ARB)",
                "dosage": {
                  "initialDose": "50mg",
                  "maintenanceDose": "100mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "Continuous use",
                  "calculation": {
                    "method": "Binary assignment",
                    "formula": "ARB_use = 1",
                    "parameters": {
                      "exposure": "Using ARB"
                    },
                    "expectedMeanChange": 1,
                    "standardDeviation": 0,
                    "targetValueRange": {
                      "lowerBound": 1,
                      "upperBound": 1
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -1.2,
                    "standardDeviation": 0.5,
                    "unit": "g/day"
                  },
                  {
                    "affectedNodeId": "RENAL:UricAcid",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.5,
                    "standardDeviation": 0.2,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -10,
                    "standardDeviation": 4,
                    "unit": "mm[Hg]"
                  }
                ]
              },
              {
                "drugName": "Losartan",
                "drugClass": "ARB",
                "dosage": {
                  "initialDose": "50 mg",
                  "maintenanceDose": "100 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-12 weeks",
                  "calculation": {
                    "method": "Linear decline (for RENAL:Proteinuria_gd)",
                    "formula": "currentValue - (0.35 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.35,
                    "standardDeviation": 0.15,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:UricAcid",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.6,
                    "standardDeviation": 0.3,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -6,
                    "standardDeviation": 3,
                    "unit": "mm[Hg]"
                  }
                ]
              },
              {
                "drugName": "Telmisartan",
                "drugClass": "Angiotensin II receptor blocker (ARB)",
                "dosage": {
                  "initialDose": "40mg",
                  "maintenanceDose": "80mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "Continuous use",
                  "calculation": {
                    "method": "Binary assignment",
                    "formula": "ARB_use = 1",
                    "parameters": {
                      "exposure": "Using ARB"
                    },
                    "expectedMeanChange": 1,
                    "standardDeviation": 0,
                    "targetValueRange": {
                      "lowerBound": 1,
                      "upperBound": 1
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -1.0,
                    "standardDeviation": 0.4,
                    "unit": "g/day"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -11,
                    "standardDeviation": 4,
                    "unit": "mm[Hg]"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Diabetic Kidney Disease",
            "diagnosticCriteria": "Type 2 diabetes patients with microalbuminuria or overt proteinuria, intolerant to ACEI or with significant cough side effects.",
            "recommendedDrugs": [
              {
                "drugName": "Candesartan",
                "drugClass": "Angiotensin II receptor blocker (ARB)",
                "dosage": {
                  "initialDose": "8mg",
                  "maintenanceDose": "16-32mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "Continuous use",
                  "calculation": {
                    "method": "Binary assignment",
                    "formula": "ARB_use = 1",
                    "parameters": {
                      "exposure": "Using ARB"
                    },
                    "expectedMeanChange": 1,
                    "standardDeviation": 0,
                    "targetValueRange": {
                      "lowerBound": 1,
                      "upperBound": 1
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:Proteinuria_gd",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -1.3,
                    "standardDeviation": 0.5,
                    "unit": "g/day"
                  },
                  {
                    "affectedNodeId": "RENAL:eGFR_slope",
                    "expectedTrend": "Long-term improvement",
                    "expectedMeanChange": 1.9,
                    "standardDeviation": 0.7,
                    "unit": "mL/min/1.73m²/year"
                  }
                ]
              },
              {
                "drugName": "Valsartan",
                "drugClass": "ARB",
                "dosage": {
                  "initialDose": "80 mg",
                  "maintenanceDose": "160 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12-16 weeks",
                  "calculation": {
                    "method": "Exponential decay (for RENAL:Proteinuria_gd)",
                    "formula": "currentValue - (0.32 * (1 - exp(-0.25 * t)))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.32,
                    "standardDeviation": 0.16,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:CysC",
                    "expectedTrend": "Mild increase",
                    "expectedMeanChange": 0.05,
                    "standardDeviation": 0.03,
                    "unit": "mg/L"
                  },
                  {
                    "affectedNodeId": "RENAL:Albumin_serum",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.15,
                    "standardDeviation": 0.1,
                    "unit": "g/dL"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "IgA Nephropathy with Persistent Proteinuria",
            "diagnosticCriteria": "Renal biopsy confirms IgA nephropathy with proteinuria ≥0.3 g/d.",
            "recommendedDrugs": [
              {
                "drugName": "Losartan",
                "drugClass": "ARB",
                "dosage": {
                  "initialDose": "50 mg",
                  "maintenanceDose": "100 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "8-12 weeks",
                  "calculation": {
                    "method": "Linear decline (for RENAL:Proteinuria_gd)",
                    "formula": "currentValue - (0.35 * (t / 12))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.35,
                    "standardDeviation": 0.15,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:UricAcid",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -0.6,
                    "standardDeviation": 0.3,
                    "unit": "mg/dL"
                  },
                  {
                    "affectedNodeId": "CARDIO:SBP_day",
                    "expectedTrend": "Decrease",
                    "expectedMeanChange": -6,
                    "standardDeviation": 3,
                    "unit": "mm[Hg]"
                  }
                ]
              }
            ]
          },
          {
            "diseaseName": "Diabetic Kidney Disease (DKD)",
            "diagnosticCriteria": "Diabetes with proteinuria ≥0.3 g/d.",
            "recommendedDrugs": [
              {
                "drugName": "Valsartan",
                "drugClass": "ARB",
                "dosage": {
                  "initialDose": "80 mg",
                  "maintenanceDose": "160 mg",
                  "frequency": "Once daily",
                  "route": "Oral"
                },
                "expectedIndicatorChange": {
                  "timeframe": "12-16 weeks",
                  "calculation": {
                    "method": "Exponential decay (for RENAL:Proteinuria_gd)",
                    "formula": "currentValue - (0.32 * (1 - exp(-0.25 * t)))",
                    "parameters": {
                      "t": "Weeks after medication"
                    },
                    "expectedMeanChange": -0.32,
                    "standardDeviation": 0.16,
                    "targetValueRange": {
                      "lowerBound": 0,
                      "upperBound": 0.3
                    }
                  }
                },
                "sideEffects": [
                  {
                    "affectedNodeId": "RENAL:CysC",
                    "expectedTrend": "Mild increase",
                    "expectedMeanChange": 0.05,
                    "standardDeviation": 0.03,
                    "unit": "mg/L"
                  },
                  {
                    "affectedNodeId": "RENAL:Albumin_serum",
                    "expectedTrend": "Increase",
                    "expectedMeanChange": 0.15,
                    "standardDeviation": 0.1,
                    "unit": "g/dL"
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:Loop_use",
        "label": "Loop diuretic (assignment)",
        "unit": "binary",
        "system": "RENAL",
        "type": "exposure",
        "datasetHint": ["018-medications"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Acute Heart Failure with Volume Overload",
              "diagnosticCriteria": "Presence of dyspnea, pulmonary rales, lower extremity edema, imaging showing pulmonary congestion, BNP>400pg/mL",
              "recommendedDrugs": [
                {
                  "drugName": "Furosemide",
                  "drugClass": "Loop diuretic",
                  "dosage": {
                    "initialDose": "20-40mg",
                    "maintenanceDose": "20-80mg",
                    "frequency": "1-2 times daily",
                    "route": "Oral or intravenous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 hours",
                    "calculation": {
                      "method": "Rapid diuretic effect",
                      "formula": "Urine output increased to 2-3L/day",
                      "parameters": {
                        "t": "Hours after medication"
                      },
                      "expectedMeanChange": "Weight loss of 2-4kg",
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "description": "Symptom relief, stable weight"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.8,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:MetabolicAcid",
                      "expectedTrend": "Risk of metabolic alkalosis",
                      "description": "Excessive diuresis may lead to hypochloremic alkalosis"
                    }
                  ]
                },
                {
                  "drugName": "Torsemide",
                  "drugClass": "Loop diuretic",
                  "dosage": {
                    "initialDose": "10-20mg",
                    "maintenanceDose": "10-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 hours",
                    "calculation": {
                      "method": "Sustained diuretic effect",
                      "formula": "Steady increase in urine output",
                      "parameters": {
                        "t": "Hours after medication"
                      },
                      "expectedMeanChange": "Weight loss of 2-3kg",
                      "standardDeviation": 1.2,
                      "targetValueRange": {
                        "description": "Symptom improvement, more stable bioavailability"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.6,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Short-term mild decline",
                      "expectedMeanChange": -5,
                      "standardDeviation": 3,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Kidney Disease with Edema",
              "diagnosticCriteria": "eGFR<60 mL/min/1.73m² for >3 months, with lower extremity edema or generalized edema",
              "recommendedDrugs": [
                {
                  "drugName": "Furosemide",
                  "drugClass": "Loop diuretic",
                  "dosage": {
                    "initialDose": "40mg",
                    "maintenanceDose": "40-120mg",
                    "frequency": "1-2 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Progressive diuresis",
                      "formula": "Gradual edema reduction",
                      "parameters": {
                        "t": "Days after medication"
                      },
                      "expectedMeanChange": "Edema score decreased by 2-3 points",
                      "standardDeviation": 1,
                      "targetValueRange": {
                        "description": "Significant edema reduction"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Possible accelerated decline",
                      "expectedMeanChange": -3,
                      "standardDeviation": 2,
                      "unit": "mL/min/1.73m2/y"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2.0,
                      "standardDeviation": 1.0,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:Albumin_serum",
                      "expectedTrend": "Decreased blood volume may cause relative increase in serum albumin",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "g/dL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:MetabolicAcid",
        "label": "Metabolic acidosis (bicarbonate low)",
        "unit": "binary",
        "system": "RENAL",
        "type": "state",
        "datasetHint": ["016-blood_tests"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "CKD-related Metabolic Acidosis",
              "diagnosticCriteria": "Serum bicarbonate <22 mmol/L, eGFR<60 mL/min/1.73m², normal anion gap",
              "recommendedDrugs": [
                {
                  "drugName": "Sodium Bicarbonate",
                  "drugClass": "Alkalinizing agent",
                  "dosage": {
                    "initialDose": "650mg",
                    "maintenanceDose": "1300-2600mg",
                    "frequency": "2-4 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "HCO3- = currentValue + (2 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2,
                      "standardDeviation": 0.8,
                      "targetValueRange": {
                        "lowerBound": 22,
                        "upperBound": 26,
                        "description": "Normalization of serum bicarbonate"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 3,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]",
                      "description": "Increased sodium load"
                    },
                    {
                      "affectedNodeId": "RENAL:DietaryNa",
                      "expectedTrend": "Increased sodium intake",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.5,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "unit": "mg/dL",
                      "description": "Alkalinization may reduce free calcium"
                    }
                  ]
                },
                {
                  "drugName": "Potassium Sodium Citrate",
                  "drugClass": "Alkalinizing agent",
                  "dosage": {
                    "initialDose": "10-20mEq",
                    "maintenanceDose": "20-40mEq",
                    "frequency": "2-3 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "HCO3- = currentValue + (2.5 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 0.9,
                      "targetValueRange": {
                        "lowerBound": 22,
                        "upperBound": 26
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:DietaryK",
                      "expectedTrend": "Increased potassium intake",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.3,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "RENAL:StoneHx",
                      "expectedTrend": "Reduced stone risk",
                      "description": "Citrate inhibits calcium stone formation"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Renal Tubular Acidosis (RTA)",
              "diagnosticCriteria": "Normal anion gap metabolic acidosis, abnormal urine pH (RTA Type I >5.5, RTA Type II variable)",
              "recommendedDrugs": [
                {
                  "drugName": "Sodium Bicarbonate",
                  "drugClass": "Alkalinizing agent",
                  "dosage": {
                    "initialDose": "1-2 mEq/kg/day",
                    "maintenanceDose": "1-3 mEq/kg/day",
                    "frequency": "Divided doses",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Rapid correction",
                      "formula": "HCO3- = currentValue + (4 * (t / 2))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 4,
                      "standardDeviation": 1.2,
                      "targetValueRange": {
                        "lowerBound": 22,
                        "upperBound": 26
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:Phosphate",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "unit": "mg/dL"
                    }
                  ]
                },
                {
                  "drugName": "Potassium Citrate",
                  "drugClass": "Alkalinizing agent",
                  "dosage": {
                    "initialDose": "20-30mEq",
                    "maintenanceDose": "40-80mEq",
                    "frequency": "2-3 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Stable correction",
                      "formula": "HCO3- = currentValue + (3.5 * (t / 2))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 3.5,
                      "standardDeviation": 1.0,
                      "targetValueRange": {
                        "lowerBound": 22,
                        "upperBound": 26
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:StoneHx",
                      "expectedTrend": "Stone prevention",
                      "description": "Especially suitable for distal RTA patients prone to kidney stones"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Improved calcium balance",
                      "expectedMeanChange": 0.1,
                      "standardDeviation": 0.1,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:StoneHx",
        "label": "Kidney stone history",
        "unit": "binary",
        "system": "RENAL",
        "type": "state",
        "datasetHint": ["058-health_and_medical_history"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Recurrent Calcium Oxalate Stones",
              "diagnosticCriteria": "History of 2 or more kidney stones, stone analysis showing calcium oxalate, 24-hour urine oxalate >40mg",
              "recommendedDrugs": [
                {
                  "drugName": "Potassium Citrate",
                  "drugClass": "Alkalinizing agent/Stone prevention",
                  "dosage": {
                    "initialDose": "30mEq",
                    "maintenanceDose": "40-80mEq",
                    "frequency": "2-3 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "3-6 months",
                    "calculation": {
                      "method": "Reduce stone recurrence rate",
                      "formula": "Stone recurrence risk reduced by 50-60%",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": "Urine citrate increased to >320mg/day",
                      "standardDeviation": 50,
                      "targetValueRange": {
                        "description": "Urine pH 6.5-7.0, normalized urine citrate"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:DietaryK",
                      "expectedTrend": "Increased potassium intake",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.4,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "RENAL:MetabolicAcid",
                      "expectedTrend": "Improvement",
                      "description": "Alkalinizes urine, corrects mild acidosis"
                    }
                  ]
                },
                {
                  "drugName": "Thiazide Diuretics (Hydrochlorothiazide)",
                  "drugClass": "Diuretic",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "25-50mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Reduce urinary calcium excretion",
                      "formula": "Urine calcium decreased by 30-40%",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": "Urine calcium <200mg/day",
                      "standardDeviation": 40,
                      "targetValueRange": {
                        "description": "Normalized urine calcium, reduced stone risk"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:DietaryK",
                      "expectedTrend": "Need to increase potassium intake",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.2,
                      "unit": "g/d",
                      "description": "Prevent hypokalemia"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Uric Acid Stones",
              "diagnosticCriteria": "Stone analysis showing uric acid stones, serum uric acid >7mg/dL, urine pH <5.5",
              "recommendedDrugs": [
                {
                  "drugName": "Allopurinol",
                  "drugClass": "Xanthine oxidase inhibitor",
                  "dosage": {
                    "initialDose": "100mg",
                    "maintenanceDose": "200-300mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "Uric acid = currentValue - (2 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -2,
                      "standardDeviation": 0.8,
                      "targetValueRange": {
                        "lowerBound": 4,
                        "upperBound": 6,
                        "description": "Serum uric acid <6mg/dL"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.5,
                      "standardDeviation": 1.0,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Possible mild improvement",
                      "expectedMeanChange": 1,
                      "standardDeviation": 0.5,
                      "unit": "mL/min/1.73m2/y",
                      "description": "Lowering uric acid may slow CKD progression"
                    }
                  ]
                },
                {
                  "drugName": "Sodium Bicarbonate",
                  "drugClass": "Alkalinizing agent",
                  "dosage": {
                    "initialDose": "650mg",
                    "maintenanceDose": "1300-2600mg",
                    "frequency": "2-4 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Alkalinize urine",
                      "formula": "Urine pH increased to 6.5-7.0",
                      "parameters": {
                        "t": "Days after medication"
                      },
                      "expectedMeanChange": "Urine pH increased by 1.0-1.5",
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "description": "Urine pH 6.5-7.0, dissolve uric acid stones"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:DietaryNa",
                      "expectedTrend": "Increased sodium intake",
                      "expectedMeanChange": 2.0,
                      "standardDeviation": 0.6,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Possible mild increase",
                      "expectedMeanChange": 4,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "May promote calcium phosphate stones",
                      "description": "Excessive alkalinization requires monitoring"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Cystine Stones",
              "diagnosticCriteria": "Familial cystinuria, urine cystine >250mg/day, characteristic hexagonal crystals",
              "recommendedDrugs": [
                {
                  "drugName": "Penicillamine",
                  "drugClass": "Chelating agent",
                  "dosage": {
                    "initialDose": "250mg",
                    "maintenanceDose": "1000-2000mg",
                    "frequency": "4 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "3-6 months",
                    "calculation": {
                      "method": "Reduce urine cystine",
                      "formula": "Urine cystine decreased by 40-50%",
                      "parameters": {
                        "t": "Months after medication"
                      },
                      "expectedMeanChange": "Urine cystine <250mg/day",
                      "standardDeviation": 50,
                      "targetValueRange": {
                        "description": "Reduce stone formation risk"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Possible proteinuria",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "RENAL:Albumin_serum",
                      "expectedTrend": "Possible decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "unit": "g/dL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:DietaryNa",
        "label": "Dietary sodium intake",
        "unit": "g/d",
        "system": "RENAL",
        "type": "state",
        "datasetHint": ["005-diet_logging", "055-lifestyle_and_environment"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "High Sodium Intake-related Hypertension",
              "diagnosticCriteria": "Dietary sodium intake >6g/day, blood pressure ≥140/90 mmHg, salt-sensitive hypertension",
              "recommendedDrugs": [
                {
                  "drugName": "Hydrochlorothiazide",
                  "drugClass": "Thiazide diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2-4 weeks",
                    "calculation": {
                      "method": "Increased sodium excretion, blood pressure reduction",
                      "formula": "SBP = currentValue - (12 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "description": "Better effect combined with low sodium diet (<5g/day)"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.6,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "RENAL:DietaryK",
                      "expectedTrend": "Need to increase potassium intake",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.3,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Possible mild increase",
                      "description": "Monitor glucose metabolism"
                    }
                  ]
                },
                {
                  "drugName": "Losartan Potassium",
                  "drugClass": "Angiotensin II receptor antagonist (ARB)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "100mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Inhibit RAAS system",
                      "formula": "SBP = currentValue - (15 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -15,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 120,
                        "upperBound": 139,
                        "description": "Blood pressure target achieved"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:DietaryK",
                      "expectedTrend": "Need to monitor potassium intake",
                      "description": "Avoid hyperkalemia"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Long-term improvement",
                      "expectedMeanChange": 2,
                      "standardDeviation": 1,
                      "unit": "mL/min/1.73m2/y"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Kidney Disease with High Sodium Intake",
              "diagnosticCriteria": "eGFR<60 mL/min/1.73m², dietary sodium >5g/day, proteinuria or edema",
              "recommendedDrugs": [
                {
                  "drugName": "Enalapril",
                  "drugClass": "Angiotensin-converting enzyme inhibitor (ACEI)",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10-20mg",
                    "frequency": "1-2 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Reduce proteinuria, slow kidney function decline",
                      "formula": "Proteinuria decreased by 30-40%",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": "Proteinuria reduction",
                      "standardDeviation": "High variability",
                      "targetValueRange": {
                        "description": "Best effect combined with low sodium diet"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:DietaryK",
                      "expectedTrend": "Need to restrict potassium intake",
                      "description": "Prevent hyperkalemia, especially when GFR<30"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Initial possible mild decline then improvement",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 1.2,
                      "unit": "mL/min/1.73m2/y"
                    },
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.4,
                      "unit": "g/d"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:DietaryK",
        "label": "Dietary potassium intake",
        "unit": "g/d",
        "system": "RENAL",
        "type": "state",
        "datasetHint": ["005-diet_logging", "055-lifestyle_and_environment"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Hypokalemia (Diuretic-related)",
              "diagnosticCriteria": "Serum potassium <3.5 mmol/L, use of loop or thiazide diuretics, possible muscle weakness, arrhythmia",
              "recommendedDrugs": [
                {
                  "drugName": "Potassium Chloride Extended-Release Tablets",
                  "drugClass": "Potassium supplement",
                  "dosage": {
                    "initialDose": "20-40mEq",
                    "maintenanceDose": "40-100mEq",
                    "frequency": "Divided daily doses",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "3-7 days",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "Serum potassium = currentValue + (0.5 * (t / 7))",
                      "parameters": {
                        "t": "Days after medication"
                      },
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "lowerBound": 3.5,
                        "upperBound": 5.0,
                        "description": "Normalized serum potassium"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:DietaryK",
                      "expectedTrend": "Increased potassium intake",
                      "expectedMeanChange": 2.0,
                      "standardDeviation": 0.6,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "RENAL:MetabolicAcid",
                      "expectedTrend": "Potassium chloride may worsen acidosis",
                      "description": "Use cautiously in CKD patients"
                    }
                  ]
                },
                {
                  "drugName": "Spironolactone",
                  "drugClass": "Potassium-sparing diuretic",
                  "dosage": {
                    "initialDose": "25mg",
                    "maintenanceDose": "25-50mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 weeks",
                    "calculation": {
                      "method": "Potassium-sparing effect",
                      "formula": "Serum potassium = currentValue + (0.6 * (t / 2))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.25,
                      "targetValueRange": {
                        "lowerBound": 3.5,
                        "upperBound": 5.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:DietaryK",
                      "expectedTrend": "Need to avoid excessive potassium supplementation",
                      "description": "Avoid hyperkalemia"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hyperkalemia (Chronic Kidney Disease-related)",
              "diagnosticCriteria": "Serum potassium >5.5 mmol/L, eGFR<30 mL/min/1.73m², use of ACEI/ARB",
              "recommendedDrugs": [
                {
                  "drugName": "Sodium Polystyrene Sulfonate",
                  "drugClass": "Potassium binder",
                  "dosage": {
                    "initialDose": "15g",
                    "maintenanceDose": "15-60g",
                    "frequency": "1-4 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "1-2 days",
                    "calculation": {
                      "method": "Rapid potassium reduction",
                      "formula": "Serum potassium = currentValue - (0.8 * (t / 2))",
                      "parameters": {
                        "t": "Days after medication"
                      },
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "lowerBound": 3.5,
                        "upperBound": 5.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:DietaryNa",
                      "expectedTrend": "Increased sodium load",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.5,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Possible increase",
                      "expectedMeanChange": 5,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Patiromer",
                  "drugClass": "Novel potassium binder",
                  "dosage": {
                    "initialDose": "8.4g",
                    "maintenanceDose": "8.4-25.2g",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "7 days",
                    "calculation": {
                      "method": "Sustained potassium reduction",
                      "formula": "Serum potassium = currentValue - (0.6 * (t / 7))",
                      "parameters": {
                        "t": "Days after medication"
                      },
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.25,
                      "targetValueRange": {
                        "lowerBound": 4.0,
                        "upperBound": 5.0
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:DietaryK",
                      "expectedTrend": "Reduced potassium absorption",
                      "description": "Allows continuation of ACEI/ARB therapy"
                    },
                    {
                      "affectedNodeId": "RENAL:DietaryNa",
                      "expectedTrend": "Lower sodium load",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.1,
                      "unit": "g/d"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:WC",
        "label": "Waist circumference",
        "unit": "cm",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["002-anthropometrics"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Central Obesity/Metabolic Syndrome",
              "diagnosticCriteria": "Male waist circumference ≥90cm, female ≥85cm (Asian criteria), with 2 or more of: high TG, low HDL-C, hypertension, hyperglycemia",
              "recommendedDrugs": [
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6mg",
                    "maintenanceDose": "1.2-1.8mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Progressive weight loss",
                      "formula": "WC = currentValue - (5 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -5,
                      "standardDeviation": 2.5,
                      "targetValueRange": {
                        "description": "Waist circumference reduced by 3-8cm, weight loss 5-10%"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Significant decrease",
                      "expectedMeanChange": -25,
                      "standardDeviation": 12,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "unit": "a.u."
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Possible mild nausea",
                      "description": "Common in initial phase"
                    }
                  ]
                },
                {
                  "drugName": "Semaglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.25mg",
                    "maintenanceDose": "1.0-2.4mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Significant weight loss",
                      "formula": "WC = currentValue - (8 * (t / 48))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -8,
                      "standardDeviation": 3.5,
                      "targetValueRange": {
                        "description": "Waist circumference reduced by 5-12cm, weight loss 10-15%"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Significant decrease",
                      "expectedMeanChange": -35,
                      "standardDeviation": 15,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:SAT",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -40,
                      "standardDeviation": 20,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.8,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Orlistat",
                  "drugClass": "Lipase inhibitor",
                  "dosage": {
                    "initialDose": "120mg",
                    "maintenanceDose": "120mg",
                    "frequency": "Three times daily with meals",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Moderate weight loss",
                      "formula": "WC = currentValue - (3 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -3,
                      "standardDeviation": 1.8,
                      "targetValueRange": {
                        "description": "Waist circumference reduced by 2-5cm, weight loss 3-5%"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Moderate decrease",
                      "expectedMeanChange": -15,
                      "standardDeviation": 8,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Mild improvement",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "PCOS-related Obesity",
              "diagnosticCriteria": "Reproductive-age females, waist circumference ≥85cm, irregular menstruation, hyperandrogenism, ultrasound showing polycystic ovaries",
              "recommendedDrugs": [
                {
                  "drugName": "Metformin",
                  "drugClass": "Biguanide antidiabetic",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "1500-2000mg",
                    "frequency": "2-3 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Improve insulin resistance",
                      "formula": "WC = currentValue - (2.5 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -2.5,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "description": "Waist circumference reduced by 2-4cm, improved menstrual cycle"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "a.u."
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -12,
                      "standardDeviation": 6,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Gastrointestinal discomfort",
                      "description": "Diarrhea and nausea common, slow titration can reduce symptoms"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:WHR",
        "label": "Waist-to-hip ratio",
        "unit": "ratio",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["002-anthropometrics"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Central Obesity",
              "diagnosticCriteria": "Male WHR>0.90, female WHR>0.85, indicating visceral fat accumulation",
              "recommendedDrugs": [
                {
                  "drugName": "Semaglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.25mg",
                    "maintenanceDose": "1.0mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Improve fat distribution",
                      "formula": "WHR = currentValue - (0.05 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.05,
                      "standardDeviation": 0.02,
                      "targetValueRange": {
                        "description": "WHR decreased, visceral fat preferentially reduced"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -7,
                      "standardDeviation": 3,
                      "unit": "cm"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Significant decrease",
                      "expectedMeanChange": -32,
                      "standardDeviation": 14,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.6,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6mg",
                    "maintenanceDose": "1.8mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Improve visceral fat",
                      "formula": "WHR = currentValue - (0.04 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.04,
                      "standardDeviation": 0.018,
                      "targetValueRange": {
                        "description": "WHR improvement, metabolic parameters optimized"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 2.5,
                      "unit": "cm"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -24,
                      "standardDeviation": 10,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.18,
                      "unit": "a.u."
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Metabolic Syndrome with High Waist-Hip Ratio",
              "diagnosticCriteria": "Abnormally elevated WHR, combined with ≥3 metabolic abnormalities: hypertension, hyperglycemia, high TG, low HDL-C",
              "recommendedDrugs": [
                {
                  "drugName": "Empagliflozin",
                  "drugClass": "SGLT2 inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "10-25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Improve visceral fat and metabolism",
                      "formula": "WHR = currentValue - (0.03 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.03,
                      "standardDeviation": 0.015,
                      "targetValueRange": {
                        "description": "WHR improvement, reduced cardiovascular risk"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3.5,
                      "standardDeviation": 1.8,
                      "unit": "cm"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -18,
                      "standardDeviation": 8,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -4,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:VAT",
        "label": "Visceral adipose tissue (DXA)",
        "unit": "cm2",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["011-body_composition"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Visceral Obesity/Metabolic Syndrome",
              "diagnosticCriteria": "DXA-measured VAT>100 cm² (female) or >130 cm² (male), with metabolic disorders",
              "recommendedDrugs": [
                {
                  "drugName": "Semaglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.25mg",
                    "maintenanceDose": "1.0-2.4mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Significantly reduce visceral fat",
                      "formula": "VAT = currentValue - (40 * (t / 48))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -40,
                      "standardDeviation": 18,
                      "targetValueRange": {
                        "description": "Significantly reduced VAT, improved metabolic parameters"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 3.5,
                      "unit": "cm"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WHR",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.05,
                      "standardDeviation": 0.02,
                      "unit": "ratio"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:SAT",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -42,
                      "standardDeviation": 20,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.8,
                      "standardDeviation": 0.9,
                      "unit": "mg/L"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.45,
                      "standardDeviation": 0.22,
                      "unit": "a.u."
                    }
                  ]
                },
                {
                  "drugName": "Tirzepatide",
                  "drugClass": "GIP/GLP-1 dual receptor agonist",
                  "dosage": {
                    "initialDose": "2.5mg",
                    "maintenanceDose": "10-15mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Extremely significant visceral fat reduction",
                      "formula": "VAT = currentValue - (55 * (t / 48))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -55,
                      "standardDeviation": 24,
                      "targetValueRange": {
                        "description": "Dramatically reduced VAT, comprehensive metabolic improvement"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Significant decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "unit": "cm"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:SAT",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -55,
                      "standardDeviation": 25,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Empagliflozin",
                  "drugClass": "SGLT2 inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Moderate visceral fat reduction",
                      "formula": "VAT = currentValue - (22 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -22,
                      "standardDeviation": 10,
                      "targetValueRange": {
                        "description": "Reduced VAT, cardiovascular benefit"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3.2,
                      "standardDeviation": 1.6,
                      "unit": "cm"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -4,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Improved cardiac function",
                      "expectedMeanChange": -15,
                      "standardDeviation": 10,
                      "unit": "pg/mL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Type 2 Diabetes with Visceral Obesity",
              "diagnosticCriteria": "Significantly increased VAT, HbA1c≥6.5% or FPG≥7.0 mmol/L, insulin resistance",
              "recommendedDrugs": [
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6mg",
                    "maintenanceDose": "1.2-1.8mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Reduce visceral fat and improve glucose",
                      "formula": "VAT = currentValue - (28 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -28,
                      "standardDeviation": 12,
                      "targetValueRange": {
                        "description": "Reduced VAT, HbA1c decreased by 0.8-1.2%"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Significant improvement",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.25,
                      "unit": "a.u."
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 2.5,
                      "unit": "cm"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.8,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Metformin",
                  "drugClass": "Biguanide",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "2000mg",
                    "frequency": "2-3 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-24 weeks",
                    "calculation": {
                      "method": "Improve insulin resistance",
                      "formula": "VAT = currentValue - (15 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -15,
                      "standardDeviation": 8,
                      "targetValueRange": {
                        "description": "Moderately reduced VAT"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "a.u."
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Mild decrease",
                      "expectedMeanChange": -2.5,
                      "standardDeviation": 1.5,
                      "unit": "cm"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:SAT",
        "label": "Subcutaneous adipose tissue (DXA)",
        "unit": "cm2",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["011-body_composition"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Generalized Obesity",
              "diagnosticCriteria": "Significantly increased SAT, BMI≥30 kg/m², excessive subcutaneous fat accumulation",
              "recommendedDrugs": [
                {
                  "drugName": "Semaglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.25mg",
                    "maintenanceDose": "2.4mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "48 weeks",
                    "calculation": {
                      "method": "Significantly reduce subcutaneous fat",
                      "formula": "SAT = currentValue - (50 * (t / 48))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -50,
                      "standardDeviation": 22,
                      "targetValueRange": {
                        "description": "Significantly reduced SAT, 10-15% weight loss"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Significant decrease",
                      "expectedMeanChange": -35,
                      "standardDeviation": 15,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 3.5,
                      "unit": "cm"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WHR",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.04,
                      "standardDeviation": 0.02,
                      "unit": "ratio"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -6,
                      "standardDeviation": 3,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6mg",
                    "maintenanceDose": "3.0mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Reduce subcutaneous fat",
                      "formula": "SAT = currentValue - (35 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -35,
                      "standardDeviation": 15,
                      "targetValueRange": {
                        "description": "Reduced SAT, 5-8% weight loss"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -25,
                      "standardDeviation": 12,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 2.5,
                      "unit": "cm"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.6,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Orlistat",
                  "drugClass": "Lipase inhibitor",
                  "dosage": {
                    "initialDose": "120mg",
                    "maintenanceDose": "120mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Moderately reduce subcutaneous fat",
                      "formula": "SAT = currentValue - (20 * (t / 24))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -20,
                      "standardDeviation": 10,
                      "targetValueRange": {
                        "description": "Moderately reduced SAT"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -15,
                      "standardDeviation": 8,
                      "unit": "cm2"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3,
                      "standardDeviation": 1.8,
                      "unit": "cm"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Lipodystrophy (Acquired)",
              "diagnosticCriteria": "Abnormally reduced or abnormally distributed SAT, possible insulin resistance and metabolic syndrome",
              "recommendedDrugs": [
                {
                  "drugName": "Recombinant Leptin (Metreleptin)",
                  "drugClass": "Leptin replacement therapy",
                  "dosage": {
                    "initialDose": "Based on body weight calculation",
                    "maintenanceDose": "Individualized adjustment",
                    "frequency": "Once daily",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24-48 weeks",
                    "calculation": {
                      "method": "Improve metabolic abnormalities",
                      "formula": "Improve insulin resistance and lipid abnormalities",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": "SAT itself does not increase, but metabolism improves",
                      "standardDeviation": "High individual variation",
                      "targetValueRange": {
                        "description": "Normalization of metabolic parameters"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "unit": "a.u."
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.25,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:nonHDL_C",
        "label": "Non-HDL cholesterol",
        "unit": "mmol/L",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["016-blood_tests"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Mixed Hyperlipidemia",
              "diagnosticCriteria": "Non-HDL cholesterol ≥4.9 mmol/L (190 mg/dL), both LDL-C and TG elevated",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "10-20mg",
                    "maintenanceDose": "20-80mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Linear decrease",
                      "formula": "nonHDL_C = currentValue - (1.2 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.5,
                      "targetValueRange": {
                        "lowerBound": 2.6,
                        "upperBound": 3.3,
                        "description": "Non-HDL-C<3.4 mmol/L (very high risk <2.6)"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:ApoA1",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.03,
                      "unit": "g/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "5-10mg",
                    "maintenanceDose": "10-40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4-8 weeks",
                    "calculation": {
                      "method": "Potent lipid lowering",
                      "formula": "nonHDL_C = currentValue - (1.5 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.6,
                      "targetValueRange": {
                        "lowerBound": 2.6,
                        "upperBound": 3.3
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:sdLDL",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 4,
                      "unit": "%"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.25,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:CAC",
                      "expectedTrend": "Slow progression",
                      "description": "Long-term use can slow coronary calcification"
                    }
                  ]
                },
                {
                  "drugName": "Ezetimibe",
                  "drugClass": "Cholesterol absorption inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Synergistic effect with statin",
                      "formula": "nonHDL_C = currentValue - (0.5 * (t / 4))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.2,
                      "targetValueRange": {
                        "description": "Monotherapy or combination with statin"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.2,
                      "standardDeviation": 0.1,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Familial Hypercholesterolemia",
              "diagnosticCriteria": "Non-HDL-C>5.7 mmol/L (220 mg/dL), positive family history, possible xanthomas",
              "recommendedDrugs": [
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin (high-intensity)",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8 weeks",
                    "calculation": {
                      "method": "Potent lipid lowering",
                      "formula": "nonHDL_C = currentValue - (2.0 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -2.0,
                      "standardDeviation": 0.8,
                      "targetValueRange": {
                        "lowerBound": 2.6,
                        "upperBound": 3.3
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:sdLDL",
                      "expectedTrend": "Significant decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 5,
                      "unit": "%"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.5,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Evolocumab",
                  "drugClass": "PCSK9 inhibitor",
                  "dosage": {
                    "initialDose": "140mg",
                    "maintenanceDose": "140mg or 420mg",
                    "frequency": "Every 2 weeks or monthly",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Extremely potent lipid lowering",
                      "formula": "nonHDL_C = currentValue - (2.8 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -2.8,
                      "standardDeviation": 1.0,
                      "targetValueRange": {
                        "lowerBound": 1.8,
                        "upperBound": 2.6,
                        "description": "Usually combined with statin"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Lpa",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -25,
                      "standardDeviation": 15,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:ApoA1",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.08,
                      "standardDeviation": 0.04,
                      "unit": "g/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:CAC",
                      "expectedTrend": "Significantly slow progression",
                      "description": "Significantly reduced cardiovascular event risk"
                    }
                  ]
                },
                {
                  "drugName": "Bempedoic Acid",
                  "drugClass": "ATP citrate lyase inhibitor",
                  "dosage": {
                    "initialDose": "180mg",
                    "maintenanceDose": "180mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Moderate lipid lowering",
                      "formula": "nonHDL_C = currentValue - (0.8 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.35,
                      "targetValueRange": {
                        "description": "Suitable for statin-intolerant patients"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL",
                      "description": "Use cautiously in gout patients"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Metabolic Syndrome-related Dyslipidemia",
              "diagnosticCriteria": "Elevated non-HDL-C, with high TG, low HDL-C, abdominal obesity, insulin resistance",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Improve lipid profile",
                      "formula": "nonHDL_C = currentValue - (1.1 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -1.1,
                      "standardDeviation": 0.5,
                      "targetValueRange": {
                        "lowerBound": 2.6,
                        "upperBound": 3.3
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.1,
                      "standardDeviation": 0.05,
                      "unit": "a.u.",
                      "description": "May mildly affect blood glucose"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.9,
                      "standardDeviation": 0.45,
                      "unit": "mg/L"
                    }
                  ]
                },
                {
                  "drugName": "Fenofibrate",
                  "drugClass": "Fibrate",
                  "dosage": {
                    "initialDose": "145mg",
                    "maintenanceDose": "145mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6-8 weeks",
                    "calculation": {
                      "method": "Reduce TG and remnant",
                      "formula": "nonHDL_C = currentValue - (0.6 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication"
                      },
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "description": "Mainly reduces TG, moderate improvement in nonHDL-C"
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Significant decrease",
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:ApoA1",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.12,
                      "standardDeviation": 0.06,
                      "unit": "g/L"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Need to monitor renal function",
                      "description": "Watch for myopathy risk when combined with statin"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:ApoA1",
        "label": "Apolipoprotein A1",
        "unit": "g/L",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["016-blood_tests"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Low HDL Cholesterolemia",
              "diagnosticCriteria": "ApoA1 < 1.0 g/L, often accompanied by decreased HDL-C, increasing cardiovascular disease risk.",
              "recommendedDrugs": [
                {
                  "drugName": "Fenofibrate",
                  "drugClass": "Fibrate lipid-regulating drug",
                  "dosage": {
                    "initialDose": "145mg",
                    "maintenanceDose": "145mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8-12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (0.15 * log(t + 1))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 0.15,
                      "standardDeviation": 0.05,
                      "targetValueRange": {
                        "lowerBound": 1.2,
                        "upperBound": 1.8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.08,
                      "standardDeviation": 0.04,
                      "unit": "mg/L",
                      "note": "Cystatin C increase reflects mild decline in kidney function"
                    },
                    {
                      "affectedNodeId": "RENAL:eGFR_slope",
                      "expectedTrend": "Accelerated decline",
                      "expectedMeanChange": -2,
                      "standardDeviation": 1.5,
                      "unit": "mL/min/1.73m2/y",
                      "note": "eGFR annual change rate accelerates"
                    }
                  ]
                },
                {
                  "drugName": "Niacin extended-release",
                  "drugClass": "Niacin-type lipid-regulating drug",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "1500mg",
                    "frequency": "Once daily at bedtime",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (0.25 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 0.25,
                      "standardDeviation": 0.08,
                      "targetValueRange": {
                        "lowerBound": 1.2,
                        "upperBound": 1.8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.5,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Metabolic Syndrome",
              "diagnosticCriteria": "Presence of at least 3 of: abdominal obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low HDL-C/ApoA1.",
              "recommendedDrugs": [
                {
                  "drugName": "Metformin",
                  "drugClass": "Biguanide antidiabetic drug",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "1500-2000mg",
                    "frequency": "2-3 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12-16 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (0.08 * (t / 16))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 0.08,
                      "standardDeviation": 0.04,
                      "targetValueRange": {
                        "lowerBound": 1.2,
                        "upperBound": 1.8
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.4,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.5,
                      "standardDeviation": 1.2,
                      "unit": "cm"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Primary/Secondary Low HDL Cholesterolemia",
              "diagnosticCriteria": "Two fasting tests on different days: HDL-C decreased (male <1.0 mmol/L; female <1.3 mmol/L) and/or ApoA1 <1.2 g/L; excluding secondary factors (inflammation, liver disease, malnutrition, etc.).",
              "recommendedDrugs": [
                {
                  "drugName": "Niacin (extended-release)",
                  "drugClass": "Niacin class",
                  "dosage": {
                    "initialDose": "500 mg",
                    "maintenanceDose": "1000–2000 mg",
                    "frequency": "Once nightly",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8–12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (0.15 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 0.15,
                      "standardDeviation": 0.06,
                      "targetValueRange": { "lowerBound": 1.2, "upperBound": 1.6 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:sdLDL",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8.0,
                      "standardDeviation": 4.0,
                      "unit": "%"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.15,
                      "standardDeviation": 0.08,
                      "unit": "a.u."
                    }
                  ]
                },
                {
                  "drugName": "Fenofibrate",
                  "drugClass": "Fibrate class",
                  "dosage": {
                    "initialDose": "145 mg",
                    "maintenanceDose": "145 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8–12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (0.10 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 0.10,
                      "standardDeviation": 0.05,
                      "targetValueRange": { "lowerBound": 1.2, "upperBound": 1.6 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.30,
                      "standardDeviation": 0.15,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:sdLDL",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10.0,
                      "standardDeviation": 3.0,
                      "unit": "%"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Metabolic Syndrome/Type 2 Diabetes-related Low ApoA1",
              "diagnosticCriteria": "Metabolic syndrome (≥3 of: increased waist circumference, elevated triglycerides, decreased HDL-C, elevated blood pressure, elevated fasting glucose) or confirmed type 2 diabetes, accompanied by low ApoA1.",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin class",
                  "dosage": {
                    "initialDose": "20 mg",
                    "maintenanceDose": "20–40 mg",
                    "frequency": "Once daily (at bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "6–12 weeks",
                    "calculation": {
                      "method": "Slow increase",
                      "formula": "currentValue + (0.05 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 0.05,
                      "standardDeviation": 0.03,
                      "targetValueRange": { "lowerBound": 1.2, "upperBound": 1.6 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:sdLDL",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10.0,
                      "standardDeviation": 4.0,
                      "unit": "%"
                    }
                  ]
                },
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6 mg",
                    "maintenanceDose": "1.2–1.8 mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (0.08 * log(t + 1))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 0.08,
                      "standardDeviation": 0.04,
                      "targetValueRange": { "lowerBound": 1.2, "upperBound": 1.6 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.40,
                      "standardDeviation": 0.15,
                      "unit": "a.u."
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },    
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:Lpa",
        "label": "Lipoprotein(a)",
        "unit": "mg/dL",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["016-blood_tests"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "High Lipoprotein(a) Syndrome",
              "diagnosticCriteria": "Lipoprotein(a) > 30 mg/dL, hereditary risk factor, associated with increased risk of atherosclerotic cardiovascular disease.",
              "recommendedDrugs": [
                {
                  "drugName": "Evolocumab",
                  "drugClass": "PCSK9 inhibitor",
                  "dosage": {
                    "initialDose": "140mg",
                    "maintenanceDose": "140mg",
                    "frequency": "Every two weeks",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic decline",
                      "formula": "currentValue - (currentValue * 0.25 * log(t + 1) / log(13))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -25,
                      "standardDeviation": 10,
                      "targetValueRange": {
                        "lowerBound": 10,
                        "upperBound": 30
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.8,
                      "standardDeviation": 0.6,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:nonHDL_C as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.12,
                      "unit": "g/L",
                      "note": "Using METABOLIC_ENDO:nonHDL_C as surrogate indicator"
                    }
                  ]
                },
                {
                  "drugName": "Alirocumab",
                  "drugClass": "PCSK9 inhibitor",
                  "dosage": {
                    "initialDose": "75mg",
                    "maintenanceDose": "150mg",
                    "frequency": "Every two weeks",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic decline",
                      "formula": "currentValue - (currentValue * 0.23 * log(t + 1) / log(13))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -23,
                      "standardDeviation": 9,
                      "targetValueRange": {
                        "lowerBound": 10,
                        "upperBound": 30
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.7,
                      "standardDeviation": 0.5,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:nonHDL_C as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.9,
                      "standardDeviation": 0.6,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Familial Hypercholesterolemia",
              "diagnosticCriteria": "LDL-C significantly elevated (>4.9 mmol/L) combined with elevated Lp(a), with family history of premature cardiovascular disease.",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin lipid-lowering drug",
                  "dosage": {
                    "initialDose": "20mg",
                    "maintenanceDose": "40-80mg",
                    "frequency": "Once daily at bedtime",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8 weeks",
                    "calculation": {
                      "method": "Logarithmic decline",
                      "formula": "currentValue - (currentValue * 0.10 * log(t + 1) / log(9))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 8,
                      "targetValueRange": {
                        "lowerBound": 10,
                        "upperBound": 30
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.5,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:nonHDL_C as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 8,
                      "standardDeviation": 5,
                      "unit": "U/L",
                      "note": "Using CARDIO:hsCRP as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 15,
                      "standardDeviation": 10,
                      "unit": "U/L",
                      "note": "Using CARDIO:hsCRP as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Hereditary Lp(a) Elevation",
              "diagnosticCriteria": "Two tests on different days showing Lp(a) ≥50 mg/dL, with no acute phase response.",
              "recommendedDrugs": [
                {
                  "drugName": "Evolocumab",
                  "drugClass": "PCSK9 inhibitor",
                  "dosage": {
                    "initialDose": "140 mg",
                    "maintenanceDose": "140 mg",
                    "frequency": "Every 2 weeks",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (25 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -25,
                      "standardDeviation": 10,
                      "targetValueRange": { "lowerBound": 10, "upperBound": 50 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.5,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:sdLDL",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -15.0,
                      "standardDeviation": 6.0,
                      "unit": "%"
                    }
                  ]
                },
                {
                  "drugName": "Niacin (extended-release)",
                  "drugClass": "Niacin class",
                  "dosage": {
                    "initialDose": "500 mg",
                    "maintenanceDose": "1000–2000 mg",
                    "frequency": "Once nightly",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8–12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (15 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -15,
                      "standardDeviation": 8,
                      "targetValueRange": { "lowerBound": 10, "upperBound": 50 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.2,
                      "standardDeviation": 0.5,
                      "unit": "mg/dL"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "ASCVD Combined with Lp(a) Elevation",
              "diagnosticCriteria": "Confirmed atherosclerotic cardiovascular disease with Lp(a) ≥30 mg/dL.",
              "recommendedDrugs": [
                {
                  "drugName": "Alirocumab",
                  "drugClass": "PCSK9 inhibitor",
                  "dosage": {
                    "initialDose": "75 mg",
                    "maintenanceDose": "75–150 mg",
                    "frequency": "Every 2 weeks",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (20 * log(t + 1))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -20,
                      "standardDeviation": 9,
                      "targetValueRange": { "lowerBound": 10, "upperBound": 50 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:Remnant_C",
        "label": "Remnant cholesterol",
        "unit": "mmol/L",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["016-blood_tests", "029-nightingale_metabolomics"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Hypertriglyceridemia",
              "diagnosticCriteria": "Triglycerides ≥ 2.3 mmol/L, remnant cholesterol elevated (>0.9 mmol/L), increasing atherosclerosis risk.",
              "recommendedDrugs": [
                {
                  "drugName": "Bezafibrate",
                  "drugClass": "Fibrate lipid-regulating drug",
                  "dosage": {
                    "initialDose": "200mg",
                    "maintenanceDose": "200mg",
                    "frequency": "Three times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.45 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -0.45,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.3,
                        "upperBound": 0.9
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.5,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:Remnant_C as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 6,
                      "standardDeviation": 4,
                      "unit": "U/L",
                      "note": "Using CARDIO:hsCRP as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "RENAL:CysC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.12,
                      "standardDeviation": 0.06,
                      "unit": "mg/dL",
                      "note": "Using RENAL:CysC as surrogate indicator"
                    }
                  ]
                },
                {
                  "drugName": "Omega-3 fatty acid ethyl esters",
                  "drugClass": "Fish oil preparation",
                  "dosage": {
                    "initialDose": "2g",
                    "maintenanceDose": "4g",
                    "frequency": "Once daily or divided into two doses",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic decline",
                      "formula": "currentValue - (0.35 * log(t + 1) / log(13))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -0.35,
                      "standardDeviation": 0.12,
                      "targetValueRange": {
                        "lowerBound": 0.3,
                        "upperBound": 0.9
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.9,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:Remnant_C as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Mild increase",
                      "expectedMeanChange": 0.15,
                      "standardDeviation": 0.08,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:nonHDL_C as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Mixed Hyperlipidemia",
              "diagnosticCriteria": "Total cholesterol ≥ 6.2 mmol/L and triglycerides ≥ 2.3 mmol/L, remnant cholesterol significantly elevated.",
              "recommendedDrugs": [
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin lipid-lowering drug",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.40 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.15,
                      "targetValueRange": {
                        "lowerBound": 0.3,
                        "upperBound": 0.9
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.8,
                      "standardDeviation": 0.6,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:nonHDL_C as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.2,
                      "standardDeviation": 0.7,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:nonHDL_C as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 12,
                      "standardDeviation": 8,
                      "unit": "U/L",
                      "note": "Using CARDIO:hsCRP as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Mixed/Hypertriglyceridemia",
              "diagnosticCriteria": "Fasting triglycerides ≥2.3 mmol/L or VLDL elevation, Remnant_C >0.8 mmol/L.",
              "recommendedDrugs": [
                {
                  "drugName": "Fenofibrate",
                  "drugClass": "Fibrate class",
                  "dosage": {
                    "initialDose": "145 mg",
                    "maintenanceDose": "145 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.60 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -0.60,
                      "standardDeviation": 0.25,
                      "targetValueRange": { "lowerBound": 0.2, "upperBound": 0.8 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:sdLDL",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -12.0,
                      "standardDeviation": 4.0,
                      "unit": "%"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.50,
                      "standardDeviation": 0.20,
                      "unit": "a.u."
                    }
                  ]
                },
                {
                  "drugName": "EPA (eicosapentaenoic acid, icosapent ethyl)",
                  "drugClass": "ω-3 fatty acid (high-purity EPA)",
                  "dosage": {
                    "initialDose": "2 g",
                    "maintenanceDose": "2 g",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.40 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -0.40,
                      "standardDeviation": 0.20,
                      "targetValueRange": { "lowerBound": 0.2, "upperBound": 0.8 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.50,
                      "standardDeviation": 0.20,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Metabolic Syndrome",
              "diagnosticCriteria": "Meets metabolic syndrome diagnostic criteria with elevated remnant cholesterol.",
              "recommendedDrugs": [
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin class",
                  "dosage": {
                    "initialDose": "10 mg",
                    "maintenanceDose": "10–20 mg",
                    "frequency": "Once daily (at bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8–12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.30 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -0.30,
                      "standardDeviation": 0.15,
                      "targetValueRange": { "lowerBound": 0.2, "upperBound": 0.8 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.00,
                      "standardDeviation": 0.40,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },    
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:sdLDL",
        "label": "Small dense LDL fraction",
        "unit": "%",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["008-serum_lipidomics"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Atherosclerotic Cardiovascular Disease",
              "diagnosticCriteria": "Small dense LDL proportion > 50%, commonly seen in patients with metabolic syndrome and diabetes, with stronger atherogenic properties.",
              "recommendedDrugs": [
                {
                  "drugName": "Pitavastatin",
                  "drugClass": "Statin lipid-lowering drug",
                  "dosage": {
                    "initialDose": "2mg",
                    "maintenanceDose": "4mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic decline",
                      "formula": "currentValue - (15 * log(t + 1) / log(13))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -15,
                      "standardDeviation": 6,
                      "targetValueRange": {
                        "lowerBound": 30,
                        "upperBound": 50
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:nonHDL_C as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 5,
                      "standardDeviation": 3,
                      "unit": "U/L",
                      "note": "Using CARDIO:hsCRP as surrogate indicator"
                    }
                  ]
                },
                {
                  "drugName": "Ezetimibe",
                  "drugClass": "Cholesterol absorption inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (10 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -10,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 30,
                        "upperBound": 50
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.2,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:nonHDL_C as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.7,
                      "standardDeviation": 0.25,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Type 2 Diabetes with Dyslipidemia",
              "diagnosticCriteria": "HbA1c ≥ 6.5%, elevated small dense LDL proportion, often accompanied by hypertriglyceridemia.",
              "recommendedDrugs": [
                {
                  "drugName": "Semaglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.25mg",
                    "maintenanceDose": "1.0mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "16 weeks",
                    "calculation": {
                      "method": "Logarithmic decline",
                      "formula": "currentValue - (12 * log(t + 1) / log(17))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "targetValueRange": {
                        "lowerBound": 30,
                        "upperBound": 50
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3.5,
                      "standardDeviation": 1.5,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.4,
                      "unit": "%",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:Remnant_C as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Insulin Resistance/Type 2 Diabetes",
              "diagnosticCriteria": "Elevated fasting glucose or impaired glucose tolerance, accompanied by elevated sdLDL proportion (>40%).",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin class",
                  "dosage": {
                    "initialDose": "20 mg",
                    "maintenanceDose": "20–40 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (10 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -10,
                      "standardDeviation": 4,
                      "targetValueRange": { "lowerBound": 20, "upperBound": 40 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.30,
                      "standardDeviation": 0.15,
                      "unit": "a.u."
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Familial Combined Hyperlipidemia",
              "diagnosticCriteria": "Positive family history, elevated non-HDL-C and triglycerides, increased sdLDL proportion.",
              "recommendedDrugs": [
                {
                  "drugName": "Fenofibrate",
                  "drugClass": "Fibrate class",
                  "dosage": {
                    "initialDose": "145 mg",
                    "maintenanceDose": "145 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (15 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -15,
                      "standardDeviation": 5,
                      "targetValueRange": { "lowerBound": 20, "upperBound": 40 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.50,
                      "standardDeviation": 0.20,
                      "unit": "mmol/L"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:TyG",
        "label": "Triglyceride-glucose index",
        "unit": "a.u.",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["016-blood_tests"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Insulin Resistance",
              "diagnosticCriteria": "TyG index ≥ 8.5, reflecting insulin resistance state, commonly seen in metabolic syndrome and prediabetes.",
              "recommendedDrugs": [
                {
                  "drugName": "Metformin",
                  "drugClass": "Biguanide antidiabetic drug",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "1500-2000mg",
                    "frequency": "2-3 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.8 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "targetValueRange": {
                        "lowerBound": 7.5,
                        "upperBound": 8.5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.6,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.5,
                      "unit": "a.u.",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.5,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    }
                  ]
                },
                {
                  "drugName": "Pioglitazone",
                  "drugClass": "Thiazolidinedione",
                  "dosage": {
                    "initialDose": "15mg",
                    "maintenanceDose": "30mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "16 weeks",
                    "calculation": {
                      "method": "Logarithmic decline",
                      "formula": "currentValue - (1.0 * log(t + 1) / log(17))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.4,
                      "targetValueRange": {
                        "lowerBound": 7.5,
                        "upperBound": 8.5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.8,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "RENAL:Hb",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.3,
                      "unit": "g/dL"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.5,
                      "standardDeviation": 0.6,
                      "unit": "a.u.",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Type 2 Diabetes",
              "diagnosticCriteria": "HbA1c ≥ 6.5% or fasting glucose ≥ 7.0 mmol/L, TyG index significantly elevated.",
              "recommendedDrugs": [
                {
                  "drugName": "Empagliflozin",
                  "drugClass": "SGLT2 inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.9 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -0.9,
                      "standardDeviation": 0.35,
                      "targetValueRange": {
                        "lowerBound": 7.5,
                        "upperBound": 8.5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "unit": "%",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.0,
                      "standardDeviation": 1.0,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -4,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Insulin Resistance/Prediabetes",
              "diagnosticCriteria": "TyG elevation (e.g., ≥8.5–8.8), with impaired fasting glucose or elevated HOMA-IR.",
              "recommendedDrugs": [
                {
                  "drugName": "Metformin",
                  "drugClass": "Biguanide/insulin sensitizer",
                  "dosage": {
                    "initialDose": "500 mg",
                    "maintenanceDose": "1500–2000 mg",
                    "frequency": "Twice daily (initially once daily)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8–12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.80 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -0.80,
                      "standardDeviation": 0.30,
                      "targetValueRange": { "lowerBound": 8.0, "upperBound": 8.8 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:MetabolicAcid",
                      "expectedTrend": "Risk increase"
                    }
                  ]
                },
                {
                  "drugName": "Dapagliflozin",
                  "drugClass": "SGLT2 inhibitor",
                  "dosage": {
                    "initialDose": "10 mg",
                    "maintenanceDose": "10 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.60 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -0.60,
                      "standardDeviation": 0.25,
                      "targetValueRange": { "lowerBound": 8.0, "upperBound": 8.8 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.30,
                      "standardDeviation": 0.15,
                      "unit": "g/d"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Type 2 Diabetes",
              "diagnosticCriteria": "Meets diabetes diagnostic criteria (fasting glucose ≥7.0 mmol/L or OGTT 2h ≥11.1 mmol/L, etc.), with elevated TyG.",
              "recommendedDrugs": [
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6 mg",
                    "maintenanceDose": "1.2–1.8 mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue - (0.70 * log(t + 1))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -0.70,
                      "standardDeviation": 0.25,
                      "targetValueRange": { "lowerBound": 8.0, "upperBound": 8.8 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:GLP1",
        "label": "Glucagon-like peptide-1",
        "unit": "pmol/L",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["016-blood_tests"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "GLP-1 Deficiency Type Diabetes",
              "diagnosticCriteria": "Postprandial GLP-1 level < 5 pmol/L, impaired insulin secretion, commonly seen in early type 2 diabetes.",
              "recommendedDrugs": [
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6mg",
                    "maintenanceDose": "1.2-1.8mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Exogenous supplementation",
                      "formula": "Pharmacological concentration (endogenous GLP-1 not directly measured)",
                      "parameters": {
                        "t": "Weeks after medication initiation",
                        "note": "Exogenous GLP-1 receptor agonist does not change endogenous GLP-1 measurements"
                      },
                      "expectedMeanChange": 0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.1,
                      "standardDeviation": 0.4,
                      "unit": "%",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.8,
                      "standardDeviation": 1.2,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3,
                      "standardDeviation": 2,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Dulaglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.75mg",
                    "maintenanceDose": "1.5mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Exogenous supplementation",
                      "formula": "Pharmacological concentration (endogenous GLP-1 not directly measured)",
                      "parameters": {
                        "t": "Weeks after medication initiation",
                        "note": "Long-acting GLP-1 receptor agonist"
                      },
                      "expectedMeanChange": 0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.4,
                      "unit": "%",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.5,
                      "standardDeviation": 1.0,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Obesity",
              "diagnosticCriteria": "BMI ≥ 28 kg/m2 (Chinese standard), accompanied by metabolic abnormalities, weakened GLP-1 secretion response.",
              "recommendedDrugs": [
                {
                  "drugName": "Semaglutide",
                  "drugClass": "GLP-1 receptor agonist (high dose)",
                  "dosage": {
                    "initialDose": "0.25mg",
                    "maintenanceDose": "2.4mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "20 weeks",
                    "calculation": {
                      "method": "Exogenous supplementation",
                      "formula": "Pharmacological concentration",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": null,
                        "upperBound": null
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -5.5,
                      "standardDeviation": 2.0,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8.5,
                      "standardDeviation": 3.0,
                      "unit": "cm"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:VAT",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -35,
                      "standardDeviation": 15,
                      "unit": "cm2"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Type 2 Diabetes (Impaired Incretin Response)",
              "diagnosticCriteria": "Oral glucose or postprandial GLP-1 response below age/sex reference range.",
              "recommendedDrugs": [
                {
                  "drugName": "Sitagliptin",
                  "drugClass": "DPP-4 inhibitor",
                  "dosage": {
                    "initialDose": "100 mg",
                    "maintenanceDose": "100 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (6 * (t / 8))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 6,
                      "standardDeviation": 3,
                      "targetValueRange": { "lowerBound": 5, "upperBound": 20 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.20,
                      "standardDeviation": 0.10,
                      "unit": "a.u."
                    }
                  ]
                },
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6 mg",
                    "maintenanceDose": "1.2–1.8 mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (8 * log(t + 1))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 8,
                      "standardDeviation": 4,
                      "targetValueRange": { "lowerBound": 5, "upperBound": 20 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Obesity-related GLP-1 Response Blunting",
              "diagnosticCriteria": "Postprandial GLP-1 peak or increment below normal population reference with obesity.",
              "recommendedDrugs": [
                {
                  "drugName": "Semaglutide (weekly formulation)",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.25 mg",
                    "maintenanceDose": "0.5–1.0 mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (10 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 10,
                      "standardDeviation": 5,
                      "targetValueRange": { "lowerBound": 5, "upperBound": 20 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:Ghrelin",
        "label": "Ghrelin",
        "unit": "pmol/L",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["016-blood_tests"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Prader-Willi Syndrome",
              "diagnosticCriteria": "Fasting serum Ghrelin significantly elevated (>200 pmol/L), accompanied by uncontrollable appetite hyperactivity and obesity.",
              "recommendedDrugs": [
                {
                  "drugName": "Growth hormone",
                  "drugClass": "Hormone replacement therapy",
                  "dosage": {
                    "initialDose": "0.24mg/kg/week",
                    "maintenanceDose": "0.24mg/kg/week",
                    "frequency": "Daily subcutaneous injection",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "24 weeks",
                    "calculation": {
                      "method": "Indirect regulation",
                      "formula": "currentValue - (20 * log(t + 1) / log(25))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -20,
                      "standardDeviation": 15,
                      "targetValueRange": {
                        "lowerBound": 80,
                        "upperBound": 120
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.4,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:GLP1",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 80,
                      "standardDeviation": 40,
                      "unit": "ng/mL",
                      "note": "Using METABOLIC_ENDO:GLP1 as surrogate indicator"
                    }
                  ]
                },
                {
                  "drugName": "Octreotide",
                  "drugClass": "Somatostatin analog",
                  "dosage": {
                    "initialDose": "100μg",
                    "maintenanceDose": "100-200μg",
                    "frequency": "Three times daily",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Secretion inhibition",
                      "formula": "currentValue - (30 * (t / 12))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": -30,
                      "standardDeviation": 12,
                      "targetValueRange": {
                        "lowerBound": 80,
                        "upperBound": 120
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Ghrelin",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.5,
                      "standardDeviation": 0.3,
                      "unit": "mIU/L",
                      "note": "Using METABOLIC_ENDO:Ghrelin as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Anorexia Nervosa",
              "diagnosticCriteria": "BMI < 17.5, Ghrelin level significantly elevated (compensatory), but appetite suppressed.",
              "recommendedDrugs": [
                {
                  "drugName": "Olanzapine",
                  "drugClass": "Atypical antipsychotic",
                  "dosage": {
                    "initialDose": "2.5mg",
                    "maintenanceDose": "5-10mg",
                    "frequency": "Once daily at bedtime",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Indirect regulation",
                      "formula": "currentValue - (25 * log(t + 1) / log(13))",
                      "parameters": {
                        "t": "Weeks after medication initiation",
                        "note": "As weight recovers, Ghrelin level gradually decreases"
                      },
                      "expectedMeanChange": -25,
                      "standardDeviation": 18,
                      "targetValueRange": {
                        "lowerBound": 80,
                        "upperBound": 120
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.2,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.5,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:Remnant_C",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.6,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:Remnant_C as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Anorexia Nervosa/Cachexia",
              "diagnosticCriteria": "Significant weight loss or low body weight, elevated ghrelin.",
              "recommendedDrugs": [
                {
                  "drugName": "Mirtazapine",
                  "drugClass": "Noradrenergic-serotonergic reuptake inhibitor/antagonist (NaSSA)",
                  "dosage": {
                    "initialDose": "15 mg",
                    "maintenanceDose": "30 mg",
                    "frequency": "Once nightly",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (80 * (t / 8))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 80,
                      "standardDeviation": 30,
                      "targetValueRange": { "lowerBound": 300, "upperBound": 800 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:Sleepiness",
                      "expectedTrend": "Occurrence"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Obesity (Decreased Ghrelin)",
              "diagnosticCriteria": "Elevated BMI, fasting/postprandial ghrelin below reference.",
              "recommendedDrugs": [
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6 mg",
                    "maintenanceDose": "1.2–1.8 mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (20 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -20,
                      "standardDeviation": 10,
                      "targetValueRange": { "lowerBound": 300, "upperBound": 800 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:GLP1RA_use",
        "label": "GLP-1 receptor agonist (assignment)",
        "unit": "binary",
        "system": "METABOLIC_ENDO",
        "type": "exposure",
        "datasetHint": ["018-medications"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Type 2 Diabetes",
              "diagnosticCriteria": "Meets diabetes diagnostic criteria with indications for weight management or cardiovascular-renal benefits.",
              "recommendedDrugs": [
                {
                  "drugName": "Semaglutide (weekly formulation)",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.25 mg",
                    "maintenanceDose": "0.5–1.0 mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks (medication assignment probability)",
                    "calculation": {
                      "method": "Linear adoption probability model",
                      "formula": "p(t) = min(1, p0 + 0.15 * t)",
                      "parameters": {
                        "t": "Weeks",
                        "p0": "Baseline medication assignment probability (0–1)"
                      },
                      "expectedMeanChange": 0.60,
                      "standardDeviation": 0.20,
                      "targetValueRange": { "lowerBound": 0, "upperBound": 1 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.70,
                      "standardDeviation": 0.25,
                      "unit": "a.u."
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Obesity",
              "diagnosticCriteria": "Adult BMI ≥30, or BMI ≥27 with weight-related comorbidities.",
              "recommendedDrugs": [
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6 mg",
                    "maintenanceDose": "3.0 mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks (medication assignment probability)",
                    "calculation": {
                      "method": "Linear adoption probability model",
                      "formula": "p(t) = min(1, p0 + 0.12 * t)",
                      "parameters": { "t": "Weeks", "p0": "Baseline medication assignment probability (0–1)" },
                      "expectedMeanChange": 0.50,
                      "standardDeviation": 0.18,
                      "targetValueRange": { "lowerBound": 0, "upperBound": 1 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:Metformin_use",
        "label": "Metformin (assignment)",
        "unit": "binary",
        "system": "METABOLIC_ENDO",
        "type": "exposure",
        "datasetHint": ["018-medications"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Prediabetes",
              "diagnosticCriteria": "Fasting glucose 5.6–6.9 mmol/L or OGTT 2h 7.8–11.0 mmol/L, high-risk population considering pharmacological intervention.",
              "recommendedDrugs": [
                {
                  "drugName": "Metformin",
                  "drugClass": "Biguanide/insulin sensitizer",
                  "dosage": {
                    "initialDose": "500 mg",
                    "maintenanceDose": "1500–2000 mg",
                    "frequency": "Twice daily (or extended-release once daily)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks (medication assignment probability)",
                    "calculation": {
                      "method": "Linear adoption probability model",
                      "formula": "p(t) = min(1, p0 + 0.20 * t)",
                      "parameters": { "t": "Weeks", "p0": "Baseline medication assignment probability (0–1)" },
                      "expectedMeanChange": 0.60,
                      "standardDeviation": 0.22,
                      "targetValueRange": { "lowerBound": 0, "upperBound": 1 }
                    }
                  },
                  "sideEffects": [
                    { "affectedNodeId": "RENAL:MetabolicAcid", "expectedTrend": "Risk increase" },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.60,
                      "standardDeviation": 0.25,
                      "unit": "a.u."
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Type 2 Diabetes",
              "diagnosticCriteria": "First-line medication indication clearly established (excluding contraindications).",
              "recommendedDrugs": [
                {
                  "drugName": "Metformin",
                  "drugClass": "Biguanide/insulin sensitizer",
                  "dosage": {
                    "initialDose": "500 mg",
                    "maintenanceDose": "2000 mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks (medication assignment probability)",
                    "calculation": {
                      "method": "Linear adoption probability model",
                      "formula": "p(t) = min(1, p0 + 0.18 * t)",
                      "parameters": { "t": "Weeks", "p0": "Baseline medication assignment probability (0–1)" },
                      "expectedMeanChange": 0.55,
                      "standardDeviation": 0.20,
                      "targetValueRange": { "lowerBound": 0, "upperBound": 1 }
                    }
                  },
                  "sideEffects": [
                    { "affectedNodeId": "RENAL:MetabolicAcid", "expectedTrend": "Risk increase" }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:SGLT2i_use",
        "label": "SGLT2 inhibitor (assignment)",
        "unit": "binary",
        "system": "METABOLIC_ENDO",
        "type": "exposure",
        "datasetHint": ["018-medications"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Type 2 Diabetes",
              "diagnosticCriteria": "Poor glycemic control or cardiovascular-renal risk, considering addition of SGLT2 inhibitor.",
              "recommendedDrugs": [
                {
                  "drugName": "Empagliflozin",
                  "drugClass": "SGLT2 inhibitor",
                  "dosage": {
                    "initialDose": "10 mg",
                    "maintenanceDose": "25 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks (medication assignment probability)",
                    "calculation": {
                      "method": "Linear adoption probability model",
                      "formula": "p(t) = min(1, p0 + 0.16 * t)",
                      "parameters": { "t": "Weeks", "p0": "Baseline medication assignment probability (0–1)" },
                      "expectedMeanChange": 0.55,
                      "standardDeviation": 0.18,
                      "targetValueRange": { "lowerBound": 0, "upperBound": 1 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.30,
                      "standardDeviation": 0.15,
                      "unit": "g/d"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Kidney Disease/Proteinuria",
              "diagnosticCriteria": "Elevated urinary protein (g/d) or UACR, eGFR allows medication use.",
              "recommendedDrugs": [
                {
                  "drugName": "Dapagliflozin",
                  "drugClass": "SGLT2 inhibitor",
                  "dosage": {
                    "initialDose": "10 mg",
                    "maintenanceDose": "10 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks (medication assignment probability)",
                    "calculation": {
                      "method": "Linear adoption probability model",
                      "formula": "p(t) = min(1, p0 + 0.14 * t)",
                      "parameters": { "t": "Weeks", "p0": "Baseline medication assignment probability (0–1)" },
                      "expectedMeanChange": 0.50,
                      "standardDeviation": 0.18,
                      "targetValueRange": { "lowerBound": 0, "upperBound": 1 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:Statin_use",
        "label": "Statin (assignment)",
        "unit": "binary",
        "system": "METABOLIC_ENDO",
        "type": "exposure",
        "datasetHint": ["018-medications"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Hypercholesterolemia",
              "diagnosticCriteria": "Non-HDL-C or LDL-C above target.",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin class",
                  "dosage": {
                    "initialDose": "20 mg",
                    "maintenanceDose": "20–40 mg",
                    "frequency": "Once daily (at bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks (medication assignment probability)",
                    "calculation": {
                      "method": "Linear adoption probability model",
                      "formula": "p(t) = min(1, p0 + 0.18 * t)",
                      "parameters": { "t": "Weeks", "p0": "Baseline medication assignment probability (0–1)" },
                      "expectedMeanChange": 0.55,
                      "standardDeviation": 0.20,
                      "targetValueRange": { "lowerBound": 0, "upperBound": 1 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.00,
                      "standardDeviation": 0.40,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:sdLDL",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10.0,
                      "standardDeviation": 4.0,
                      "unit": "%"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "ASCVD Secondary Prevention",
              "diagnosticCriteria": "Confirmed ASCVD requiring intensive lipid-lowering.",
              "recommendedDrugs": [
                {
                  "drugName": "Rosuvastatin",
                  "drugClass": "Statin class",
                  "dosage": {
                    "initialDose": "20 mg",
                    "maintenanceDose": "20–40 mg",
                    "frequency": "Once daily (at bedtime)",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks (medication assignment probability)",
                    "calculation": {
                      "method": "Linear adoption probability model",
                      "formula": "p(t) = min(1, p0 + 0.20 * t)",
                      "parameters": { "t": "Weeks", "p0": "Baseline medication assignment probability (0–1)" },
                      "expectedMeanChange": 0.60,
                      "standardDeviation": 0.20,
                      "targetValueRange": { "lowerBound": 0, "upperBound": 1 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:PCSK9i_use",
        "label": "PCSK9 inhibitor (assignment)",
        "unit": "binary",
        "system": "METABOLIC_ENDO",
        "type": "exposure",
        "datasetHint": ["018-medications"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Familial Hypercholesterolemia (or Very High Risk Not at Goal)",
              "diagnosticCriteria": "Maximum tolerated statin ± ezetimibe still not at goal.",
              "recommendedDrugs": [
                {
                  "drugName": "Evolocumab",
                  "drugClass": "PCSK9 inhibitor",
                  "dosage": {
                    "initialDose": "140 mg",
                    "maintenanceDose": "140 mg",
                    "frequency": "Every 2 weeks",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks (medication assignment probability)",
                    "calculation": {
                      "method": "Linear adoption probability model",
                      "formula": "p(t) = min(1, p0 + 0.15 * t)",
                      "parameters": { "t": "Weeks", "p0": "Baseline medication assignment probability (0–1)" },
                      "expectedMeanChange": 0.50,
                      "standardDeviation": 0.18,
                      "targetValueRange": { "lowerBound": 0, "upperBound": 1 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.50,
                      "standardDeviation": 0.50,
                      "unit": "mmol/L"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:sdLDL",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -15.0,
                      "standardDeviation": 6.0,
                      "unit": "%"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "ASCVD Very High Risk Not at Goal",
              "diagnosticCriteria": "Intensive statin therapy still not at goal.",
              "recommendedDrugs": [
                {
                  "drugName": "Alirocumab",
                  "drugClass": "PCSK9 inhibitor",
                  "dosage": {
                    "initialDose": "75 mg",
                    "maintenanceDose": "75–150 mg",
                    "frequency": "Every 2 weeks",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks (medication assignment probability)",
                    "calculation": {
                      "method": "Linear adoption probability model",
                      "formula": "p(t) = min(1, p0 + 0.14 * t)",
                      "parameters": { "t": "Weeks", "p0": "Baseline medication assignment probability (0–1)" },
                      "expectedMeanChange": 0.48,
                      "standardDeviation": 0.18,
                      "targetValueRange": { "lowerBound": 0, "upperBound": 1 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "RENAL:DietaryNa",
        "label": "Dietary sodium intake",
        "unit": "g/d",
        "system": "RENAL",
        "type": "state",
        "datasetHint": ["005-diet_logging", "055-lifestyle_and_environment"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Salt-Sensitive Hypertension",
              "diagnosticCriteria": "Sodium intake > 6 g/d, blood pressure sensitive to sodium intake changes (positive sodium loading test), commonly seen in hypertensive patients.",
              "recommendedDrugs": [
                {
                  "drugName": "Hydrochlorothiazide",
                  "drugClass": "Thiazide diuretic",
                  "dosage": {
                    "initialDose": "12.5mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Promotes sodium excretion (dietary sodium intake monitoring unchanged)",
                      "formula": "Sodium intake itself unchanged, but urinary sodium excretion increases",
                      "parameters": {
                        "t": "Weeks after medication initiation",
                        "note": "This indicator reflects dietary intake, medication does not change intake amount"
                      },
                      "expectedMeanChange": 0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 3,
                        "upperBound": 5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "unit": "mmol/L",
                      "note": "Using RENAL:Calcium as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "RENAL:UricAcid",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.8,
                      "standardDeviation": 0.4,
                      "unit": "mg/dL"
                    }
                  ]
                },
                {
                  "drugName": "Amiloride",
                  "drugClass": "Potassium-sparing diuretic",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "5-10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "2 weeks",
                    "calculation": {
                      "method": "Promotes sodium excretion",
                      "formula": "Sodium intake unchanged",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 3,
                        "upperBound": 5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.3,
                      "standardDeviation": 0.15,
                      "unit": "mmol/L",
                      "note": "Using RENAL:Calcium as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Kidney Disease",
              "diagnosticCriteria": "eGFR < 60 mL/min/1.73m2, high sodium intake aggravates kidney burden and proteinuria.",
              "recommendedDrugs": [
                {
                  "drugName": "Benazepril",
                  "drugClass": "ACEI antihypertensive drug",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10-20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Dietary sodium intake unchanged",
                      "formula": "Sodium intake itself unchanged",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 0,
                      "standardDeviation": 0,
                      "targetValueRange": {
                        "lowerBound": 3,
                        "upperBound": 5
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 5,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:ACR_cat",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -30,
                      "standardDeviation": 15,
                      "unit": "%",
                      "note": "Using RENAL:ACR_cat as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.25,
                      "standardDeviation": 0.12,
                      "unit": "mmol/L",
                      "note": "Using RENAL:Calcium as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Primary Hypertension",
              "diagnosticCriteria": "Multiple measurements in unmedicated state showing blood pressure ≥140/90 mmHg or abnormal ambulatory blood pressure; salt-sensitive patients often have high sodium intake.",
              "recommendedDrugs": [
                {
                  "drugName": "Potassium chloride salt substitute (reduced sodium, increased potassium)",
                  "dosage": {
                    "initialDose": "5 g",
                    "maintenanceDose": "Adjusted according to taste and nutritional guidance",
                    "frequency": "Same frequency as cooking/eating",
                    "route": "Oral/with meals"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–8 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (1.0 * (t / 8))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -1.0,
                      "standardDeviation": 0.5,
                      "targetValueRange": { "lowerBound": 3.0, "upperBound": 5.0 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:DietaryK",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.5,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3.0,
                      "standardDeviation": 1.5,
                      "unit": "mm[Hg]"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Heart Failure (Requiring Sodium Restriction)",
              "diagnosticCriteria": "Confirmed heart failure with tendency for fluid retention, recommended dietary sodium restriction.",
              "recommendedDrugs": [
                {
                  "drugName": "Potassium chloride salt substitute (auxiliary sodium restriction)",
                  "dosage": {
                    "initialDose": "3–5 g",
                    "maintenanceDose": "Individualized",
                    "frequency": "Same frequency as cooking/eating",
                    "route": "Oral/with meals"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–12 weeks",
                    "calculation": {
                      "method": "Linear decline",
                      "formula": "currentValue - (0.8 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": -0.80,
                      "standardDeviation": 0.4,
                      "targetValueRange": { "lowerBound": 3.0, "upperBound": 5.0 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:Steps",
        "label": "Steps per day",
        "unit": "count/d",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["055-lifestyle_and_environment"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Sedentary Lifestyle-Related Diseases",
              "diagnosticCriteria": "Daily steps < 5000, accompanied by metabolic syndrome, obesity, or cardiovascular disease risk factors.",
              "recommendedDrugs": [
                {
                  "drugName": "Metformin",
                  "drugClass": "Biguanide antidiabetic drug",
                  "dosage": {
                    "initialDose": "500mg",
                    "maintenanceDose": "1500mg",
                    "frequency": "2-3 times daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Behavioral indicator (medication does not directly change)",
                      "formula": "Requires combination with lifestyle intervention",
                      "parameters": {
                        "t": "Weeks after medication initiation",
                        "note": "Medication combined with exercise prescription can enhance activity level"
                      },
                      "expectedMeanChange": 500,
                      "standardDeviation": 800,
                      "targetValueRange": {
                        "lowerBound": 7000,
                        "upperBound": 10000
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.2,
                      "standardDeviation": 0.6,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.7,
                      "standardDeviation": 0.3,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    }
                  ]
                },
                {
                  "drugName": "Orlistat",
                  "drugClass": "Lipase inhibitor",
                  "dosage": {
                    "initialDose": "60mg",
                    "maintenanceDose": "120mg",
                    "frequency": "Three times daily with meals",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "16 weeks",
                    "calculation": {
                      "method": "Indirect promotion (combined with exercise prescription)",
                      "formula": "Requires lifestyle intervention",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 300,
                      "standardDeviation": 600,
                      "targetValueRange": {
                        "lowerBound": 7000,
                        "upperBound": 10000
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.5,
                      "standardDeviation": 1.0,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:sdLDL",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.3,
                      "standardDeviation": 0.15,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:sdLDL as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Type 2 Diabetes (Insufficient Activity Type)",
              "diagnosticCriteria": "HbA1c ≥ 6.5%, daily steps significantly below recommended level.",
              "recommendedDrugs": [
                {
                  "drugName": "Empagliflozin",
                  "drugClass": "SGLT2 inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Indirect improvement (increased vitality)",
                      "formula": "Glycemic control improvement may enhance activity capacity",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 800,
                      "standardDeviation": 1000,
                      "targetValueRange": {
                        "lowerBound": 7000,
                        "upperBound": 10000
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.8,
                      "standardDeviation": 0.3,
                      "unit": "%",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -2.0,
                      "standardDeviation": 0.8,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Osteoarthritis (Pain Limiting Activity)",
              "diagnosticCriteria": "Joint X-ray/clinical diagnosis confirmed, limited activity, reduced steps.",
              "recommendedDrugs": [
                {
                  "drugName": "Duloxetine",
                  "drugClass": "SNRIs (analgesic/antidepressant)",
                  "dosage": {
                    "initialDose": "30 mg",
                    "maintenanceDose": "60 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (2000 * (t / 4))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 2000,
                      "standardDeviation": 800,
                      "targetValueRange": { "lowerBound": 6000, "upperBound": 10000 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -4,
                      "standardDeviation": 2
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Depression (Decreased Activity)",
              "diagnosticCriteria": "PHQ-9 score indicating moderate or higher depression, reduced activity.",
              "recommendedDrugs": [
                {
                  "drugName": "Bupropion extended-release",
                  "drugClass": "NDRI antidepressant",
                  "dosage": {
                    "initialDose": "150 mg",
                    "maintenanceDose": "300 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "4–6 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (1500 * (t / 6))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 1500,
                      "standardDeviation": 600,
                      "targetValueRange": { "lowerBound": 6000, "upperBound": 10000 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -6,
                      "standardDeviation": 3
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:MVPA",
        "label": "Moderate-to-vigorous PA (min/d)",
        "unit": "min/d",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["055-lifestyle_and_environment"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "High Cardiovascular Disease Risk",
              "diagnosticCriteria": "Moderate-to-vigorous physical activity < 30 min/d, accompanied by hypertension, dyslipidemia, or obesity.",
              "recommendedDrugs": [
                {
                  "drugName": "Atorvastatin",
                  "drugClass": "Statin lipid-lowering drug",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "20mg",
                    "frequency": "Once daily at bedtime",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Behavioral indicator (requires combined exercise prescription)",
                      "formula": "Medication treatment combined with exercise intervention",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 5,
                      "standardDeviation": 8,
                      "targetValueRange": {
                        "lowerBound": 30,
                        "upperBound": 60
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:nonHDL_C",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -1.3,
                      "standardDeviation": 0.4,
                      "unit": "mmol/L",
                      "note": "Using METABOLIC_ENDO:nonHDL_C as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "CARDIO:hsCRP",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 10,
                      "standardDeviation": 8,
                      "unit": "U/L",
                      "note": "Using CARDIO:hsCRP as surrogate indicator"
                    }
                  ]
                },
                {
                  "drugName": "Enalapril",
                  "drugClass": "ACEI antihypertensive drug",
                  "dosage": {
                    "initialDose": "5mg",
                    "maintenanceDose": "10-20mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8 weeks",
                    "calculation": {
                      "method": "Exercise tolerance may improve",
                      "formula": "Exercise capacity improves after blood pressure control",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 8,
                      "standardDeviation": 10,
                      "targetValueRange": {
                        "lowerBound": 30,
                        "upperBound": 60
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -12,
                      "standardDeviation": 5,
                      "unit": "mm[Hg]"
                    },
                    {
                      "affectedNodeId": "RENAL:Calcium",
                      "expectedTrend": "Increase",
                      "expectedMeanChange": 0.2,
                      "standardDeviation": 0.1,
                      "unit": "mmol/L",
                      "note": "Using RENAL:Calcium as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Obesity (Insufficient Activity Type)",
              "diagnosticCriteria": "BMI ≥ 28 kg/m2, MVPA significantly insufficient (< 15 min/d).",
              "recommendedDrugs": [
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6mg",
                    "maintenanceDose": "1.8mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous injection"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "16 weeks",
                    "calculation": {
                      "method": "Activity capacity improves after weight loss",
                      "formula": "Indirectly promotes increased exercise volume",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 12,
                      "standardDeviation": 15,
                      "targetValueRange": {
                        "lowerBound": 30,
                        "upperBound": 60
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:WC",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3.2,
                      "standardDeviation": 1.3,
                      "unit": "kg/m2",
                      "note": "Using METABOLIC_ENDO:WC as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.9,
                      "standardDeviation": 0.4,
                      "unit": "%",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Obesity/Low Physical Activity",
              "diagnosticCriteria": "Physical activity monitoring indicates MVPA insufficient (<30 min/d), combined with overweight/obesity.",
              "recommendedDrugs": [
                {
                  "drugName": "Liraglutide",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.6 mg",
                    "maintenanceDose": "3.0 mg",
                    "frequency": "Once daily",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (20 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 20,
                      "standardDeviation": 8,
                      "targetValueRange": { "lowerBound": 30, "upperBound": 60 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.30,
                      "standardDeviation": 0.15,
                      "unit": "a.u."
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Depression",
              "diagnosticCriteria": "PHQ-9 indicates depression, reduced activity.",
              "recommendedDrugs": [
                {
                  "drugName": "Sertraline",
                  "drugClass": "SSRI antidepressant",
                  "dosage": {
                    "initialDose": "50 mg",
                    "maintenanceDose": "50–100 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8–12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (10 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 10,
                      "standardDeviation": 6,
                      "targetValueRange": { "lowerBound": 30, "upperBound": 60 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "NEURO:PHQ9",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -5,
                      "standardDeviation": 3
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    },
    {
      "indicatorNode": {
        "nodeId": "METABOLIC_ENDO:VO2max",
        "label": "Cardiorespiratory fitness (VO2max)",
        "unit": "mL/kg/min",
        "system": "METABOLIC_ENDO",
        "type": "state",
        "datasetHint": ["exercise_testing"],
        "subIndicators": {
          "potentialDiseases": [
            {
              "diseaseName": "Low Cardiopulmonary Function",
              "diagnosticCriteria": "VO2max < 25 mL/kg/min (male) or < 20 mL/kg/min (female), significantly increased risk of cardiovascular disease and all-cause mortality.",
              "recommendedDrugs": [
                {
                  "drugName": "Carvedilol",
                  "drugClass": "Beta-blocker",
                  "dosage": {
                    "initialDose": "6.25mg",
                    "maintenanceDose": "25mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Exercise capacity improves after cardiac function improvement",
                      "formula": "currentValue + (3 * log(t + 1) / log(13))",
                      "parameters": {
                        "t": "Weeks after medication initiation",
                        "note": "Applicable to heart failure patients"
                      },
                      "expectedMeanChange": 3,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 25,
                        "upperBound": 40
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:HRV_RMSSD",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -10,
                      "standardDeviation": 5,
                      "unit": "bpm",
                      "note": "Using CARDIO:HRV_RMSSD as surrogate indicator"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -8,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Trimetazidine",
                  "drugClass": "Cardiac metabolic modulator",
                  "dosage": {
                    "initialDose": "35mg",
                    "maintenanceDose": "35mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "8 weeks",
                    "calculation": {
                      "method": "Improves myocardial energy metabolism",
                      "formula": "currentValue + (2.5 * (t / 8))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 2.5,
                      "standardDeviation": 1.5,
                      "targetValueRange": {
                        "lowerBound": 25,
                        "upperBound": 40
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 3,
                      "standardDeviation": 2,
                      "unit": "%"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Chronic Heart Failure",
              "diagnosticCriteria": "LVEF < 40%, VO2max significantly decreased (< 15 mL/kg/min), reduced exercise tolerance.",
              "recommendedDrugs": [
                {
                  "drugName": "Sacubitril/Valsartan",
                  "drugClass": "ARNI (Angiotensin Receptor-Neprilysin Inhibitor)",
                  "dosage": {
                    "initialDose": "50mg",
                    "maintenanceDose": "200mg",
                    "frequency": "Twice daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "16 weeks",
                    "calculation": {
                      "method": "Cardiac function improvement",
                      "formula": "currentValue + (4 * log(t + 1) / log(17))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 4,
                      "standardDeviation": 2.5,
                      "targetValueRange": {
                        "lowerBound": 15,
                        "upperBound": 25
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -150,
                      "standardDeviation": 80,
                      "unit": "pg/mL"
                    },
                    {
                      "affectedNodeId": "CARDIO:LVEF",
                      "expectedTrend": "Improvement",
                      "expectedMeanChange": 5,
                      "standardDeviation": 3,
                      "unit": "%"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -7,
                      "standardDeviation": 4,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Dapagliflozin",
                  "drugClass": "SGLT2 inhibitor",
                  "dosage": {
                    "initialDose": "10mg",
                    "maintenanceDose": "10mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Improves cardiopulmonary function",
                      "formula": "currentValue + (3.5 * log(t + 1) / log(13))",
                      "parameters": {
                        "t": "Weeks after medication initiation"
                      },
                      "expectedMeanChange": 3.5,
                      "standardDeviation": 2,
                      "targetValueRange": {
                        "lowerBound": 15,
                        "upperBound": 25
                      }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "CARDIO:BNP",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -100,
                      "standardDeviation": 60,
                      "unit": "pg/mL"
                    },
                    {
                      "affectedNodeId": "METABOLIC_ENDO:TyG",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.4,
                      "standardDeviation": 0.2,
                      "unit": "%",
                      "note": "Using METABOLIC_ENDO:TyG as surrogate indicator"
                    }
                  ]
                }
              ]
            },
            {
              "diseaseName": "Heart Failure (Preserved or Reduced Ejection Fraction)",
              "diagnosticCriteria": "Confirmed heart failure diagnosis, decreased exercise endurance (low VO2max).",
              "recommendedDrugs": [
                {
                  "drugName": "Dapagliflozin",
                  "drugClass": "SGLT2 inhibitor",
                  "dosage": {
                    "initialDose": "10 mg",
                    "maintenanceDose": "10 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (2.0 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 2.0,
                      "standardDeviation": 0.8,
                      "targetValueRange": { "lowerBound": 30, "upperBound": 50 }
                    }
                  },
                  "sideEffects": [
                    {
                      "affectedNodeId": "RENAL:Proteinuria_gd",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -0.20,
                      "standardDeviation": 0.10,
                      "unit": "g/d"
                    },
                    {
                      "affectedNodeId": "CARDIO:SBP_day",
                      "expectedTrend": "Decrease",
                      "expectedMeanChange": -3.0,
                      "standardDeviation": 1.5,
                      "unit": "mm[Hg]"
                    }
                  ]
                },
                {
                  "drugName": "Benazepril",
                  "drugClass": "ACEI",
                  "dosage": {
                    "initialDose": "10 mg",
                    "maintenanceDose": "20 mg",
                    "frequency": "Once daily",
                    "route": "Oral"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Linear increase",
                      "formula": "currentValue + (1.0 * (t / 12))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 1.0,
                      "standardDeviation": 0.6,
                      "targetValueRange": { "lowerBound": 30, "upperBound": 50 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            },
            {
              "diseaseName": "Obesity-related Low Fitness",
              "diagnosticCriteria": "Excessive weight/fat mass and VO2max below same-age reference.",
              "recommendedDrugs": [
                {
                  "drugName": "Semaglutide (weekly formulation)",
                  "drugClass": "GLP-1 receptor agonist",
                  "dosage": {
                    "initialDose": "0.25 mg",
                    "maintenanceDose": "0.5–1.0 mg",
                    "frequency": "Once weekly",
                    "route": "Subcutaneous"
                  },
                  "expectedIndicatorChange": {
                    "timeframe": "12 weeks",
                    "calculation": {
                      "method": "Logarithmic model",
                      "formula": "currentValue + (1.5 * log(t + 1))",
                      "parameters": { "t": "Weeks" },
                      "expectedMeanChange": 1.5,
                      "standardDeviation": 0.7,
                      "targetValueRange": { "lowerBound": 30, "upperBound": 50 }
                    }
                  },
                  "sideEffects": []
                }
              ]
            }
          ]
        }
      }
    }
  ]
}